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1 SUMMARY – ZUSAMMENFASSUNG 
Summary 
Eukaryotic cell growth is tightly linked to the synthesis of new ribosomes, the molecular 
machineries responsible for protein production. The transcription of a ribosomal precursor RNA 
(pre-rRNA) by RNA polymerase I (Pol I) constitutes an initial and central step in the complex process 
of ribosome biogenesis and is therefore one of the main targets for regulation. The initiation of 
each round of transcription is dependent on the formation of a complex between Pol I and the 
essential transcription factor Rrn3p. Subsequent processing of this precursor transcript yields three 
of the four mature ribosomal RNAs (rRNAs) forming a scaffold to which ribosomal proteins 
(r-proteins/RPs) assemble in the course of ribosome maturation.  
Since ribosome biogenesis is one of the most energy-consuming cellular processes, eukaryotic cells 
cease the production of ribosomes very rapidly upon unfavorable growth conditions like nutrient 
deprivation in order to ensure survival. The conserved target of rapamycin (TOR)-pathway plays an 
essential role in both sensing environmental changes and mediating adequate cellular responses. 
Inhibition of TOR complex 1 (TORC1) induces an immediate drop in the synthesis rate of ribosomes. 
It was previously suggested that TOR inactivation interferes with ribosome synthesis in many ways, 
but it was unclear whether and how these processes are coordinated.  
To distinguish between primary and secondary effects on ribosome biogenesis in the yeast 
Saccharomyces cerevisiae and to determine the target mediating the fast response to TOR 
inactivation, Pol I transcription and rRNA synthesis were investigated shortly after TOR inhibition by 
rapamycin. This drug mimics nutrient starvation of cells by specifically inactivating the kinase 
activity of TORC1. The following conclusions could be drawn:  
1) A rather long-term response constitutes the decrease in the level of Rrn3p leading to less 
initiation-competent Pol I-Rrn3p complex formation and thus reduced Pol I transcription. Rrn3p is 
characterized by a short half-life which is due to its constitutive ubiquitin-dependent degradation. 
Consequently, the level of Rrn3p is quickly down-regulated when the neo-synthesis of the protein 
is inhibited.  
2) The fast down-regulation of mature rRNA synthesis correlates with serious pre-rRNA processing 
defects and subsequent RNA degradation, but not with the inhibition of Pol I transcription, since 
the association of Pol I with the rRNA gene locus is yet unaltered and the Pol I molecules engaged 
in transcription are still mobile.  
3) The quick down-regulation of r-protein synthesis is sufficient to explain the severe pre-rRNA 
processing defects. The strong decrease in general translation, presumably along with the 
specifically reduced transcription rate of ribosomal protein genes, seems to cause the drastic 
repression of r-protein production.  
 
Since the level of Rrn3p appears to play a crucial role in Pol I transcription in yeast, this issue was 
investigated in more detail. Interestingly, already scarce amounts of Rrn3p are sufficient to 
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promote Pol I transcription and cell growth, whereas strong overexpression of this factor results in 
growth defects. Elevated levels of Rrn3p lead to enhanced Pol I-Rrn3p complex formation, 
however, the question whether the growth defect is caused by the concomitantly observed 
increase in pre-rRNA-levels remains to be elucidated.  
 
Finally, Pol5p, which was published to play an essential role in the synthesis of ribosomal RNA in 
yeast, co-purified with Rrn3p through several purification steps suggesting an interaction between 
the two proteins. However, further experiments provided only weak additional evidence for Pol5p 
as a genuine interaction partner of Rrn3p and failed to confirm the reported association of this 
protein with the rRNA gene locus. Therefore, further investigation is required to elucidate the role 
of Pol5p in ribosome biogenesis.  
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Zusammenfassung 
Das Wachstum eukaryotischer Zellen ist stark abhängig von der Synthese neuer Ribosomen, den 
molekularen Maschinerien, die für die Herstellung von Proteinen verantwortlich sind. Die 
Transkription einer ribosomalen Vorläufer-RNA (Prä-rRNA) durch die RNA Polymerase I (Pol I) stellt 
einen initialen und zentralen Schritt im komplizierten Prozess der Ribosomen-Biogenese dar und 
ist dadurch einer der Hauptangriffspunkte regulatorischer Vorgänge. Die Initiation jeder 
Transkriptionsrunde ist abhängig von der Komplexbildung zwischen Pol I und dem essenziellen 
Transkriptionsfaktor Rrn3p. Durch die anschließende Prozessierung dieses Vorläufer-Transkripts 
entstehen drei der vier reifen ribosomalen RNAs (rRNAs), die als Gerüst dienen, an welches die 
ribosomalen Proteine (r-Proteine/RPs) im Zuge der Ribosomen-Reifung assemblieren.  
Da die Ribosomen-Biogenese einer der zellulären Prozesse ist, die am meisten Energie 
verbrauchen, stoppen eukaryotische Zellen die Ribosomen-Produktion sehr schnell bei 
ungünstigen Wachstumsbedingungen wie Nährstoffmangel, um ihr Überleben zu sichern. Der 
konservierte „target of rapamycin“ (TOR)-Signalweg spielt sowohl bei der Wahrnehmung von 
Umweltveränderungen als auch bei der Einleitung entsprechender Zellantworten eine 
entscheidende Rolle. Die Inhibierung des TOR-Komplex 1 (TORK1) induziert einen sofortigen Abfall 
in der Syntheserate von Ribosomen. Es ist zwar bekannt, dass die Inaktivierung des TOR-
Signalwegs die Ribosomen-Biogenese auf mehreren Ebenen stört, doch ob und wie diese Prozesse 
koordiniert werden, ist unklar.  
Um zwischen primären und sekundären Effekten auf die Ribosomen-Biogenese der Hefe 
Saccharomyces cerevisiae unterscheiden zu können, und um aufzuklären, was die schnelle 
Zellantwort auf die Inaktivierung des TOR-Signalwegs auslöst, wurde die Pol I-Transkription und 
die rRNA-Synthese kurz nach der Inhibierung des TOR-Signalwegs durch Rapamycin untersucht. 
Dieser Wirkstoff simuliert eine Nährstoffmangel-Situation für die Zellen, indem er spezifisch die 
Kinase-Aktivität von TORK1 inaktiviert. Die folgenden Schlussfolgerungen konnten gezogen 
werden:  
1) Eine relativ langfristige Art der Regulation stellt das Absinken des Rrn3p-Niveaus dar, das zu 
einer verringerten Bildung an initiations-kompetenten Pol I-Rrn3p-Komplexen und dadurch zu 
einer reduzierten Pol I-Transkriptionsrate führt. Da Rrn3p aufgrund seines konstitutiven ubiquitin-
abhängigen Abbaus eine kurze Halbwertszeit aufweist, wird das Rrn3p-Niveau schnell 
herunterreguliert, wenn die Neusynthese des Proteins inhibiert wird.  
2) Der schnelle Rückgang in der Produktion an reifen rRNAs korreliert mit schwerwiegenden 
Defekten in der Prozessierung der Prä-rRNAs und deren anschließendem Abbau, nicht aber mit der 
Inhibierung der Pol I-Transkription, da noch keine Änderungen in der Assoziation von Pol I mit dem 
rRNA-Gen-Lokus detektierbar sind und die transkribierenden Pol I-Moleküle sich noch bewegen.  
3) Allein der schnelle Rückgang in der Produktion von ribosomalen Proteinen reicht aus, um die 
erheblichen Defekte in der Prozessierung von Prä-rRNAs zu erklären. Das starke Absinken der 
Translationsrate, wahrscheinlich zusammen mit der reduzierten Transkriptionsrate spezifisch von 
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ribosomalen Proteinen, scheint dem drastischen Rückgang in der Produktion von r-Proteinen zu 
Grunde zu liegen.  
 
Da das Rrn3p-Niveau eine entscheidende Rolle in der Pol I-Transkription der Hefe zu spielen 
scheint, wurde dieser Sachverhalt genauer untersucht. Interessanterweise reichen schon geringe 
Mengen an Rrn3p aus, um die Pol I-Transkription und das Zellwachstum aufrechtzuerhalten, 
wohingegen eine starke Überexpression dieses Faktors zu Wachstumsdefekten führt. Erhöhte 
Mengen an Rrn3p bewirken verstärkte Pol I-Rrn3p-Komplexbildung. Die Frage jedoch, ob der 
Wachstumsdefekt durch den gleichzeitig detektierten Anstieg im Prä-rRNA-Niveau herrührt, bleibt 
noch zu klären.  
 
Schließlich ließ sich Pol5p, dem eine essentielle Rolle in der Synthese von ribosomaler RNA in der 
Hefe zugeschrieben wird, zusammen mit Rrn3p über verschiedene Reinigungsschritte anreichern, 
was auf eine mögliche Interaktion dieser beiden Proteine hindeutet. Weitere Experimente lieferten 
jedoch nur schwache zusätzliche Hinweise für Pol5p als echten Interaktionspartner von Rrn3p und 
konnten zudem die beschriebene Assoziation dieses Faktors mit dem rRNA-Gen-Lokus nicht 
bestätigen. Daher sind weitere Untersuchungen nötig, um die Rolle von Pol5p in der Ribosomen-
Biogenese zu klären.  
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2 INTRODUCTION 
2.1 Ribosome biogenesis and cell growth 
The ability of cells to produce large amounts of proteins is indispensable for growth and 
proliferation, since proteins are required for almost every cellular process. Ribosomes are the 
molecular factories that carry out protein synthesis by translating the genetic code into the poly 
amino acid chains of proteins. Therefore, synthesis of ribosomes is one of the most important tasks 
of a growing cell (Rudra and Warner, 2004; Lempiäinen and Shore, 2009).  
The eukaryotic ribosome is a ribonucleoprotein particle (RNP) consisting of two different subunits, 
the 40S small ribosomal subunit (SSU) and the 60S large ribosomal subunit (LSU) (Wilson and 
Nierhaus, 2003). These subunits in turn are comprised of four ribosomal RNA (rRNA) species and 79 
ribosomal proteins (r-proteins/RPs). In yeast [mammals], the small ribosomal subunit is composed 
of the 18S rRNA and 33 r-proteins (rpS – ribosomal protein small subunit), whereas the 25S [28S], 
5.8S and 5S rRNA along with 46 [49] r-proteins (rpL – ribosomal protein large subunit) form the 
large ribosomal subunit (Planta and Mager, 1998; Gerbasi et al., 2004; Moss et al., 2007).  
Ribosome biogenesis requires the coordinated activity of all three nuclear RNA polymerases 
present in eukaryotic cells. A specialized RNA polymerase, RNA polymerase I (Pol I), is exclusively 
responsible for the transcription of a 35S [47S] precursor rRNA which is subsequently processed 
into the mature 18S, 5.8S and 25S [28S] rRNA species (see section 2.2). The transcription of the 
genes coding for ribosomal proteins is dependent on the activity of RNA polymerase II (Pol II), 
whereas the 5S rRNA gene is transcribed by RNA polymerase III (Pol III). In addition to the RNA and 
protein components of the ribosome itself, over 150 trans-acting ribosome biogenesis factors and 
about 100 small nucleolar RNAs (snoRNAs) participate in the complex maturation pathway of 
ribosomes (Figure 1) (Kressler et al., 1999; Venema and Tollervey, 1999; Fatica and Tollervey, 2002; 
Tschochner and Hurt, 2003).  
Logarithmically growing cells of the budding yeast Saccharomyces cerevisiae harbor roughly 
200000 ribosomes. Considering a generation time of 100 min, each cell has to produce 2000 
ribosomes per min, thereby consuming a huge part of the cell´s energy. Strikingly, 60% of total 
transcription is devoted to ribosomal RNA and 50% of the RNA polymerase II-mediated 
transcription initiation events involve ribosomal protein genes (Warner, 1999). Hence, a precise and 
quick regulation of ribosome biogenesis in response to environmental changes is essential for the 
cell in order to avoid the waste of valuable resources. The target of rapamycin (TOR) (see section 
2.3) and the protein kinase A (PKA) pathway are examples for signal transduction pathways that 
positively and/or negatively influence the ribosome biogenesis machinery and in turn cell growth 
with respect to the availability of nutrients, growth factors, carbon or nitrogen, respectively (Klein 
and Struhl, 1994; Thomas and Hall, 1997; Powers and Walter, 1999; Warner, 1999; Rudra and 
Warner, 2004).  
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Figure 1. Overview of ribosome biogenesis in Saccharomyces cerevisiae.  
The 35S pre-rRNA is assembled into the pre-90S particle which is separated into the pre-60S and the pre-40S particle 
upon cleavage of its rRNA component. During serveral maturation steps, these precursor particles are further processed 
into the mature 60S and 40S ribosomal subunits consisting finally of 4 rRNA species and 79 ribosomal proteins. More than 
150 ribosome biogenesis factors and about 100 snoRNAs are transiently involved in this complex process. [from 
(Tschochner and Hurt, 2003)] 
 
2.2 RNA polymerase I transcription in eukaryotes 
2.2.1 Structure of ribosomal RNA genes 
In eukaryotic cells, the synthesis of ribosomal RNAs is spatially restricted to a specialized 
compartment of the nucleus, the nucleolus, which is morphologically composed of the fibrillar 
centre, the dense fibrillar component and the granular component (Léger-Silvestre et al., 1999). 
Here, each cell of the yeast Saccharomyces cerevisiae holds about 100-140 copies of the genes 
coding for ribosomal RNA which are located in a tandemly repeated manner on chromosome XII 
(Schweizer et al., 1969; Petes, 1979). Mammalian cells contain 200-300 copies of ribosomal RNA 
genes per haploid genome which exist as direct repeats on the five acrocentric chromosomes 
(Henderson et al., 1972). Each of these sites has the potential to form a nucleolus and is hence 
referred to as a nucleolar organizer region (NOR). However, it was shown that in both lower and 
higher eukaryotes only about 50% of the chromosomal rDNA repeats are actively transcribed at 
any given time, whereas the other half of the rDNA genes is transcriptionally inactive (Conconi et 
al., 1989; Dammann et al., 1993; Moss, 2004).  
In yeast, three of the four rRNAs, encoded by one 9.1 kb rDNA repeat, are transcribed by RNA 
polymerase I as a single polycistronic precursor, the 35S pre-rRNA. This transcript contains the 
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mature rRNA sequences (18S, 5.8S and 25S), separated by the two internal transcribed spacers ITS1 
and ITS2, and flanked by the two external transcribed spacers 5' ETS and 3' ETS. The remaining part 
of the rDNA unit is formed by the two non-transcribed spacers NTS1 and NTS2, separated by the 5S 
rRNA gene which is transcribed by RNA polymerase III in the opposite direction as the 35S rRNA 
gene (Figure 2). The 35S pre-rRNA is cleaved at the indicated sites (A0 – E) in the course of 
subsequent processing and maturation steps to yield the mature rRNA species (see section 2.2.4) 
(Venema and Tollervey, 1999).  
 
 
Figure 2. The basic organization of an rDNA repeat unit of Saccharomyces cerevisiae.  
The yeast 9.1 kb rDNA unit consists of the 35S pre-rRNA operon and the two non-transcribed spacers NTS1 and NTS2, 
interrupted by the 5S rRNA gene. The 35S pre-rRNA contains the sequences for the mature 18S, 5.8S and 25S rRNAs, 
separated by the two internal transcribed spacers ITS1 and ITS2, and flanked by the two external transcribed spacers 
5' ETS and 3' ETS. The locations of the known processing sites are indicated. (Pr: promoter, Tr: terminator, En: enhancer) 
[from (Kressler et al., 1999)] 
 
The yeast Saccharomyces cerevisiae is the only known exception among eukaryotes, in which the 5S 
genes are linked to the rRNA genes and hence must necessarily be transcribed in the nucleolus. In 
mammalian cells, the 5S rRNA genes are transcribed from a different chromosomal location than 
the precursor transcripts containing the sequences of the mature 18S, 5.8S and 28S rRNAs and thus 
need to be imported into the nucleolus (Moss et al., 2007). However, the 47S pre-rRNA, transcribed 
from one 43 kb rDNA repeat, is subsequently processed to yield the mature rRNAs in a way very 
similar to that in yeast.  
 
2.2.2 Subunit composition of RNA polymerase I 
The yeast enzyme RNA polymerase I has a molecular weight of 590 kDa and is a multi-protein 
complex consisting of 10 different core-subunits and 4 different additional subunits (Carles et al., 
1991; Carles and Riva, 1998; Kuhn et al., 2007). Their designation in the common Pol I nomenclature 
is composed of the letter A, B and/or C indicating the appearance of the subunit in RNA 
polymerase I, II and/or III, respectively, and of a number denoting the respective molecular weight 
in kDa as determined by SDS-PAGE (Table 1).  
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Five of the subunits, ABC27, ABC23, ABC14.5, ABC10β and ABC10α, are identical in all three nuclear 
polymerases (Carles et al., 1991). The two large subunits A190 and A135, comprising the active 
center of the enzyme, are unique to RNA polymerase I but contain regions homologous to the Pol II 
subunits Rpb1p and Rpb2p, respectively (Mémet et al., 1988). Furthermore, the two subunits AC40 
and AC19 are common in Pol I and Pol III and share homologies with Rpb3p and Rpb11p, the 
corresponding subunits of RNA polymerase II (Lalo et al., 1993). The subunits A14 and A43 form a 
heterodimer which is distantly related to Rpb4p/Rpb7p in Pol II and Rpc17p/Rpc25p in Pol III 
(Peyroche et al., 2002; Geiger et al., 2008). A43 plays an important role in transcription initiation, 
since the basal transcription factor Rrn3p recruits RNA polymerase I to the promoter via this 
subunit (see section 2.2.3) (Milkereit and Tschochner, 1998; Peyroche et al., 2000). Subunit A12.2 is 
homologous to subunit Rpb9p in Pol II and Rpc11p in Pol III. Additionally, its C-terminal domain is 
related to the Pol II transcript cleavage factor TFIIS. This subunit indeed confers intrinsic RNA 
cleavage activity which is supposed both to enable rRNA proofreading and to play a major part in 
its role in efficient transcription termination (Prescott et al., 2004; Kuhn et al., 2007). No 
counterparts in other polymerases have been found for subunits A49 and A34.5. However, local 
homologies were detected between these two and the Pol II-associated factors TFIIF and TFIIE. It 
was shown that these subunits form a TFIIF-like heterodimer which provides a built-in elongation 
factor for RNA polymerase I (Kuhn et al., 2007; Geiger et al., 2010).  
 
Yeast Mammal/Human 
Pol I subunit gene locus in Pol(s) Pol I subunit orthologue 
A190 RPA190 I hRPA190 (A190, A194) 
A135 RPA135 I hRPA135 (A127) 
A49 RPA49 I hRPA49 (hPAF53) 
A43 RPA43 I hRPA43 (A43, TWIST neighbor) 
AC40 RPA40 I, III hRPA40 (AC40, hRPA5) 
A34.5 RPA34.5 I hRPA34.5 (hPAF49, CAST, ASE-1) 
ABC27 RPB5 I, II, III hRPB5 
ABC23 RPB6 I, II, III hRPB6 
AC19 RPA19 I, III hRPA19 (AC19) 
ABC14.5 RPB8 I, II, III hRPB8 
A14 RPA14 I - 
A12.2 RPA12.2 I hRPA12.2 
ABC10β RPB10 I, II, III hRPB10 
ABC10α RPB12 I, II, III hRPB12 
Table 1. The 14 Pol I subunits of Saccharomyces cerevisiae and their mammalian/human orthologues.  
See text for further explanation. [from (Panov et al., 2006b), modified] 
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Of all the 14 Pol I subunits in yeast, just four are not essential for cell growth, which are: A34.5, A49, 
A14 and A12.2. The respective deletion of the last three, however, leads to growth defects 
(Liljelund et al., 1992; Nogi et al., 1993; Smid et al., 1995).  
There are mammalian orthologues for all but yeast RNA Pol I subunit A14 (Table 1) (Panov et al., 
2006b), indicating that the yeast enzyme constitutes a good model for studying eukaryotic RNA 
polymerase I.  
 
2.2.3 RNA polymerase I transcription factors and their function 
In all eukaryotes from yeast to mammals, the DNA elements directing Pol I transcription are very 
similar. The promoter region of each rDNA repeat unit consists of two cis elements: the upstream 
(control) element (UE/UCE) and the core element (CE/Core) (Figure 3 and Figure 4). The core 
element, mapped from about -40 to +8 relative to the transcription start site, is essential for both 
basal levels of transcription and accurate transcription initiation, whereas the upstream element, 
mapped from about -150 to -40 relative to the start site, is required for a high level of transcription, 
but is dispensable for transcription initiation in vitro. Interestingly, the maintenance of correct 
spacing between the two elements is critical (Musters et al., 1989; Kulkens et al., 1991; Choe et al., 
1992; Paule, 1998). The terminator region in the 3' ETS of each rDNA repeat unit is characterized by 
the presence of a T-rich element and a further downstream binding site for a sequence-specific 
protein (Mason et al., 1997; Reeder and Lang, 1998).  
 
 
Figure 3. The RNA polymerase I initiation complex in Saccharomyces cerevisiae.  
The upstream activating factor (UAF), consisting of 6 subunits, and the core factor (CF), consisting of 3 subunits, bind to 
the upstream element (UE) or the core element (Core), respectively, two characteristic features within the rDNA promoter 
region. The TATA-binding protein (TBP) forms a bridge between the two transcription factors thereby stabilizing this 
platform provided for the binding of RNA polymerase I. Pol I is recruited to the promoter via the essential transcription 
initiation factor Rrn3p interacting both with CF subunit Rrn6p and Pol I subunit A43. Binding of the HMG-box protein 
Hmo1p throughout the rRNA genes is required for efficient rDNA transcription. [from (Moss et al., 2007), modified] 
 
In yeast, transcription initiation involves the coordinated interactions of at least four transcription 
factors with these promoter elements and RNA polymerase I: the upstream activating factor (UAF) 
(Keys et al., 1996; Keener et al., 1997), the core factor (CF) (Keys et al., 1994; Lalo et al., 1996; Lin et 
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al., 1996), the TATA-binding protein (TBP) (Steffan et al., 1996, 1998) and Rrn3p (Yamamoto et al., 
1996) (Figure 3).  
The CF is a multi-subunit complex consisting of the three proteins Rrn6p, Rrn7p and Rrn11p which 
are all essential in vivo. It binds to the Core and is able to direct a basal level of Pol I transcription. 
The UAF, which interacts with the UE, constitutes a complex of six proteins including the four non-
essential subunits Rrn5p, Rrn9p, Rrn10p and Uaf30p and the two histones H3 and H4. Contrary to 
the CF, the UAF is not absolutely required for specific initiation, but stimulates transcription by 
efficiently recruiting the CF to the promoter. The TBP, which interacts both with CF via Rrn6p and 
UAF via Rrn9p, appears to be necessary only for the UAF-dependent recruitment of the CF. In order 
to gain competence for initiation, RNA polymerase I forms a stable complex with the transcription 
initiation factor Rrn3p via its subunit A43. Rrn3p is crucial for recruiting the enzyme to the 
promoter by providing a bridge to the CF subunit Rrn6p. After transcription initiation, both TBP 
and CF dissociate from the promoter while UAF remains behind. Similarly, Rrn3p is released both 
from the promoter and the elongating form of RNA polymerase I. Pol I subunit A49 appears to play 
a crucial role in both the formation of the Pol I-Rrn3p complex and its subsequent dissociation 
(Milkereit and Tschochner, 1998; Peyroche et al., 2000; Aprikian et al., 2001; Bier et al., 2004; 
Beckouet et al., 2008).  
Furthermore, binding of the factor Hmo1p throughout the complete rRNA gene locus is a 
prerequisite for efficient RNA Pol I transcription (Gadal et al., 2002). Since this high mobility group 
(HMG)-box protein is reported not only to associate with rRNA genes but also with many 
promoters of RP genes, it is speculated that it might function in coordinating the transcription of 
ribosomal RNA and ribosomal protein genes (Hall et al., 2006). Besides Hmo1p, other proteins are 
reported to play a role in efficient Pol I transcription elongation in yeast. For instance, the 
enzymatic activity of Fcp1p, a phosphatase originally described to be involved in Pol II transcription 
elongation, is likewise involved in the Pol I system (Fath et al., 2004). Similar results were obtained 
for Spt4p and Spt5p. This heterodimer influences both Pol II and Pol I transcription elongation. 
Deletion of the non-essential gene for Spt4p leads also to clear defects in pre-rRNA processing, 
indicating that transcription and processing are intimately linked (Schneider et al., 2006). RNA 
polymerase-associated factor 1 complex (Paf1C), a complex composed of five subunits, was 
recently shown to promote Pol I transcription through the rDNA by increasing the net rate of 
elongation (Zhang et al., 2009, 2010). Additionally, Net1p, which forms the regulator of nucleolar 
silencing and telophase exit (RENT) complex along with at least Cdc14p and Sir2p, was described to 
mediate high rates of Pol I transcription besides its roles in controlling mitotic exit and diverse 
other nucleolar processes (Shou et al., 2001). Another example for factors involved in the 
regulation of Pol I transcription elongation is Ctk1p, the kinase subunit of a complex described to 
participate in the regulation of mRNA synthesis by Pol II (Bouchoux et al., 2004).  
Results from in vitro studies suggest that accurate Pol I transcription termination in yeast depends 
on the binding of the essential protein Reb1p to its target sequence within the terminator region 
which forces the polymerase to pause. This, along with the weak base pairing between template 
DNA and RNA transcript within the T-rich element, leads to the release of both the polymerase and 
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the transcript from the DNA template (Lang et al., 1994; Lang and Reeder, 1995). It was further 
shown that Pol I depends on an additional factor to release terminated transcripts from the 
template (Tschochne and Milkereit, 1997). In an alternative model of transcription termination in 
yeast, co-transcriptional cleavage of the pre-rRNA by the endonuclease Rnt1p is proposed to 
generate a loading site for the exonuclease Rat1p which degrades the nascent transcript from the 
5' end and finally torpedoes the polymerase (El Hage et al., 2008; Kawauchi et al., 2008; Braglia et 
al., 2010).  
Although distinct functional similarities between the yeast and the mammalian Pol I transcription 
system are obvious, there are nevertheless certain differences regarding the factors involved.  
 
 
Figure 4. The RNA polymerase I initiation complex in mammals.  
The upstream binding factor (UBF) binds probably as a dimer both to the upstream control element (UCE) and the core 
element (Core) and creates a situation propitious for selectivity factor 1 (SL1)/transcription initiation factor IB (TIF-IB), 
consisting of at least 4 subunits, to bind and to form a stable pre-initiation complex. Pol I recruitment is accomplished by 
the human RRN3 (hRRN3)/transcription initiation factor IA (TIF-IA) which interacts both with Pol I subunit A43 and 
SL1/TIF-IB subunits TAFI63/68 or TAFI110/95, respectively. TFIIH is additionally required for productive rDNA transcription. 
[from (Moss et al., 2007), modified] 
 
In mammals, the human selectivity factor 1 (SL1) (Learned et al., 1985) or the mouse transcription 
initiation factor IB (TIF-IB) (Clos et al., 1986), respectively, in combination with the upstream binding 
factor (UBF) (Jantzen et al., 1990) is required to promote efficient transcription initiation by 
providing a platform to which RNA polymerase I is recruited via the human RRN3 (hRRN3) 
(Moorefield et al., 2000) or the mouse transcription initiation factor IA (TIF-IA) (Bodem et al., 2000), 
respectively (Figure 4).  
SL1 is composed of TBP and at least three TBP-associated factors (TAFs), including TAFI48, TAFI63 
and TAFI110. TIF-IB exhibits the same composition except for the last two TAFs being named 
TAFI68 and TAFI95. These essential TAFs are apparently the mammalian orthologues to the three CF 
subunits in yeast. In vitro, SL1/TIF-IB is sufficient to provoke basal levels of transcription by Pol I. 
Activated transcription, however, also requires the non-specific DNA-binding protein UBF which in 
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part resembles yeast Hmo1p and UAF. UBF binds as a dimer to the UCE and the Core via its HMG-
boxes. SL1/TIF-IB subunits TAFI48 and TBP interact with the highly acidic C-terminus of UBF, 
thereby recruiting SL1 to the promoter. Similarly to the situation in yeast, the essential factor 
hRRN3/TIF-IA brings RNA polymerase I to the promoter by forming a bridge between the Pol I 
subunit A43 and the two SL1/TIF-IB subunits TAFI63/68 or TAFI110/95, respectively. After initiation, 
Pol I escapes the promoter and converts into the elongating form which coincides with the loss 
and inactivation of hRRN3/TIF-IA (Grummt, 2003; Moss, 2004; Russell and Zomerdijk, 2005; Moss et 
al., 2007).  
Besides its role in transcription initiation, UBF is also shown to play a role in correct promoter 
escape and in efficient transcription elongation (Stefanovsky et al., 2006; Panov et al., 2006a). 
Similarly, the facilitates chromatin transcription (FACT) complex stimulates elongation by 
facilitating Pol I transcription through nucleosomal templates (Birch et al., 2009). Furthermore, two 
Pol II transcription factors are reported to be involved in the Pol I system. On the one hand, there is 
no productive transcription in the absence of TFIIH, which implies a post-initiation role for this 
multi-subunit complex. On the other hand, it was suggested that the RNA cleavage activity 
mediated by TFIIS is required for both Pol II and Pol I to overcome transcriptional impediments 
during RNA chain elongation (Schnapp et al., 1996; Iben et al., 2002). It should be noted, however, 
that such a role for TFIIS in the yeast Pol I system was not detected in a different study (Tschochner, 
1996).  
Accurate transcription termination in mammals depends also on auxiliary factors. Here, binding of 
the transcription termination factor I (TTF-I) to its target site in the 3' ETS induces DNA bending and 
pausing of Pol I. TTF-I cooperates with the polymerase and transcript release factor (PTRF) in 
conjunction with the T-rich element to mediate transcription termination and dissociation of both 
the elongating Pol I and the transcript from the template (Jansa and Grummt, 1999; Russell and 
Zomerdijk, 2005). To date, no alternative model for Pol I transcription termination has been 
proposed in mammals resembling the yeast torpedo-mechanism.  
 
2.2.4 Pre-rRNA processing and rRNA maturation 
As mentioned above, the 18S, 5.8S and 25S [28S] ribosomal RNA species in yeast [mammals] are 
transcribed by RNA polymerase I as a single polycistronic precursor, the 35S [47S] pre-rRNA, which 
is subsequently matured in a complex series of co- and post-transcriptional processing steps to 
yield the mature RNAs.  
In yeast, a subset of ribosomal and non-ribosomal proteins along with diverse small nucleolar 
ribonucleoprotein particles (snoRNPs) assemble to the precursor rRNA in the course of 
transcription to establish the initial 90S pre-ribosomal particle. Co-transcriptional cleavage at site B0 
within the 3' ETS releases the pre-90S particle containing the 35S pre-rRNA which is target of 
extensive processing events and modification processes comprising mainly 2' O-methylations and 
pseudouridylations.  
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Subsequent processing at sites A0 and A1 in the 5' ETS of the 35S pre-rRNA yields the 32S pre-rRNA 
which is endonucleolytically cleaved at site A2 in the ITS1 to give birth to the pre-40S and pre-60S 
particle containing either the 20S or the 27SA2 pre-rRNA species, respectively. The pre-40S particle 
is exported to the cytoplasm where it is converted into the mature small ribosomal subunit by 
cleavage of the 20S pre-rRNA at site D producing the 18S rRNA (Figure 5).  
 
 
Figure 5. Overview of pre-rRNA processing pathways in Saccharomyces cerevisiae.  
The upper panel shows a schematic drawing of the 35S pre-rRNA transcript with the locations of the respective 
processing sites. The central panal depicts the successive processing steps from the 35S to the 32S pre-rRNA within the 
pre-90S particle. An endonucleolytic cleavage event separates the processing pathways of the pre-40S and the pre-60S 
particle, both of which are illustrated in the two lower panels. Subsequent conversion of the 20S pre-rRNA and the 27SA2 
pre-rRNA into the mature rRNA species is shown. The intermediate rRNA species and the implications of diverse exo- and 
endonucleolytic cleavage activities are depicted, as are the cell compartments where the respective processing steps 
occur. [from (Henras et al., 2008)] 
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Processing of the 27SA2 pre-rRNA occurs by two alternative pathways. The major pathway involves 
cleavage at site A3 in the ITS1 producing the 27SA3 pre-rRNA. This is very rapidly followed by 
exonucleolytic digestion to site B1S forming the mature 5' end of the short form of the 5.8S rRNA 
(5.8SS) within the 27SBs pre-rRNA. The second, minor pathway is characterized by a processing step 
at site B1L which creates the 27SBL pre-rRNA harboring the mature 5' end of the long form of the 
5.8S rRNA (5.8SL). Exonucleolytic digestion at site B2 generates the 3' end of the mature 25S rRNA. 
The subsequent processing steps of the 27SBS and 27SBL pre-rRNA species appear to be identical. 
Both are cleaved at site C2 within the ITS2. The released upstream fragments, 7SS and 7SL, are 
processed at their 3' ends by diverse exoribonucleases, thereby forming the 6SS and 6SL pre-rRNA 
species which are further processed to the mature 5.8SS and 5.8SL rRNAs. Finally, the 5' end of the 
mature 25S rRNA is obtained by exonucleolytic digestion to site C1. Contrary to the pre-40S particle, 
all rRNA species of the pre-60S particle are matured completely before the particle is exported to 
the cytoplasm to function as the large ribosomal subunit (Figure 5) (Venema and Tollervey, 1999; 
Tschochner and Hurt, 2003; Fromont-Racine et al., 2003; Henras et al., 2008).  
It is noteworthy that eukaryotic cells contain at least two different types of ribosomes, possessing 
either the long or the short form of the 5.8S rRNA, which may in principle be capable of translating 
different sets of mRNAs (Schmitt and Clayton, 1993).  
Although there are differences in the pre-rRNA processing and modification pathways between 
yeast and mammals, the overall sequence of maturation events in eukaryotes seems very related, 
since trans-acting factors involved in ribosome biogenesis are highly conserved (Henras et al., 
2008).  
Importantly, continuous availability of ribosomal proteins in at least stoichiometric amounts with 
the rRNA is crucial for proper maturation of ribosomal subunits. Reduced production of individual 
ribosomal proteins due to conditional depletion or r-protein gene haploinsufficiency rapidly leads 
to severe pre-rRNA processing defects (Lucioli et al., 1988; Song et al., 1996; Deutschbauer et al., 
2005; Ferreira-Cerca et al., 2005; Robledo et al., 2008; Pöll et al., 2009).  
It was suggested that the primary 35S pre-rRNA transcript most probably starts to fold and to 
interact with snoRNAs and both ribosomal and non-ribosomal proteins already during 
transcription. Several years ago, the opinion prevailed that pre-rRNA processing and modification 
does not commence until cleavage at site B0 in the 3' ETS is completed (Venema and Tollervey, 
1999). However, although RNA polymerase I transcription proceeds in some cases unabated until 
the 3' ETS is synthesized, the nascent transcript could also be modified and cleaved co-
transcriptionally in the ITS1, thereby immediately releasing a pre-40S particle without prior pre-90S 
particle formation (Osheim et al., 2004; Kos and Tollervey, 2010). This observation along with 
further recent findings suggest that rRNA gene transcription and the downstream pre-rRNA 
processing events are intimately linked (Granneman and Baserga, 2005). Indeed, accurate 
transcription elongation by RNA Pol I is a prerequisite for efficient pre-rRNA processing and pre-
ribosome assembly (Schneider et al., 2007). Similarly, two independent studies revealed a subset of 
early assembling non-ribosomal proteins to be implicated not only in accurate pre-rRNA 
processing but also in efficient rDNA transcription (Gallagher et al., 2004; Prieto and McStay, 2007). 
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Further evidence for a connection between these processes derived from the observation that 
depletion of the Pol II elongation factor Spt4p, which is similarly involved in the Pol I system, results 
in a pre-rRNA processing defect (Schneider et al., 2006).  
In the next section, two proteins are introduced which are potential candidates for coordinating 
rDNA transcription and pre-rRNA processing.  
 
2.2.5 Pol5p and Mybbp1a – potential regulators of ribosomal RNA synthesis 
Pol5p, a constitutively expressed 116 kDa protein, was originally characterized to be the fifth 
essential DNA polymerase in Saccharomyces cerevisiae and is therefore named DNA polymerase φ 
(Shimizu et al., 2002). However, although this factor both exhibits significant DNA polymerization 
activity in vitro and contains each of the six characteristic Pol domains that are present in all B-type 
polymerases, its role as a bona fide DNA polymerase is still discussed controversially (Yang et al., 
2003). Mutational analysis showed that Pol5p plays an essential role in a cellular function other 
than chromosomal DNA replication. Since Pol5p co-localizes exclusively with the nucleolar marker 
protein Nop1p, a role in regulating the synthesis of ribosomal RNA seemed to be possible. Indeed, 
temperature-sensitive POL5 mutant strains rapidly ceased growth, displayed severe inhibition of 
rRNA synthesis and increased the number of rDNA repeat units on chromosome XII at the 
restrictive temperature. Additionally, cultivation of these mutant cells at the restrictive temperature 
led to an altered cellular distribution pattern of Pol5p. Instead of nucleolar localization, the factor 
was now detected in punctate foci in the cytoplasm (Shimizu et al., 2002). Furthermore, association 
of Pol5p with the rRNA gene locus was shown by chromatin immunoprecipitation experiments 
pointing to a function in rDNA transcription. Various studies report specific crosslinking of Pol5p to 
the promoter region, the 25S rRNA-coding region and the rDNA enhancer region (Shimizu et al., 
2002; Nadeem et al., 2006; Wery et al., 2009). The latter is located in the 3' ETS and overlaps with the 
Reb1p-binding site which is important for transcription termination. The enhancer element was 
shown to exhibit a stimulatory effect on rRNA synthesis by Pol I in in vitro and in vivo experiments 
from Pol I reporter templates (Elion and Warner, 1984, 1986), but is dispensable for rDNA 
transcription in the chromosomal context in vivo (Wai et al., 2001). Moreover, Pol5p was recently 
identified within a complex that early assembles to the 35S pre-rRNA suggesting a function in pre-
rRNA maturation (Krogan et al., 2004).  
In summary, these data strongly indicate a role for Pol5p in rRNA synthesis, though it is still 
unknown whether this protein participates predominantly in rDNA transcription, in pre-rRNA 
processing or in both, thereby potentially coordinating these essential events concerning 
ribosome production.  
In mammals, Myb-binding protein 1a (Mybbp1a) is considered to be the corresponding 
homologue of Pol5p. The designation of this ubiquitously expressed and predominantly nucleolar 
protein initially derived from its ability to interact with the proto-oncogene product c-Myb, a 
transcription factor that is critical for cell proliferation and differentiation (Favier and Gonda, 1994; 
Tavner et al., 1998; Keough et al., 2003). To date, the function of Mybbp1a has been mainly 
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described in the context of RNA polymerase II-dependent transcription. Nevertheless, very recent 
findings support the speculation for Mybbp1a to be involved in the Pol I transcription system as 
well. Strong evidence exist that Mybbp1a interacts with Pol I subunit hPAF53/A49. Additional 
experiments in this study revealed that this protein serves both as a negative regulator of rRNA 
gene transcription and as a functional subunit of the ribosome biogenesis machinery, thereby 
influencing pre-rRNA processing (Hochstatter et al., submitted). This dual role in the rDNA 
metabolism points to Mybbp1a to be a coordinator of rDNA transcription and pre-rRNA processing.  
Taken together, lots of factors are evidently involved in Pol I transcription and/or pre-rRNA 
processing. However, it is not clear yet, which of these factors are influenced by the essential TOR 
pathway in order to precisely regulate the complex process of ribosome biogenesis in response to 
environmental changes.  
 
2.3 TOR – a central component of the eukaryotic growth regulatory 
network 
2.3.1 General description of the target of rapamycin (TOR) 
In the 1970s, a potent antifungal metabolite was discovered which was produced by the bacterial 
strain Streptomyces hygroscopicus isolated from a soil sample from Easter Island, locally known as 
Rapa Nui (Vézina et al., 1975; Sehgal et al., 1975). This macrocyclic lactone, which was named 
rapamycin after its place of discovery, showed immunosuppressive properties and inhibited 
proliferation of mammalian cells. Rapamycin was further investigated to elucidate its mode of 
action. During these studies, the target of rapamycin (TOR) was originally identified by the 
mutations tor1-1 and tor2-1 in Saccharomyces cerevisiae that confer resistance to the growth 
inhibitory properties of rapamycin. Concomitantly, availability of an intracellular co-factor was 
described to be crucial for rapamycin toxicity (Heitman et al., 1991). Prior to binding and thus 
inhibiting TOR, rapamycin has to form a complex with the peptidyl-prolyl cis/trans isomerase 
FKBP12.  
To date, every eukaryote genome examined contains a TOR gene. Most higher eukaryotes possess 
a single TOR gene, whereas Saccharomyces cerevisiae holds two of these genes. All the proteins 
encoded by such genes belong to a group of kinases known as the phosphatidylinositol kinase-
related kinase (PIKK) family, the members of which share distinct domain features (Figure 6). A 
ser/thr-kinase domain confers the respective enzymatic activity. The matter of the FKBP12-
rapamycin-binding (FRB) domain is already explained by its designation. FAT and FATC domains 
are supposed to interact within the protein, whereas the tandem HEAT repeats may provide 
interfaces for protein-protein interactions (Wullschleger et al., 2006).  
The target of rapamycin constitutes a conserved cellular regulator of cell growth and metabolism 
which controls these complex processes in response to environmental changes via its kinase 
activity. Studies in yeast demonstrated that TOR performs essentially two distinct functions: it 
controls both when a cell grows and where a cell grows (Loewith and Hall, 2004). Two distinct TOR 
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complexes are involved to accomplish this challenging task in the cell: TOR complex 1 (TORC1) and 
TOR complex 2 (TORC2) (Figure 6). The structure and function of these complexes are conserved 
from yeast to mammals. Interestingly, just TORC1 is sensitive to rapamycin treatment, whereas 
TORC2 is characterized by rapamycin resistance.  
In yeast, TOR complex 1 consists of four proteins which are: Kog1p, Tco89p, Lst8p and either Tor1p 
or Tor2p. Interactions between the factors Avo1p, Avo2p, Avo3p, Lst8p, Bit61p and Tor2p 
constitute TOR complex 2 (Figure 6) (Loewith et al., 2002). Both TORC1 and TORC2 as well as the 
mammalian equivalents are supposed to be oligomeric supercomplexes, most likely dimers, based 
on the interaction between the respective Tor proteins (Figure 6) (Wullschleger et al., 2005).  
When nutrients are available, signaling by the active TOR complex 1 regulates temporal aspects of 
cell growth by providing a robust rate of ribosome biogenesis, translation initation and nutrient 
import. Treatment of the cells with rapamycin, however, amino acid starvation or exposure of the 
cells to any other form of stress, inactivates TORC1 leading to a rapid down-regulation of general 
protein synthesis and concomitantly to an activation of both macroautophagy and stress-
responsive transcription factors. Thus, the cells abruptly arrest growth and enter a G0-like state. In 
contrast, TORC2 controls spatial aspects of cell growth by organizing the polarization of the actin 
cytoskeleton through a rapamycin-insensitive signaling branch (Figure 6) (Wullschleger et al., 2006; 
De Virgilio and Loewith, 2006a, 2006b).  
 
 
Figure 6. TOR complex 1 (TORC1) and TOR complex 2 (TORC2) of Saccharomyces cerevisiae.  
The protein composition (Kog1p, Tco89p, Lst8p, Avo1-3p, Bit61p and Tor1p or Tor2p) of TOR complex 1 and TOR 
complex 2 is depicted, as is the domain organization (HEAT, FAT, FRB, Kinase, FATC) of Tor1p or Tor2p, respectively. Both 
complexes are oligomers, likely dimers. Rapamycin-sensitive TORC1 regulates growth in dependency of environmental 
conditions, whereas rapamycin-resistant TORC2 is involved in the organization of the actin cytoskeleton. Stimuli that 
activate TORC1 and TORC1 outputs that promote growth as well as the scope of TORC2 are illustrated with black arrows. 
Inputs that inhibit TORC1 signaling and processes that are negatively regulated by TORC1 are depicted with red bars. 
[from (Wullschleger et al., 2006)] 
 
In mammals, the corresponding equivalents, mTORC1 and mTORC2, exhibit virtually the same 
characteristics and functions as their yeast homologues. Rapamycin-sensitive mTORC1 appears 
likewise to regulate the temporal aspects of cell growth, whereas mTORC2 controls the spatial 
aspects of cell growth in a rapamycin-resistant manner (Wullschleger et al., 2006).  
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In metazoans, TOR primarily controls growth during development, but in the adult, where cell 
growth plays a rather minor role, TOR controls aging and other aspects of nutrient-related 
physiology. Interestingly, partial inhibition of TOR function in worms and flies, but also in yeast, 
results in a significant increase in the life span of these organisms (Martin and Hall, 2005; Kaeberlein 
et al., 2005).  
 
2.3.2 Upstream and downstream of the TOR signaling network 
TOR integrates various signals to regulate cell growth. Four major inputs are considered to be 
involved in modulating TOR signaling in eukaryotic cells, which are: hormones and growth factors, 
nutrients, energy and stress (Wullschleger et al., 2006).  
In mammals, several signaling pathways are shown to be implicated in both increasing and 
decreasing the activity of mammalian TOR complex 1. In most of these cases, the heterodimer 
TSC1-TSC2 acts as a central integration unit and conveys the essential information to mTORC1. 
Mammalian TOR complex 2 might also act downstream of TSC1-TSC2, but further investigation is 
required to elucidate this issue. To date, no upstream regulators of mTORC2 are reported 
(Wullschleger et al., 2006; De Virgilio and Loewith, 2006b).  
In yeast, however, distinct upstream regulators of both TOR complex 1 and TOR complex 2 remain 
elusive to this day. It is noteworthy that no orthologues of TSC1 and TSC2 are identified yet in yeast 
indicating that upstream signals may be sensed differently in this organism (Wullschleger et al., 
2006; De Virgilio and Loewith, 2006b).  
Generally, active signaling by eukaryotic TOR complex 1 promotes overall protein synthesis via 
stimulation of both ribosome biogenesis (see section 2.3.3) and translation as well as other 
anabolic processes. In contrast, macroautophagy, other catabolic processes and the activity of 
stress-responsive transcription factors are down-regulated. Eukaryotic TOR complex 2 primarily 
plays a role in the regulation of cell polarity by organizing the actin cytoskeleton. Although a large 
number of TORC1- and TORC2-regulated readouts have been elucidated, the understanding of the 
signaling pathways that couple TOR to these downstream targets remains limited.  
In mammals, the best characterized effectors of rapamycin-sensitive mTORC1 are the translation 
regulators ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein 1 (4E-BP1) (Hay and 
Sonenberg, 2004).  
Full activation of S6K1, which is a member of the AGC kinase family, is achieved by the 
phosphorylation of two sites within distinct protein domains. Upon phosphorylation by both 
pyruvate dehydrogenase kinase 1 (PDK1) and mTORC1, S6K1 is activated and in turn 
phosphorylates ribosomal protein S6. Apparently, the posttranslational modification of this factor 
leads to an increase in the translation of a subset of mRNAs which contain a specific tract of 
oligopyrimidine at the 5' end (5' TOP). Since this kind of mRNAs encodes predominantly 
components of the translation apparatus such as ribosomal proteins and elongation factors, active 
S6K1 is thought to up-regulate general translation capacity. However, recent work has provided 
new evidence that neither S6K1/S6K2 activity nor phosphorylation of ribosomal protein S6 is 
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required for mTORC1 to alter the translation efficiency of 5' TOP mRNAs. Furthermore, S6K1 
appears to promote translation elongation by inhibiting the phosphorylation of the eukaryotic 
elongation factor 2 (eEF2). In a similar cascade, mTORC1 controls cap-dependent translation 
initiation via the translational inhibitor 4E-BP1. Phosphorylation of 4E-BP1 by mTORC1 leads to its 
dissociation from the eukaryotic initiation factor 4E (eIF4E) which is then free to associate with its 
target eIF4G to stimulate translation initiation.  
Besides translation, mTORC1 signaling is further involved in macroautophagy, a cellular process by 
which cytoplasmic contents, including organelles, are degraded and thereby recycled in the 
vacuole in order to ensure the survival of the cell when nutrients are scarce. Activity of this 
catabolic pathway is largely dependent on mTORC1 signaling. Inactivation of mTORC1 by 
starvation conditions leads to enhanced macroautophagy, whereas under favorable growth 
conditions, this process is largely impaired.  
Moreover, mTORC1 regulates many aspects of cellular metabolism including amino acid 
biosynthesis, glucose homeostasis and others. In particular, mTORC1 and S6K1 appear to play an 
important role in the fat metabolism. Loss of mTORC1 activity correlates with a significant decrease 
in fat accumulation highlighting the economical nature of this pathway.  
The involvement of mTORC1 signaling in the transcriptional regulation of many genes, in the 
trafficking and activation of numerous nutrient transporters and in mRNA stability was suggested, 
but is also much less well characterized (Wullschleger et al., 2006; De Virgilio and Loewith, 2006a, 
2006b; Soulard et al., 2009).  
Rapamycin-resistant mTORC2 controls the cell cycle-dependent polarization of the actin 
cytoskeleton. Although the exact mechanism by which the mammalian TOR complex 2 signals to 
the actin cytoskeleton is still unknown, it appears that PKB/Akt, RHO family GTPases and protein 
kinase C (PKC) play essential roles in this process (Wullschleger et al., 2006; De Virgilio and Loewith, 
2006a, 2006b; Soulard et al., 2009).  
In yeast, the best studied direct downstream targets of TORC1 are the essential protein Tap42p and 
the non-essential AGC family kinase Sch9p (Di Como and Arndt, 1996; Jiang and Broach, 1999; 
Urban et al., 2007; Huber et al., 2009). Whereas Sch9p is predominantly involved in the regulation 
and coordination of ribosome biogenesis (see section 2.3.3), Tap42p-dependent TORC1 signaling 
controls primarily the localization and activity of various transcription factors. Additionally, both 
Sch9p and Tap42p participate in the regulation of translation.  
In rapidly growing cells, Tap42p is phosphorylated by TORC1 and associates tightly with the 
oligomeric complexes of both type 2A (PP2A) and type 2A-related (PP2Ar) protein phosphatases. 
Impaired TOR signaling, however, results in the dephosphorylation of Tap42p and thus reduced 
interaction with both PP2A and PP2Ar. By controlling this switch, TORC1 modulates several 
transcription factors such as Gln3p. Dephosphorylation of this protein by active PP2A and PP2Ar in 
nitrogen starvation conditions causes its dissociation from the cytoplasmic repressor protein Ure2p 
and its translocation in the nucleus. Hereupon, the expression of nitrogen-catabolite repression 
(NCR)-sensitive genes enables the cell to use poor nitrogen sources. The heterodimeric 
transcription factor Rtg1p-Rtg3p is likewise tethered to the cytoplasm by TORC1 in growing cells. 
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The retrograde response pathway signals mitochondrial dysfunction to TORC1 whose inactivation 
leads to the dephosphorylation of both Rtg1p-Rtg3p-heterodimer and its cytoplasmic anchor 
protein Mks1p. The activated transcription factor is now capable of inducing the expression of the 
corresponding genes in the nucleus in order to overcome this dysfunction. Msn2p and Msn4p, two 
more transcription factors, regulate stress-responsive element (STRE)-dependent transcription in 
response to a wide range of stresses. Active TORC1 maintains the phosphorylated and thus 
phosphatase-inhibiting status of Tap42p which in turn ensures the phosphorylation of Msn2p and 
Msn4p and their accumulation in the cytoplasm.  
Besides regulating transcription factors, both TORC1 and Tap42-dependent PP2A/PP2Ar play a role 
in the degradation of amino acid transporters and in cell wall integrity by controlling the activity of 
either Npr1p or kinase Mpk1p, respectively.  
Moreover, TORC1 also modulates the cellular protein synthesis rate both via Tap42p and Sch9p. In 
growing cells, the phosphorylated form of kinase Gcn2p is supported by the activity of kinase 
Sch9p along with the PP2A/PP2Ar-inhibitory function of phosphorylated Tap42p. Keeping Gcn2p 
phoshoprylated prevents phosphorylation and thus inactivation of the eIF2 subunit α ensuring a 
robust rate of translation initiation. Like its putative mammalian orthologue S6K1, Sch9p 
phosphorylates the respective yeast ribosomal protein S6, thereby positively regulating translation 
in a TORC1-dependent manner. Another positive effect on translation represents the diminished 
degradation rate of eIF4G which seems to be accomplished by TORC1 without the involvement of 
either Tap42p or Sch9p.  
Interestingly, additional Tap42p- and Sch9p-independent TORC1 signaling pathways exist in the 
cell. Active TORC1 signaling promotes hyperphosphorylation of the protein Atg13p in growing 
cells which prevents its interaction with Atg1p and thus the initiation of macroautophagy. A further 
target of the TOR signaling pathway is the protein Ime1p. The function of this transcription factor is 
crucial in diploid cells to initiate meiosis and sporulation in response to unfavorable growth 
conditions by inducing a transcriptional cascade of sporulation-specific genes in the nucleus 
(Wullschleger et al., 2006; De Virgilio and Loewith, 2006a, 2006b; Soulard et al., 2009; Urban et al., 
2007; Huber et al., 2009).  
In contrast to TOR complex 1, the readouts downstream of TOR complex 2 in yeast are less well 
characterized. Currently the hypothesis prevails that TORC2-dependent activation of the GTPase 
Rho1p activates the AGC family kinase Pkc1p which in turn signals to the actin cytoskeleton via a 
subsequent phosphorylation cascade including kinases Bck1p, Mkk1p/Mkk2p and Mpk1p 
(Wullschleger et al., 2006; De Virgilio and Loewith, 2006a, 2006b; Soulard et al., 2009).  
 
2.3.3 TOR signaling in the context of growth-dependent regulation of ribosome 
biogenesis 
As already mentioned, ribosome biogenesis is an energetically very costly process in the cell that 
has to be tightly regulated in response to nutrient and energy conditions. RNA polymerase I 
transcription plays an essential role in this process, since it synthesizes most of the ribosomal RNA. 
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Logarithmically growing yeast cells display high rRNA synthesis rates, whereas stationary yeast 
cells almost completely lack the production of ribosomal RNAs (Ju and Warner, 1994). Similarly, 
nutrient deprivation or rapamycin treatment of eukaryotic cells, which both leads to the inhibition 
of TOR signaling, results in a rapid decrease in Pol I transcription rates (Grummt et al., 1976; 
Zaragoza et al., 1998; Powers and Walter, 1999). Therefore, the activity of RNA polymerase I and 
thus ribosome biogenesis is apparently strictly regulated in a TOR-dependent manner.  
RNA polymerase I is present in two distinct populations in both lower and higher eukaryotic cells 
(Bateman and Paule, 1986; Tower and Sollner-Webb, 1987; Milkereit et al., 1997; Miller et al., 2001). 
Both populations are capable of unspecifically synthesizing RNA in vitro, but only one is able to 
initiate at the rDNA promoter in cell-free transcription systems. As mentioned before, the initiation-
competent population of Pol I is characterized by the fact of existing in a complex with the 
transcription factor Rrn3p or hRRN3/TIF-IA, respectively (Milkereit and Tschochner, 1998; Miller et 
al., 2001; Yuan et al., 2002). Interestingly, Pol I-Rrn3p complexes are exclusively detectable in 
growing cells, whereas in stationary cells and in cells starved for amino acids or treated with the 
protein synthesis inhibitor cycloheximide, this specialized Pol I fraction is largely absent (Buttgereit 
et al., 1985; Bateman and Paule, 1986; Tower and Sollner-Webb, 1987; Milkereit and Tschochner, 
1998).  
Consistently, in yeast cells following rapamycin-induced TOR inactivation, the amount of Pol I-
Rrn3p complexes is decreased as is the association of Pol I with both the promoter and the 
transcribed region of the rDNA locus, nicely resembling the situation in stationary phase (Claypool 
et al., 2004). These observations suggest that in yeast the rate of Pol I transcription is strongly 
dependent on the formation of Pol I-Rrn3p complexes. In vitro experiments using transcriptional-
inactive extracts of yeast or mammalian cells, respectively, showed that Rrn3p is only capable of 
restoring promoter-dependent Pol I transcription when it is bound to Pol I, whereas both 
recombinant and purified active TIF-IA by itself is sufficient to obtain the same result (Buttgereit et 
al., 1985; Milkereit and Tschochner, 1998; Yuan et al., 2002). Thus, in mammalian cells, the rate of 
Pol I transcription appears to be rather dependent on the activity of hRRN3/TIF-IA.  
Since in yeast Rrn3p as well as the five Pol I subunits A190, A43, A34.5, ABC23 and AC19 are 
described to be phosphorylated in vivo (Bell et al., 1976, 1977; Buhler et al., 1976; Bréant et al., 1983; 
Fath et al., 2001), TOR signaling was speculated to influence the formation of Pol I-Rrn3p 
complexes via phosphorylation-dephosphorylation cascades in a growth-dependent manner. 
Indeed, in vitro experiments suggest that Pol I needs to be phosphorylated for binding to Rrn3p, 
whereas the latter is able to bind to Pol I in its unphosphorylated form. In addition, the free 
population of Rrn3p, accounting for roughly 75% of the total protein, is predominantly 
phosphorylated in vivo (Fath et al., 2001; Bier et al., 2004). Similarly, the 2% of total Pol I being 
associated with Rrn3p display a different phosphorylation pattern than the excess of unbound Pol I 
(Milkereit and Tschochner, 1998; Fath et al., 2001). However, the kinase and phosphatase activities 
responsible for these posttranslational modifications remain elusive to this day. Interestingly, 
recent findings in yeast report that kinase Tor1p is dynamically distributed in the cytoplasm and in 
the nucleus. The nuclear localization is shown to be critical for 35S pre-rRNA synthesis, which is 
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consistent with the fact that Tor1p is associated with the rDNA promoter region in a nutrient-
dependent and rapamycin-sensitive manner (Li et al., 2006). It is thus possible that Rrn3p but also 
other factors of the Pol I transcription machinery are direct targets of TORC1. Notably, nuclear-
cytoplasmic shuttling was also reported for the mammalian TOR complex 1 (Kim and Chen, 2000).  
In mammals, predominantly the phosphorylation status of hRRN3/TIF-IA appears to determine the 
ability of forming a complex with Pol I. In vitro transcription assays demonstrate that only 
phosphorylated hRRN3/TIF-IA is capable of binding to Pol I in order to promote transcription 
initiation which leads concomitantly to its dephosphorylation and thus its inability to reinitiate 
both complex formation and transcription (Cavanaugh et al., 2002; Hirschler-Laszkiewicz et al., 
2003). Subsequent studies successfully identified several regulatory phosphorylation sites of TIF-IA 
(Schlosser et al., 2002; Zhao et al., 2003; Mayer et al., 2005; Hoppe et al., 2009), two of which are 
indeed controlled by the mammalian TOR pathway (Mayer et al., 2004). Rapamycin-induced 
inhibition of Pol I transcription correlates with both the inactivation of TIF-IA due to an altered 
phosphorylation pattern and its translocation to the cytoplasm resulting in impaired initiation-
competent complex formation (Mayer et al., 2004). However, contradictory results were obtained 
by a study presenting UBF rather than hRRN3/TIF-IA as a downstream target of the mTOR pathway 
(Hannan et al., 2003).  
Another TOR-dependent determinant of initiation-competent complex formation in yeast is the 
availability of Rrn3p. Contrary to TIF-IA, which is inactivated and exported from the nucleus upon 
rapamycin treatment (Mayer et al., 2004), the level of Rrn3p was recently reported to gradually 
decrease in likewise treated yeast cells due to the combination of proteasome-dependent 
degradation and a reduction in the neo-synthesis rate of this factor (Philippi et al., 2010). 
Consequently, a decrease in the level of Pol I-Rrn3p complex formation, in the association of Pol I 
with the rDNA locus and in 35S pre-rRNA synthesis was observable. The extent of the decrease 
could be diminished in all three cases by artificially stabilizing the level of Rrn3p in rapamycin-
treated mutant cells (Philippi et al., 2010). The decrease in Pol I occupancy at the rDNA locus 
following rapamycin treatment could be further attenuated in mutant cells expressing an A43-
Rrn3p fusion protein, thereby preventing not only the degradation of Rrn3p but also its 
dissociation from Pol I. Concomitantly, the decline in 35S pre-rRNA synthesis is also significantly 
retarded in these cells (Laferté et al., 2006).  
Although all these observations suggest distinct roles for Rrn3p-levels and for the phosphorylation 
status of both Rrn3p and Pol I in the regulation of Pol I-Rrn3p complex formation and thus Pol I 
transcription, little is known about the underlying regulatory mechansims. It is further unclear, to 
which extent these parameters contribute to the drastic decrease in ribosome production 
observed after TOR inactivation.  
However, TOR inactivation affects ribosome biogenesis in yeast not only at the level of Pol I 
transcription initiation but also the elongation rate of the polymerase seems to be regulated in a 
growth-dependent manner. Recent findings demonstrated that in mutant cells characterized by 
the absence of Paf1C function, a complex which is shown to be positively involved in Pol I 
transcription elongation (Zhang et al., 2009), rRNA synthesis was affected to a significantly lower 
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extent by impaired TOR signaling than likewise treated wild type cells (Zhang et al., 2010). This 
results suggests that Paf1C plays a TOR-dependent role in the modulation of rRNA production.  
Besides Pol I transcription, TOR inactivation was also shown to specifically and rapidly down-
regulate the RNA polymerase II-dependent transcription of ribosomal protein (RP) genes, which 
define a co-regulated cluster termed the RP regulon (Powers and Walter, 1999; Cardenas et al., 
1999). Another regulon whose transcription by Pol II is similarly decreased following impaired TOR 
signaling is formed by the ribosome biogenesis (Ribi) genes coding for auxiliary ribosome 
biogenesis factors (Jorgensen et al., 2002, 2004). Consecutive analysis revealed several 
transcription regulators and transcription factors such as Sch9p, Sfp1p, Fhl1p and Ifh1p whose 
activity or binding to RP and Ribi gene promoters, respectively, is controlled by TOR signaling via 
alterations in their cellular localization or abundance (Jorgensen et al., 2004; Marion et al., 2004; 
Schawalder et al., 2004; Rudra et al., 2005). Since the factor Hmo1p was shown to bind both to 
ribosomal RNA and ribosomal protein genes in a rapamycin-sensitive manner (Hall et al., 2006; 
Berger et al., 2007), a function in coordinating Pol I and Pol II transcription in the context of 
ribosome biogenesis could be considered for this protein. The above effects on Pol II transcription 
will certainly contribute to the drop in ribosome production following inhibition of the TOR 
pathway, but to which extent remains to be further elucidated.  
As mentioned before, kinase Tor1p displays a rapamycin-sensitive nuclear localization which is not 
only crucial for Pol I transcription but also for RNA polymerase III transcription (Li et al., 2006). The 
nuclear localization of TORC1 is apparently important for the phosphorylation and thus 
inactivation of the Pol III transcriptional repressor Maf1p (Wei et al., 2009), which is consistent with 
earlier reports showing that rapamycin treatment represses Pol III transcription in yeast (Zaragoza 
et al., 1998).  
TOR inactivation obviously mediates the transcriptional down-regulation of all components 
required for ribosome biogenesis. However, the activity of RNA polymerase I seems to play a 
superior role in this process, since artificially stabilizing Pol I transcription in rapamycin-treated 
mutant cells expressing a constitutively initiation-competent version of Pol I attenuates the 
decrease in the level of both r-protein mRNAs and 5S rRNAs produced by Pol II and Pol III, 
respectively (Laferté et al., 2006).  
In addition to transcription, general translation is also severely compromised upon TOR 
inactivation due to the impaired function of various translation factors as described (see section 
2.3.2). 15 min of rapamycin treatment reduces the protein synthesis capacity of the cell by half 
(Barbet et al., 1996), however, the extent to which this process contributes to the down-regulation 
of ribosome biogenesis is again not well characterized.  
Strikingly, it was shown that not only Pol I transcription is repressed following rapamycin 
treatment, but also 35S pre-rRNA processing is severely and very rapidly affected, thereby nearly 
abolishing the production of mature ribosomal RNAs (Powers and Walter, 1999). This effect could 
be derived from a direct TOR-dependent inactivation of ribosome biogenesis factors, from a rapid 
depletion of proteins indispensable for proper rRNA maturation due to a transcriptional and/or 
translational reduction in their expression level or from a combination of these processes. Indeed, 
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decreasing levels of the ribosome biogenesis factors Nog1p and Nop7p were reported following 
TOR inactivation (Honma et al., 2006). Another example for TOR-mediated effects on RNA 
metabolism is the specific inhibition of splicing of r-protein mRNAs induced by amino acid 
starvation (Pleiss et al., 2007).  
Finally, evidence exist suggesting that TOR signaling is involved in the control of pre-ribosomal 
transport processes. TOR inactivation leads to a rapid nucleolar entrapment of various ribosome 
biogenesis factors, thereby causing cessation of late rRNA maturation steps and defects in the 
nuclear-cytoplasmic translocation of pre-ribosomal particles (Honma et al., 2006; Vanrobays et al., 
2008).  
As mentioned before (see section 2.3.2), Sch9p, a genuine downstream target of TORC1, appears to 
play a central role in the regulation and coordination of ribosome biogenesis in response to 
environmental conditions. Besides its role in translation initiation, Sch9p was revealed both to be 
involved in the regulation of Pol I and Pol III transcription and to influence the expression of RP and 
Ribi genes. Notably, its influence on the transcriptional activity of RNA polymerase I is at least in 
part mediated by Rrn3p (Huber et al., 2009). However, since Sch9p is a non-essential protein and a 
constitutively active version of this protein confers only very slight resistance to rapamycin, its 
proposed role as a master regulator of protein synthesis should be at least considered 
questionable.  
 
2.4 Objectives 
Inactivation of the TOR pathway in eukaryotic cells appears to interfere with proper ribosome 
biogenesis at several different levels with varying stringency. Following rapamycin treatment or 
nutrient deprivation, both transcription by all three RNA polymerases and general translation as 
well as pre-rRNA processing are substantially down-regulated or exhibit severe defects, 
respectively. However, since these processes leading to mature ribosomes seem to be intimately 
linked and co-regulated, it is a challenging task to distinguish between primary and secondary 
effects.  
Therefore, the main objective of this thesis was to elucidate which of these processes is the 
dominant target of the TOR pathway provoking the immediate shut-off of mature rRNA production 
upon rapamycin treatment. To this end, RNA polymerase I transcription and rRNA synthesis were 
investigated shortly after TOR inactivation in yeast, thereby trying to uncouple these two processes 
in order to analyze their response to rapamycin separately.  
By artificially down-regulating the level of Rrn3p with doxycycline in a mutant strain expressing this 
protein under the control of a sevenfold tetracycline-regulable promoter, overall rRNA synthesis 
could also be decreased to some extent compared to an untreated wild type strain (Figure 7, 
compare lane 4 with lane 1). However, when the same Rrn3p-level is generated in the wild type 
strain by rapamycin treatment for 120 min, the production of ribosomal RNA is nearly completely 
abolished (Figure 7, compare lane 4 with lane 3). In both strains, significant pre-rRNA processing 
defects are already observable after 20 min of rapamycin treatment, although the respective level 
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of Rrn3p is yet unaltered (Figure 7, compare lane 1 with lane 2 and lane 4 with lane 5). These 
findings already suggest that the drastic down-regulation of mature rRNA production observed 
after TOR inactivation is not only accomplished by decreasing the level of Rrn3p and consequently 
RNA polymerase I transcription, but also by interfering with pre-rRNA processing.  
 
 
Figure 7. Reduced levels of Rrn3p upon TOR inactivation does not explain the complete shut-off of rRNA 
synthesis.  
Although the level of Rrn3p is lowered to an equal extent in a mutant strain and a corresponding wild type strain either 
by artificially reducing the amount of the protein or by treating the cells with rapamycin for 120 min, respectively, the 
observed effects on rRNA synthesis in the two strains differ substantially (compare lane 3 with lane 4). Just additional 
rapamycin treatment for the same time decreases rRNA production in the mutant strain to a comparable extent 
(compare lane 3 with lane 6). Obviously, reduced levels of Rrn3p contribute to the down-regulation of both Pol I 
transcription and rRNA synthesis, however, there must be additional mechanisms which mediate the complete shut-off 
of mature rRNA production in yeast cells upon TOR inactivation. [from (Philippi et al., 2010)] 
 
Furthermore, since the level of Rrn3p appears to play a distinct role in the regulation of Pol I-Rrn3p 
complex formation and thus Pol I transcription and ribosome biogenesis, the impact of Rrn3p 
overexpression on rRNA synthesis and yeast cell growth was investigated in more detail. 
Additionally, Rrn3p was purified from yeast cell extracts in order to identify phosphorylation sites 
of this phosphoprotein which presumably play an important role in the process of Pol I-Rrn3p 
complex formation. In parallel, co-purifying proteins were analyzed closely, since they constitute 
putative interaction partners of Rrn3p which might also be involved in the regulation of Rrn3p 
function.  
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3 RESULTS 
3.1 Effects of TOR inactivation on RNA polymerase I transcription, 
rRNA production, and yeast cell growth 
3.1.1 Proteasome-dependent reduction of Rrn3p-levels in growth-arrested yeast 
cells 
It has been previously shown that there is a concomitant down-regulation of rRNA synthesis and 
Pol I-Rrn3p complex formation in stationary yeast cells (Milkereit and Tschochner, 1998). 
Furthermore, when cells are treated with rapamycin, a drug which mimics conditions of nutrient 
starvation by inactivating the kinase Tor1p, or with the protein synthesis inhibitor cycloheximide, 
both a reduction of Pol I-Rrn3p complexes and pre-rRNA synthesis could be observed (Yuan et al., 
2002; Cavanaugh et al., 2002; Hirschler-Laszkiewicz et al., 2003; Mayer et al., 2004; Claypool et al., 
2004).  
This reduction of Pol I-Rrn3p complexes in yeast cells appeared to correlate with decreasing 
amounts of Rrn3p in whole cell extracts (WCE) (Philippi, 2008). To confirm these results and to 
elucidate further the general mechanism underlying the reduction of Rrn3p-levels, exponentially 
growing yeast cells of the strain RRN3-Prot.A were treated with either rapamycin (RAPA) or 
cycloheximide (CHX). Indeed, the level of Rrn3p dropped continuously in both cases (Figure 8, 
upper panel). After 120 min of rapamycin or cycloheximide treatment, the level of this factor 
decreased below 20% of the initial amount. In contrast, Pol I-levels remained rather stable within 
this time frame (Figure 8, lower panel).  
 
 
Figure 8. Reduction of Rrn3p-levels in growth arrested yeast cells.  
Yeast strain Y2183 expressing a chromosomally Prot.A-tagged Rrn3p was grown in YPD at 30°C to mid-log phase 
(OD600 ∼ 0,4) before cells were either treated with 200 ng/ml of rapamycin (RAPA) or with 100 µg/ml of cycloheximide 
(CHX). At the time points indicated, cells were collected and lyzed. Same amounts of WCE (20 µg) were analyzed by 
Western blotting using antibodies directed against the Prot.A-tag of Rrn3p and the Pol I subunit A43, respectively.  
 
These observations demonstrate that inactivation of both TOR pathway and protein synthesis 
results in a reduction in the level of Pol I transcription initiation factor Rrn3p. The quick down-
regulation of Rrn3p-levels in growth arrested yeast cells was recently suggested to be dependent 
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on the proteolytic activity of the proteasome (Philippi et al., 2010). In the temperature-sensitive 
mutant strain cim3-1-RRN3-TAP, which is defective in CIM3/SUG1, a gene coding for an essential 
subunit of the regulatory particle of the 26S proteasome (Rubin et al., 1996; Gerlinger et al., 1997), 
Rrn3p-levels are stable when TOR signaling is impaired upon amino acid depletion at the restrictive 
temperature (Philippi et al., 2010). Since ubiquitylation targets a protein for destruction by the 
proteasome system, the ubiquitylation status of Rrn3p was analyzed before and after inhibition of 
the TOR pathway. It was previously reported that (poly)ubiquitylated proteins can be specifically 
enriched by their affinity to the immobilized (poly)ubiquitin-binding protein Dsk2p (Funakoshi et 
al., 2002). Whole cell extracts generated from the strain pNOP1-RRN3-Prot.A [pGAL1-Myc3-UBI4 
[G76A]] expressing Prot.A-tagged Rrn3p and Myc3-tagged ubiquitin before and after 10 min of 
rapamycin treatment were incubated with GST (Figure 9A, lanes 1-7 and Figure 9B, lanes 1-8) or 
GST-Dsk2p (Figure 9A, lanes 8-14 and Figure 9B, lanes 9-16) fusion protein bound to glutathione 
sepharose. After several wash steps, GST-baits and attached proteins were eluted and subjected to 
Western blot analysis.  
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Figure 9. Specific enrichment of (poly)ubiquitylated Rrn3p by (poly)ubiquitin-binding protein Dsk2p.  
(A) Yeast strain Y2181 expressing Prot.A-tagged Rrn3p from a plasmid under the control of the NOP1 promoter was 
grown in YPD at 30°C to mid-log phase before half of the cells were treated with 200 ng/ml of rapamycin (RAPA) for 
10 min. Cells of rapamycin treated and untreated cultures were collected and lyzed. Same amounts of WCE (6 mg) were 
incubated with either recombinant GST or recombinant GST-Dsk2p immobilized on 50 µl of glutathione sepharose. After 
washing, proteins bound to the beads were eluted with SDS sample buffer. 1% of input (IN) and flow through (FT), 0.5% 
of the wash steps (washes) and 50% of the eluate (E) were analyzed by Western blotting using antibodies directed 
against the Prot.A-tag of Rrn3p.  
(B) The same experiment as described in Figure 9A, except for growing yeast strain Y2181 in YPG at 30°C to induce 
expression of Myc3-tagged ubiquitin under the control of the GAL1 promoter and without rapamycin treatment. 
Retention of Pol I subunit A135 on the GST-Dsk2p-beads was analyzed by Western blotting using antibodies directed 
against A135. Ubiquitylation was analyzed using antibodies directed against the Myc3-tag of ubiquitin.  
(C) The proteasome temperature-sensitive mutant strain Y652 expressing chromosomally TAP-tagged Rrn3p was grown 
in YPD at 24°C to mid-log phase before cells were shifted to 37°C for 2 h. Half of the culture was collected and lyzed, 
whereas incubation at 37°C was continued for 1 h with the remainder of the cells in the presence of 200 ng/ml rapamycin 
prior to harvest and lysis. Same amounts of WCE (20 mg) were incubated with either recombinant GST-Dsk2p or 
recombinant GST immobilized on 50 µl of glutathione sepharose. After washing, proteins bound to the beads were 
eluted with SDS sample buffer. 90% of the eluate (E) was analyzed by Western blotting using antibodies directed against 
the Prot.A-tag of Rrn3p. At longer exposure times, Rrn3p species of higher molecular weight were detected 
(polyubiquitylated Rrn3p).  
 
Rrn3p was specifically enriched by GST-Dsk2p but not GST alone (Figure 9A and Figure 9B, central 
panel). Interestingly, rapamycin treatment does not further induce ubiquitylation of Rrn3p, since 
this factor is apparently constitutively ubiquitylated and degraded. Therefore, down-regulation of 
Rrn3p-levels upon TOR inactivation must be achieved by a reduction in the neo-synthesis of this 
protein. Indeed, RRN3 mRNA-levels are reduced to 30% after 20 min of rapamycin treatment 
(Philippi et al., 2010), which is in good agreement with previous transcriptome analyses (Huang et 
al., 2004). In addition, general translation was also reported to be decreased to 50% following 
15 min of rapamycin treatment, thus providing further evidence for reduced neo-synthesis of 
Rrn3p (Barbet et al., 1996).  
Notably, Rrn3p, which is detected in the eluates, seems to represent the monoubiquitylated form, 
since it migrates with a slightly lower mobility in SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) compared to Rrn3p in the input and flow through fractions (Figure 9A, compare lanes 8 and 
9 with 14). It seems that polyubiquitylated species of Rrn3p are highly unstable and could therefore 
just be detected when Rrn3p was enriched by GST-Dsk2p in the proteasome-deficient strain 
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cim3-1-RRN3-TAP (Figure 9C). Whole cell extracts of this strain, cultivated at the restrictive 
temperature, contain additionally higher migrating species of Rrn3p which likely represent 
polyubiquitylated forms. Interestingly, preceding rapamycin treatment for 1 h does not increase 
the amount of both mono- and polyubiquitylated Rrn3p underlining again the constitutive 
degradation of this protein.  
In contrast, Pol I subunit A135 is not among the (poly)ubiquitylated protein species which are 
specifically enriched by GST-Dsk2p (Figure 9B, upper and lower panel) suggesting that A135 is not 
a target of ubiquitylation under these conditions.  
 
3.1.2 Level of Rrn3p influences Pol I-Rrn3p complex formation, Pol I recruitment to 
the rDNA, and yeast cell growth but not the rDNA copy number 
Apparently, a connection between Rrn3p-levels and cell growth exists, since previous work 
demonstrated that a decline in the abundance of Rrn3p is accompanied with a reduction in the 
growth rate of yeast cells (Philippi, 2008). To analyze to what extent artificially altered Rrn3p-levels 
influence Pol I transcription and cell growth, the yeast mutant strains pTet7-RRN3-Prot.A and pTet7-
RRN3-Prot.A-A43-HA3 were used, in which the expression levels of Rrn3p could be adjusted by the 
drug doxycycline (Dox). In these strains, an endogenous deletion of the RRN3 gene is rescued by a 
plasmid expressing RRN3-Prot.A fusion protein under the control of a sevenfold tetracycline-
regulable promoter (Garí et al., 1997; Philippi, 2008). Additionally, in the latter, Pol I subunit A43, 
which interacts with Rrn3p in the course of Pol I-Rrn3p complex formation (Peyroche et al., 2000), is 
endogenously expressed with a C-terminal HA3-tag important for subsequent chromatin 
immunoprecipitation (ChIP) analysis. Without doxycycline in the medium, a derivative of 
tetracycline, Rrn3p is heavily overexpressed. By adding increasing amounts of doxycycline to the 
medium, Rrn3p expression could artificially be down-regulated (Figure 11, upper panel).  
The mutant strain pTet7-RRN3-Prot.A grows best when wild type expression levels of Rrn3p are 
adjusted by adding 0.1 µg/ml doxycycline (Figure 10), a concentration established by preliminary 
tests and experiments with the strain pTet7-RRN3-Prot.A-A43-HA3 (Figure 11A, lane 5). Interestingly, 
both overexpression (see section 3.2) and down-regulated levels of Rrn3p cause a reduced growth 
rate of the mutant strain pTet7-RRN3-Prot.A (Figure 10) (Philippi, 2008).  
The strain pRRN3-Prot.A-A43-HA3, which is identical to the corresponding mutant strain pTet7-
RRN3-Prot.A-A43-HA3 except for expressing RRN3-Prot.A fusion protein under the control of the 
endogenous promoter, served as an appropriate doxycycline-insensitive control.  
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Figure 10. Influence of different expression levels of Rrn3p on yeast cell growth.  
Yeast strain Y667 expressing Prot.A-tagged Rrn3p only from a plasmid under the control of a sevenfold tetracycline-
regulable promoter was grown in YPD at 30°C either in the absence or in the presence of the indicated doxycycline 
concentrations (Dox). The cultures were diluted to OD600 = 0.1. The OD600 of the cultures was monitored hourly over the 
entire 10 h time course of the experiment.  
 
As mentioned before, adding 0.1 µg/ml of doxycycline to the medium results in a nearly wild type 
expression level of Rrn3p in the strain pTet7-RRN3-Prot.A-A43-HA3 when compared to the control 
strain (Figure 11A, compare lane 5 with lane 1 and lane 2). In contrast to the mutant strain pTet7-
RRN3-Prot.A, in this mutant wild type Rrn3p-levels lead to an intermediate growth rate, whereas 
raised or depressed amounts of this factor provoke higher or lower growth rates, respectively (data 
not shown). The most likely explanation for this phenomenon is that overexpression of Rrn3p also 
leads to a growth defect probably due to excessive complex formation (see section 3.2). The HA3-
tag of Pol I subunit A43 apparently interferes with this enhanced complex formation, thereby 
repressing this growth phenotype in the strain pTet7-RRN3-Prot.A-A43-HA3 under Rrn3p 
overexpression conditions.  
Notably, even treatment with a high dose of doxycycline (1 µg/ml) does not inhibit growth of both 
mutant strains completely (Figure 10) (data not shown), although Rrn3p-levels are down-regulated 
to at least the same degree as those after 2 h of rapamycin treatment (compare Figure 8, lane 1 and 
5 with Figure 11A, lane 5 and 7).  
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Figure 11. Doxycycline-dependent expression of Rrn3p in the strain pTet7-RRN3-Prot.A-A43-HA3.  
(A) Yeast strains Y2186 and Y2185, both expressing HA3-tagged Pol I subunit A43 and Prot.A-tagged Rrn3p under the 
control of the endogenous or the sevenfold tetracycline-regulable promoter, respectively, were grown in YPD at 30°C in 
the presence of the indicated doxycycline concentrations to mid-log phase before cells were collected and lyzed. Same 
amounts of WCE (20 µg) were analyzed by Western blotting using antibodies directed against the Prot.A-tag of Rrn3p 
and the HA3-tag of the Pol I subunit A43, respectively.  
(B) Quantitative analysis of the signals presented in Figure 11A was performed with the Multi Gauge software (Fujifilm). 
Rrn3p-Prot.A signals were normalized to the signals of A43-HA3 which served as a loading control. The level of Rrn3p of 
the control strain grown without doxycycline was arbitrarily set to 100%.  
 
This suggests, that the effects of rapamycin treatment are not solely mediated by the decrease in 
the expression levels of Rrn3p. There must be other mechanisms which contribute to the 
impairment of cell growth when TOR signaling is inhibited. Furthermore, it became obvious that 
very small amounts of Rrn3p are sufficient to drive growth.  
Next, the question arose as to whether different Rrn3p-levels cause an alteration in Pol I-Rrn3p 
complex formation in the mutant strain pTet7-RRN3-Prot.A. To this end, gel filtration experiments 
were performed with WCE generated from this strain grown either in the absence or in the 
presence of 1 µg/ml doxycycline. It has been previously shown that Rrn3p is present in three 
different forms in whole cell extracts of exponentially growing yeast cells (Bier et al., 2004). 21% of 
the recovered Rrn3p elutes with the void volume of the column, about 24% co-migrates with Pol I, 
whereas the largest fraction containing 55% of Rrn3p migrates with the molecular mass of 
monomeric Rrn3p. When the cellular level of Rrn3p is altered in a specific way, then the extent of 
the void fraction, the Pol I-complexed fraction and the monomeric fraction of Rrn3p is altered in 
the same manner (Figure 12). Apparently, there is a cellular mechanism maintaining a fixed ratio 
between free and complexed Rrn3p. This means that enhanced levels of Rrn3p lead to a higher 
amount of Pol I-Rrn3p complexes, whereas a reduced Rrn3p expression has the opposite effect, 
demonstrating the correlation between Rrn3p-levels and the number of Pol I-Rrn3p complexes. 
Notably, changes in the expression level of Rrn3p does not significantly influence the elution 
profile of both this protein and RNA polymerase I in the gel filtration experiment.  
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Figure 12. Overexpression of Rrn3p results in increased amounts of Pol I-Rrn3p complexes.  
Yeast strain Y667 expressing Prot.A-tagged Rrn3p under the control of the sevenfold tetracycline-regulable promoter 
was grown in YPAD at 30°C in the absence or in the presence of 1 µg/ml doxycycline to mid-log phase before cells were 
collected and lyzed. Same amounts of WCE (900 µg) were separated on a Superose 6 column in a buffer containing 
1.5 M potassium acetate. 50% (250 µl) of every second fraction were TCA precipitated and analyzed by Western blotting 
using antibodies directed against the Prot.A-tag of Rrn3p and the Pol I subunit A135, respectively.  
 
The observation that the amount of Pol I-Rrn3p complexes could be artificially increased and 
decreased by changing the expression level of Rrn3p raised the question whether the amount of 
Pol I being recruited to the rDNA could be influenced as well. To get insight into this issue, Pol I-
ChIP experiments were performed with the mutant strain pTet7-RRN3-Prot.A-A43-HA3. Cells were 
grown in YPD at 30°C to mid-log phase in the absence or in the presence of different doxycycline 
concentrations (0.02 µg/ml; 0.1 µg/ml; 0.5 µg/ml; 1 µg/ml) before cells were crosslinked with 1% 
formaldehyde for 15 min, harvested, lyzed and sonified. The HA3-tagged Pol I subunit A43 was 
immunoprecipitated from the chromatin extracts. After DNA isolation, the relative amounts of 
specific DNA fragments co-purifying with the protein were measured in triplicate real-time PCR 
reactions. RNA Pol I crosslinking to the 35S rRNA gene promoter and to two regions coding for the 
18S rRNA and the 25S rRNA was examined. The 5S rRNA-coding region was included as an internal 
control.  
Doxycycline-insensitive strain pRRN3-Prot.A-A43-HA3, either untreated or treated with 1 µg/ml of 
doxycycline, was also included in the experiment.  
Indeed, regarding the mutant strain, a stepwise reduction of approximately 60% of both promoter 
DNA and DNA fragments of the 35S rRNA-coding sequence co-precipitating with Pol I could be 
noticed when Rrn3p-levels and concomitantly Pol I-Rrn3p complexes are diminuished (Figure 13, 
right hand side). In contrast, no change in the pattern of Pol I recruitment to the rDNA could be 
detected in the doxycycline-insensitive control strain (Figure 13, left hand side). Furthermore, it 
seems that the decrease in promoter occupancy of Pol I is slightly stronger than that in the 
transcribed region of the rDNA. This could indicate that promoter clearance is a limiting step in 
cells with wild type and enhanced Rrn3p-levels. However, despite a more than 20 fold increase in 
the amount of Rrn3p in the mutant cells without doxycycline treatment, no increase in Pol I 
occupancy at the rDNA locus could be detected in this ChIP analysis. Nevertheless, the existence of 
such an increase could not be excluded due to possible limitations of the chromatin 
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immunoprecipitation method in this special case (see section 3.2.3). For example, both one and 
five Pol I molecules crosslinked to a specific DNA fragment will just result in the precipitation of this 
single fragment, concealing a fivefold increase in the Pol I loading on this DNA. In contrast, a 
reduction of Pol I molecules is detectable without limitations. The Miller chromatin spreading 
technique could contribute to the resolution of this open question, since this method can visualize 
Pol I molecules on individual rRNA genes by electron microscopy (Miller and Beatty, 1969).  
 
 
Figure 13. Decreasing levels of Rrn3p correlate with a reduced rate of Pol I recruitment to the 35S rDNA.  
Yeast strains Y2186 and Y2185, both expressing HA3-tagged Pol I subunit A43 and Prot.A-tagged Rrn3p under the control 
of the endogenous or the sevenfold tetracycline-regulable promoter, respectively, were grown in YPD at 30°C in the 
presence of the indicated doxycycline concentrations to mid-log phase before cells were crosslinked with 1% 
formaldehyde, harvested, lyzed, and sonified. The HA3-tagged Pol I subunit A43 was immunoprecipitated from the 
chromatin extracts. After DNA isolation, the relative amounts of specific DNA fragments co-purifying with the protein 
were measured in triplicate real-time PCR reactions using primers specific for the rDNA promoter (Prom I), the 18S (18S II) 
and 25S (25S III) rRNA-coding region as well as for the 5S rRNA gene (5S), which served as an internal control. The data 
represent the mean of at least three independent ChIP experiments. The positions of the amplified rDNA regions are 
indicated in a sketch on the bottom of the figure.  
 
It has also been shown that doxycycline-dependent reduction of Pol I recruitment to the rDNA in 
the mutant strain pTet7-RRN3-Prot.A leads to a down-regulation of Pol I transcription without any 
pre-rRNA processing defects (Philippi et al., 2010). In summary, these results demonstrate a 
correlation between Rrn3p-levels, the formation of Pol I-Rrn3p complexes, recruitment of Pol I to 
the rRNA genes, rRNA gene transcription and the growth rate in yeast. It is not clear, however, 
whether alterations in the level of Rrn3p induce variations in the number of rDNA repeat units.  
As already mentioned, the rRNA genes in Saccharomyces cerevisiae consist of 100-140 transcription 
units, arranged in a tandem array on chromosome XII (Petes, 1979). In a single cell, only about half 
of the rDNA repeats are actively transcribed, whereas the other half of the population is 
transcriptionally inactive (Dammann et al., 1993). The number of the repeats is dynamic and can 
vary due to unequal meiotic and mitotic recombination events (Warner, 1989). To investigate 
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whether an artificial change in the level of the transcription factor Rrn3p leads to an alteration in 
the number of rDNA copies of the yeast cell, the content of rDNA in the corresponding input 
fractions of the preceding ChIP experiment were analyzed by real-time PCR reactions using primers 
specific for the 25S rRNA-coding region. The raw data were normalized to the content of DNA in 
the samples determined by using primers specific for the single copy gene locus NOC1. Yeast 
strains NOY1071 and NOY1064, carrying approximately 25 or 190 rDNA repeats, respectively, 
served as internal controls (Cioci et al., 2003). Notably, no significant change in the number of the 
rDNA copies could be detected (Figure 14).  
 
 
Figure 14. Variations in Rrn3p-levels do not result in an alteration in the rDNA copy number.  
Yeast strains Y2186 and Y2185, both expressing HA3-tagged Pol I subunit A43 and Prot.A-tagged Rrn3p under the control 
of the endogenous or the sevenfold tetracycline-regulable promoter, respectively, and yeast strains Y353 and Y352, 
carrying approximately 25 or 190 rDNA repeats, respectively, were analyzed as described for Figure 13. After DNA 
isolation, the content of rDNA was measured in triplicate real-time PCR reactions using primers specific for the 25S rRNA-
coding region and normalized to the content of DNA using primers specific for the single copy gene locus NOC1.  
 
Furthermore, it may be possible that changes in the expression level of Rrn3p cause an alteration in 
the ratio of actively transcribed to transcriptionally inactive rRNA gene repeats. To address this 
question, several psoralen crosslinking experiments were performed, however, due to technical 
problems, no adequate statements elucidating this issue could be made.  
Since rapamycin treatment both results in down-regulation of Rrn3p-levels and growth inhibition 
of yeast cells, the question arose whether maintaining certain levels of Rrn3p in yeast cells could 
withstand or at least attenuate growth inhibition of the cells. To this end, growth kinetics of yeast 
strains RRN3-Prot.A and pTet7-RRN3-Prot.A were monitored. The latter was grown either in the 
absence or in the presence of 1 µg/ml doxycycline. After 6 h, rapamycin was added to a final 
concentration of 200 ng/ml to the moiety of each culture. As previously described, different Rrn3p-
levels result in different growth rates of the yeast cells. However, when rapamycin is added to the 
cultures, all three stop growing within a time frame of approximately 1 h. Rapamycin-induced 
growth arrest occurred with the same kinetics in all three cultures, no matter whether Rrn3p was 
overexpressed or scarce (Figure 15).  
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Figure 15. Expression levels of Rrn3p do not influence the kinetics of growth inhibition upon TOR inactivation.  
Yeast strain Y2183 expressing Prot.A-tagged Rrn3p and yeast strain Y667 expressing Prot.A-tagged Rrn3p only from a 
plasmid under the control of a sevenfold tetracycline-regulable promoter were grown in YPD at 30°C either in the 
absence or in the presence of 1 µg/ml doxycycline (note that strain Y2183 is not the exact isogenic wild type strain to 
strain Y667). The cultures were diluted to OD600 = 0.1. After 6 h, half of the cultures were withdrawn and rapamycin was 
added to a final concentration of 200 ng/ml (indicated by an arrow). The OD600 of the cultures was monitored hourly over 
the entire 10 h time course of the experiment.  
 
Therefore, the simple reduction of Rrn3p-levels and consequently the decreased association of the 
Pol I machinery with the rDNA locus do not fully explain the drastic negative effects on ribosome 
neo-production (Figure 7, compare lane 4 with lane 3) and on cellular growth (Figure 15) upon TOR 
inhibition. It rather seems that the severe and immediate effect on pre-rRNA processing, 
predominantly affecting the production of the intermediate 27S and 20S RNAs and the mature 25S 
and 18S rRNAs, is the dominant negative effect of short-term TOR inactivation (Figure 7, lane 2). 
Although the corresponding 35S pre-rRNA-levels after 20 min of rapamycin treatment are 
comparable to those observed in untreated cells, it is not clear whether Pol I transcription is indeed 
unaffected (Figure 7, compare lane 2 with lane 1 and lane 5 with lane 4). Since 35S pre-rRNA-levels 
are the result of the co-action of pre-rRNA production, pre-rRNA processing and pre-rRNA 
degradation, a straightforward interpretation of the pulse labeling data is quite difficult. To this 
end, the effects of impaired TOR signaling on RNA Pol I transcription are investigated more 
accurately.  
 
3.1.3 RNA polymerase I transcription is not affected at early stages of TOR 
inactivation in yeast cells 
Pol I transcription appears not only to be regulated by the abundance of the transcription factor 
Rrn3p. It was also reported that modulations of the posttranslational modification pattern of both 
Rrn3p and RNA polymerase I influence Pol I transcription, for example by mediating Pol I-Rrn3p 
complex formation or elongation rate (Paule et al., 1984; Fath et al., 2001, 2004; Cavanaugh et al., 
2002; Yuan et al., 2002; Hirschler-Laszkiewicz et al., 2003; Zhao et al., 2003; Mayer et al., 2004, 2005; 
Gerber et al., 2008). Therefore, Pol I transcription could still be affected more drastically upon TOR 
inactivation than the moderate down-regulation of Rrn3p-levels and 35S pre-rRNA-levels suggests. 
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Hence, RNA polymerase I association with the 35S rRNA gene before and after various time points 
of rapamycin addition was investigated. ChIP experiments were carried out using the yeast strain 
RRN3-TAP-A43-HA3. Exponentially growing cells were incubated either in the absence or in the 
presence of rapamycin. Immediately before as well as 15 min, 30 min and 60 min after rapamycin 
addition, two samples were withdrawn of both the untreated and the treated culture and either 
fixed with 1% formaldehyde for 15 min to perform ChIP experiments or used for the preparation of 
whole cell extracts and subsequent Western blot analysis to monitor the corresponding Rrn3p-
levels. Again, RNA Pol I crosslinking to the 35S rRNA gene promoter, to two regions coding for the 
18S rRNA and the 25S rRNA and to the 5S rRNA-coding region, which served as an internal control, 
was examined.  
As expected, when yeast cells were not treated with rapamycin during exponential growth in a 
control experiment, no significant changes both in Rrn3p-levels and Pol I occupancy at the rDNA 
locus could be observed (Figure 16A and 16B). No down-regulation, but rather a slight increase in 
both levels is detectable within this time frame.  
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Figure 16. Endogenous Rrn3p-levels and Pol I association with 35S rRNA genes are unaltered after 15 min of 
rapamycin treatment, but decrease after 30 min and 60 min of drug treatment.  
Yeast strain Y658 expressing HA3-tagged Pol I subunit A43 and TAP-tagged Rrn3p was grown in YPD at 30°C to mid-log 
phase before the culture was split in two parts and further cultivated in YPD either in the absence or in the presence of 
rapamycin (200 ng/ml). At the time points indicated, two samples were withdrawn of both the untreated and the treated 
culture and cells were either collected and lyzed for subsequent Western blot analysis (A/C) or treated with 1% 
formaldehyde at 30°C for 15 min, harvested, lyzed, and sonified for subsequent ChIP experiments (B/D).  
(A/C) Same amounts of WCE (10 µg) were analyzed by Western blotting using antibodies directed against the TAP-tag of 
Rrn3p and the HA3-tag of Pol I subunit A43, respectively. Quantitative analysis of the signals was performed with the 
Multi Gauge software (Fujifilm). Rrn3p-TAP signals were normalized to the signals of A43-HA3, which served as a loading 
control. The level of Rrn3p of the first time point was arbitrarily set to 100%.  
(B/D) The HA3-tagged Pol I subunit A43 was immunoprecipitated from the chromatin extracts. After DNA isolation, the 
relative amounts of specific DNA fragments co-purifying with the protein were measured in triplicate real-time PCR 
reactions using primers specific for the rDNA promoter (Prom I), the 18S (18S II) and 25S (25S III) rRNA-coding region as 
well as for the 5S rRNA gene (5S), which served as an internal control. The data represent the mean of at least three 
independent ChIP experiments. The positions of the amplified rDNA regions are indicated in a sketch on the bottom of 
the figure.  
 
However, as already shown in Figure 8, when cells were treated with rapamycin, a reduction of the 
level of Rrn3p could be stated. But also a decline of Pol I recruitment to the rDNA locus occurred, 
which correlates well with the down-regulation of Rrn3p-levels. After 30 min and 60 min of 
treatment, both the level of Rrn3p and the amount of the rRNA gene fragments co-precipitating 
C
0,0
50,0
100,0
150,0
0 min 15 min 30 min 60 min
RAPA
Rrn3p/A43 [%]
RAPA
Rrn3p-TAP
A43-HA3
0 15 30 60 min
32 41
RRN3-TAP-
A43-HA3
Prom 18S 5.8S 25S 5S
35S
0
0,5
1
1,5
2
2,5
3
3,5
4
0 15 30 60 0 15 30 60 0 15 30 60 0 15 30 60
Prom 18S 25S 5S
% IP
RAPAD
min
RESULTS 
 
39 
with RNA Pol I subunit A43 were decreased to about half of the level before drug application 
(Figure 16C and 16D), the latter of which is consistent with previous studies (Claypool et al., 2004). 
Regarding the similar kinetics of both declines, it appears that just the level of Rrn3p determines 
the association of Pol I with the rDNA under these conditions.  
Remarkably, at early stages of TOR inactivation due to 15 min of rapamycin treatment, no reduction 
in both Rrn3p-levels and 35S rRNA gene fragments co-precipitating with RNA Pol I subunit A43 
could be detected (Figure 16C and 16D), but strong pre-RNA processing defects are already 
observable after 20 min of treatment (Figure 7, lane 2).  
Despite the evidence of Pol I molecules still being engaged on the rRNA genes at an early time 
point of impaired TOR signaling, it is not clear yet whether 35S pre-rRNA is actually produced. The 
possibility remained that these polymerase molecules are transcriptionally inactive and stalled on 
the rDNA resulting in no neo-production of 35S pre-rRNA. To elucidate the integrity of the Pol I 
transcription machinery at the rRNA genes after 15 min of rapamycin treatment, chromatin 
endogenous cleavage (ChEC) experiments were performed (Schmid et al., 2004). This method 
allows to precisely map association of proteins with the DNA within large genomic regions and to 
get a quantitative estimate which percentage of this DNA is decorated with the respective protein. 
Specifically the question whether the RNA Pol I molecules can still leave the transcribed region 
after TOR inactivation and inhibition of transcription (re)initiation was addressed. To this end, the 
two isogenic yeast strains RRN3-A43-MNase-HA3 and rrn3-8-A43-MNase-HA3 were used, both 
expressing Pol I subunit A43 from its genomic locus as a fusion protein with a C-terminally HA3-
tagged micrococcus nuclease (MNase). The latter of the strains, however, carries a temperature-
sensitive allele of RRN3 (rrn3-8). It is defective in RNA Pol I transcription (re)initiation upon a shift to 
the restrictive temperature (Cadwell et al., 1997). The outline of the experiment is illustrated in 
Figure 17A. The two strains were grown in YPD at 24°C to mid-log phase before the cultures were 
split in two parts and rapamycin was added to one half of the culture. Cells were cultivated for 
additional 15 min, then one half of each culture was withdrawn and subjected to formaldehyde 
crosslinking for subsequent ChEC analysis. The remainder of the cultures was shifted to 37°C and 
incubated for another 90 min before the cells were also treated with formaldehyde and analyzed 
by ChEC.  
After formaldehyde crosslinking, cells were harvested and nuclei were prepared before calcium 
was added to activate the endonuclease activity of the fusion proteins. Thus, the DNA was cut in 
the proximity of the protein-binding site. The reaction was stopped by the addition of the calcium 
chelating reagent EDTA, total DNA was isolated, and linearized with the restriction endonuclease 
XcmI. The restriction fragments were separated by agarose gel electrophoresis prior to being 
transferred to a membrane. Indirect endlabeling analysis allows the precise localization of the 
cleavage sites mediated by the MNase fusion proteins.  
Consistent with previous results, a characteristic cleavage pattern of the A43-MNase fusion protein 
could be observed with strong cleavage events at the promoter of the 35S rRNA gene and 
throughout the entire Pol I-transcribed sequence (Merz et al., 2008) (Figure 17B and 17C, lanes 3-5, 
8-10, 13-15 and 18-20).  
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Interestingly, no significant changes in the A43-MNase-mediated cleavage pattern before and after 
15 min of rapamycin treatment could be noticed in cells grown at 24°C, regardless of expressing 
the wild type or the mutant allele of RRN3 (Figure 17B and 17C, compare lanes 1-5 with lanes 6-10). 
This is in good agreement with the observation that Rrn3p-levels and Pol I association with the 
rDNA locus is unaltered before and after 15 min of TOR inactivation (Figure 16C and 16D). After the 
temperature shift of strain RRN3-A43-MNase-HA3 to 37°C for 90 min, the extent of the cleavages of 
MNase-tagged Pol I at the rDNA promoter region is reduced in chromatin from cells treated with 
rapamycin compared to chromatin from untreated cells (Figure 17B, compare lanes 13-15 with 
lanes 18-20 and Figure 17D). This again correlates well with the decrease in both Rrn3p-levels and 
Pol I association with the rRNA gene promoter and the transcribed region after prolonged 
rapamycin treatment observed in the ChIP experiment shown in Figure 16C and 16D. Notably, after 
more than 100 min, still substantial amounts of Pol I molecules are engaged in rDNA transcription.  
In contrast, when cells of the mutant strain rrn3-8-A43-MNase-HA3 are shifted to 37°C for 90 min, 
the Pol I-MNase-mediated cleavage pattern is drastically reduced in chromatin from rapamycin 
treated and untreated cells (Figure 17C, lanes 11-20 and Figure 17D). Since no additional Pol I 
molecules can (re)initiate transcription due to the temperature shift, possible cleavage events 
could only derive from Pol I molecules still being associated to the rDNA gene. The almost 
complete loss of cleavage events suggests that in both cases the engaged Pol I molecules were 
able to finish their transcription cycle. This result led to the conclusion that TOR inactivation does 
not immobilize RNA Pol I molecules on the rDNA template.  
Similar results were obtained, when these strains were depleted of essential amino acids for 2 h 
prior to a shift to the restrictive temperature for additional 2 h (data not shown).  
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Figure 17. RNA Pol I molecules are not stalled on the rDNA template after 15 min of rapamycin treatment.  
(A) Flow chart of the experiment shown in Figure 17B and 17C. Yeast strains Y943 and Y936, both expressing MNase-HA3-
tagged Pol I subunit A43 and carrying either an RRN3 wild type allele or the temperature-sensitive rrn3-8 allele were 
grown in YPD at 24°C to mid-log phase. The cultures were split in two parts and rapamycin was added to a final 
concentration of 200 ng/ml to one half of the culture. After 15 min, samples were withdrawn from the rapamycin treated 
(RAPA) and untreated (YPD) culture. Cells were crosslinked with 1% formaldehyde, harvested, and analyzed in ChEC 
experiments. The remainder of the cultures was shifted to 37°C and incubated for another 90 min before cells were 
crosslinked with 1% formaldehyde, harvested, and analyzed in ChEC experiments.  
(B/C) After formaldehyde crosslinking for 15 min at the respective temperature (24°C or 37°C), harvesting of cells, and 
nuclei preparation, calcium was added to activate ChEC by the MNase fusion proteins. Samples were withdrawn before 
(0) and at the times indicated on top of the panels. DNA was isolated, linearized with the restriction endonuclease XcmI, 
separated in an agarose gel, and analyzed in a Southern blot by indirect endlabeling using the rDNA-specific probe XcmI-
prom. The autoradiogram of the respective experiment is shown. The sketch on the right shows a map of the 
corresponding 4.9 kb XcmI rDNA fragment to localize the cleavage events mediated by the MNase fusion proteins. The 
positions of regulatory elements within the rRNA gene promoter, the upstream element (UE) and the core element (CE), 
of the 18S, 5.8S and 25S rRNA-coding sequences, of the transcription start site (arrow), and of the target sequence of the 
radioactive probe are depicted. An arrow on the left marks the full-length XcmI fragment.  
(D) Quantitative analysis of the data presented in Figure 17B, lanes 11-20 and Figure 17C, lanes 11-20 was performed 
with the Multi Gauge software (Fujifilm). In addition to Southern blot hybridization with probe XcmI-prom, the same 
membrane was also hybridized with probe NUP57 detecting a 4.2 kb fragment encompassing the RPS23A gene locus 
(data not shown). The radioactive signal of the full-length XcmI fragment from this autoradiogram served as an internal 
loading control, since Pol I is not binding to this Pol II-transcribed gene and therefore unspecific degradation of the full-
length transcript could be detected. The radioactive signal of the full-length XcmI fragment of the XcmI-prom-hybridized 
autoradiogram for each ChEC time point was normalized to the corresponding radioactive signal of the full-length XcmI 
fragment of the NUP57-hybridized autoradiogram. The extent of degradation is a measure for the association of RNA Pol I 
with the rRNA gene.  
 
In summary, the results of the ChIP and the ChEC experiments demonstrate that rDNA transcription 
by RNA polymerase I is only moderately affected after short-term TOR inactivation in yeast cells, 
whereas pre-rRNA processing is severely and very quickly impaired (Figure 7). Consequently, a 
process different from Pol I transcription appears to mediate the fast response to TOR inactivation.  
 
3.1.4 Inhibition of translation is sufficient to mimic severe pre-rRNA processing 
defects observed at early stages of TOR inactivation in yeast cells 
Rapamycin is reported to negatively influence not only rDNA transcription but also translation 
initiation and pre-rRNA maturation in yeast cells (Barbet et al., 1996; Beretta et al., 1996; Berset et 
al., 1998; Cardenas et al., 1999; Powers and Walter, 1999). Strikingly, inhibition of translation by 
cycloheximide treatment leads to very similar pre-rRNA processing defects (de Kloet, 1966; Udem 
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and Warner, 1972; Warner and Udem, 1972). Therefore, it might be possible that impaired 
translation at early stages of TOR inactivation is the reason for the ribosomal maturation defects.  
To further elucidate this issue, pulse-chase experiments with [3H]-uracil were performed to directly 
compare the effects of short-term rapamycin treatment and cycloheximide treatment on rRNA 
neo-synthesis in yeast cells. To this end, yeast strain RRN3-TAP-A43-HA3 was grown in YPD at 30°C 
to mid-log phase before the culture was split in three parts and further cultivated in YPD either in 
the absence or in the presence of rapamycin or cycloheximide, respectively. After 15 min of 
treatment, same amounts of cells were pulsed for 5 min with [3H]-uracil and chased with an excess 
of unlabeled uracil for 4 min, 8 min or 16 min. Total RNA was isolated and analyzed by denaturing 
agarose gel electrophoresis with subsequent Northern blotting and autoradiography (experiment 
was performed by Alarich Reiter).  
Importantly, the cellular [3H]-uracil uptake was affected only moderately and to a similar extent 
after 15 min of both rapamycin and cycloheximide treatment (data not shown).  
As expected, untreated cells showed wild type levels of newly synthesized 35S pre-rRNA, which 
was subsequently processed to the intermediate 27S and 20S rRNA and finally to the mature 25S 
and 18S rRNA (Figure 18A, lanes 1-4). Strikingly, in both rapamycin and cycloheximide treated cells, 
strong maturation defects could be detected resulting in the relative accumulation of labeled 35S 
pre-rRNA. Additionally, although the initial 35S pre-rRNA-levels were comparable to those 
observed in untreated cells, the amounts of intermediate rRNA and mature rRNA were strongly 
reduced in rapamycin treated cells and almost completely lost in cycloheximide treated cells 
(Figure 18A, lanes 5-12). To illustrate the dimension of the maturation defects in the differently 
treated yeast cells, the ratio of 35S rRNA to 27S rRNA was calculated and normalized to the ratio in 
untreated cells (Figure 18B). Furthermore, the incorporation of [3H]-uracil into the mature 25S rRNA 
was quantified as a measure of ribosome neo-production (Figure 18C). 15 min of TOR inactivation 
were sufficient to decrease the neo-synthesis of 25S rRNA to 10%, whereas the effect in cells 
inhibited in translation for the same time was even stronger.  
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Figure 18. Both short-term rapamycin or cycloheximide treatment lead to severe pre-rRNA processing defects 
(experiment was performed by Alarich Reiter).  
(A) Yeast strain Y658 expressing HA3-tagged Pol I subunit A43 and TAP-tagged Rrn3p was grown in YPD at 30°C to mid-
log phase before the culture was split in three parts and further cultivated in YPD either in the absence or in the presence 
of rapamycin (200 ng/ml) or cycloheximide (100 µg/ml) for 15 min. Pulse labeling with [3H]-uracil was performed for 
5 min followed by a chase with an excess of unlabeled uracil (final concentration 1 mg/ml) for the times indicated above 
the panel. RNA was isolated, separated in a denaturing agarose gel, and transferred to a positively charged nylon 
membrane. The autoradiogram shown was obtained after exposure of the membrane treated with EN3HANCE solution. 
Positions of the different rRNA processing products are indicated on the right.  
(B) Quantitative analysis of [3H]-signals presented in Figure 18A was performed prior to EN3HANCE treatment. The ratio of 
the [3H]-signals of the 35S and 27S pre-rRNAs was calculated after 5 min pulse (0) of each experiment. The 35S/27S rRNA 
ratio of the cells grown for 15 min in YPD was arbitrarily set to 1.  
(C) Incorporation of [3H]-uracil into 25S rRNA was determined by excision of the 25S rRNA bands from an identical blot 
and analysis by liquid scintillation counting. The values obtained were normalized to the value after 5 min pulse (0) of the 
culture grown for 15 min in YPD, which was arbitrarily set to 1, and plotted against the time of the chase.  
 
Consistent with previous studies (de Kloet, 1966; Udem and Warner, 1972; Warner and Udem, 
1972), these results demonstrate that inhibition of translation by cycloheximide for 15 min leads to 
severe defects in pre-rRNA maturation and ribosome neo-production comparable to those 
observed after short-term TOR inactivation by rapamycin.  
Additionally, since 15 min of rapamycin treatment caused no alterations in Pol I occupancy at the 
rDNA locus, Pol I-ChIPs were performed to investigate in detail how the association of RNA Pol I 
with the rDNA locus is affected upon cycloheximide treatment. The experiment was identical with 
the one shown in Figure 16C and 16D, except for treatment of the cells with cycloheximide instead 
of rapamycin.  
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Figure 19. Endogenous Rrn3p-levels and Pol I association with 35S rRNA genes are at most marginally affected 
after 15 min of cycloheximide treatment.  
Yeast strain Y658 expressing HA3-tagged Pol I subunit A43 and TAP-tagged Rrn3p was grown in YPD at 30°C to mid-log 
phase before cycloheximide was added to a final concentration of 100 µg/ml. At the time points indicated, two samples 
were withdrawn and cells were either collected and lyzed for subsequent Western blot analysis (A) or treated with 1% 
formaldehyde at 30°C for 15 min, harvested, lyzed, and sonified for subsequent ChIP experiments (B).  
(A) Western blot and quantitative analysis was performed as described in the legend to Figure 16A.  
(B) ChIP experiments were performed as described in the legend to Figure 16B.  
 
The results obtained from this time course experiment were strikingly similar to those observed in 
the corresponding rapamycin experiment (Figure 19). After 15 min of cycloheximide action, just a 
slight decrease in Rrn3p-levels and in the amount of rRNA gene promoter fragments co-
precipitating with Pol I subunit A43 could be detected. Prolonged incubation with the protein 
synthesis inhibitor for 60 min, however, led to a decline to approximately 60% of both values. The 
data obtained for A43 crosslinking to the transcribed region of the rDNA were not as easy to be 
interpreted. They indicated that Pol I recruitment to this region was enhanced after 15 min of 
cycloheximide treatment compared to the untreated situation. After extended treatment, these 
levels were diminished again to or slightly below the initial value. Nevertheless, similar to the 
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rapamycin experiment, no significant decrease in RNA Pol I association with the rDNA locus after 
short-term translation inhibition could be observed, although in both cases the production of 
mature rRNAs is strongly reduced (Figure 18).  
In summary, the above results demonstrate that both short-term TOR inactivation and short-term 
translation inhibition do not significantly affect the association of Pol I with the rDNA locus, 
whereas ribosomal subunit production is severely impaired. Accordingly, impaired translation 
might be sufficient to explain the strong effects of TOR inactivation upon ribosome neo-production 
and cell growth.  
Importantly, impaired protein synthesis predominantly interferes with the abundance of proteins 
showing both a high expression rate and a high turnover rate. Furthermore, the observation that 
inhibited translation rapidly leads to a severe pre-rRNA processing defect strongly argues for an 
abrupt shortage of proteins important for rRNA maturation and ribosome biogenesis. Since the 
highly expressed ribosomal proteins are characterized by just a small pool size of free, non-
ribosome-bound r-proteins due to both a quick assembly rate into pre-ribosomal particles and a 
high turnover rate, these proteins are very likely candidates (Warner, 1977; Gorenstein and Warner, 
1977; Warner et al., 1985; Mitsui et al., 1988; Wittekind et al., 1990). Consistently, conditional shut-
down of individual r-proteins is reported to provoke strong defects in rRNA maturation and 
ribosome biogenesis (Ferreira-Cerca et al., 2005, 2007; Robledo et al., 2008; Pöll et al., 2009).  
 
3.1.5 Short-term TOR inactivation predominantly affects expression of ribosomal 
proteins whose abundance is important for yeast cell growth 
It has been published that within 15 min of rapamycin treatment the mRNA-levels of specifically 
ribosomal protein genes and ribosome biogenesis genes are significantly and quickly decreased 
(Powers and Walter, 1999; Jorgensen et al., 2004). In parallel, general translation is shown to be 
reduced to an extent of 50% (Barbet et al., 1996). Therefore, a sharp decline in the amount of these 
essential components of ribosome biogenesis under these conditions is very likely.  
To investigate whether the neo-production of ribosomal proteins is indeed significantly affected 
after 15 min of rapamycin treatment, pulse experiments with [35S]-methionine/cysteine were 
performed. To this end, wild type yeast strain W303-1A was grown in minimal medium depleted of 
amino acids methionine and cysteine (SCD-met-cys) at 30°C to mid-log phase before the culture 
was split in six parts and further cultivated in SCD-met-cys either in the absence or in the presence 
of rapamycin (200 ng/ml) or cycloheximide (0.1 µg/ml; 1 µg/ml; 10 µg/ml; 100 µg/ml). After 15 min 
of treatment, same amounts of cells were pulsed for 5 min with [35S]-methionine/cysteine. Total 
protein was extracted and subjected to SDS-PAGE with subsequent coomassie staining and 
autoradiography. To facilitate the identification of bands corresponding to r-proteins, a sample 
containing purified 80S ribosomes was loaded on the gel. Strikingly, the pattern derived from the 
r-proteins of this sample is very similar to that observed in total protein samples, especially in the 
low-molecular range. To verify the identity of the proteins, the eight prominent bands migrating 
with the corresponding mobility of putative ribosomal proteins were excised and analyzed by mass 
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spectrometry. As expected, among 45 proteins identified in these bands, 39 were indeed ribosomal 
proteins, accounting for approximately 90% of the total protein content.  
Strikingly, in the autoradiogram the labeling of these ribosomal proteins is strongly and specifically 
reduced after 15 min of rapamycin treatment compared to both the expression of overall proteins 
in this sample and the neo-production of proteins in untreated cells (Figure 20A, compare lane 9 
with lane 8). It seems that rapamycin treatment specifically and severely affects neo-production of 
r-proteins, whereas treatment with increasing cycloheximide concentrations results in a more 
general decline in the synthesis of all proteins (Figure 20A, compare lane 9 with lanes 10-13). To 
further document this statement, quantitative analysis of the fast migrating double band (7+8) was 
performed (Figure 20B). Bands were excised and subjected to liquid scintillation counting. The 
values obtained were normalized to the coomassie signal of the corresponding band, which served 
as a loading control. Whereas a significant decline in the neo-synthesis of the respective proteins 
could be detected in cells treated with 200 ng/ml of rapamycin, just a slight decrease was 
measureable in cells treated with 0.1 µg/ml of cycloheximide (Figure 20B). Importantly, the overall 
incorporation of [35S] only marginally differred under these two conditions being about half of the 
level without drug application (data not shown).  
These results correlate well with the results obtained in the pulse-chase experiment shown in 
Figure 18A. Strong impairment of r-protein expression using 200 ng/ml of rapamycin (Figure 20A, 
lane 9) led to a strong reduction of pre-rRNA processing (Figure 18A, lanes 5-8). A complete shut-
off of r-protein synthesis, however, obtained when treating the cells with 100 µg/ml of 
cycloheximide (Figure 20A, lane 13) reduced pre-rRNA maturation to background levels (Figure 
18A, lanes 9-12).  
Recently, a yeast mutant strain was described whose RNA polymerase I molecules remain 
constitutively competent for the initiation of transcription under stress conditions due to 
expressing A43-Rrn3p fusion proteins (Laferté et al., 2006). In this CARA mutant, the down-
regulation of Pol I transcription upon rapamycin treatment is attenuated, resulting concomitantly 
in a derepression of Pol II transcription that is restricted to the genes encoding ribosomal proteins. 
To analyze whether this attenuated decrease in the mRNA-levels of ribosomal proteins leads to 
increased neo-synthesis of these proteins under these conditions which might diminish the pre-
rRNA processing defects, identical pulse experiments were performed including the corresponding 
wild type strain YPH500 as an appropriate control.  
Strikingly, in both cases the same reduction in the expression levels of ribosomal proteins was 
detected as observed for strain W303-1A (Figure 20C, compare with Figure 20A). Again, this is 
consistent with results from pulse-chase experiments with [3H]-uracil analyzing the neo-synthesis 
of rRNA in the strains YPH500 and CARA. The strong impairment of r-protein expression obtained 
by treating the cells with 200 ng/ml of rapamycin led to a severe pre-rRNA processing defect in 
both strains, which could be even aggravated by treating the cells with 100 µg/ml of cycloheximide 
(data not shown). This led to the conclusion that an attenuated decline in r-protein mRNA-levels is 
not sufficient to rescue the decrease in the expression levels of ribosomal proteins.  
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Figure 20. Short-term rapamycin treatment leads to a specific and significant decrease in neo-synthesized r-
protein-levels in yeast cells.  
(A) Yeast strain Y6 was grown in SCD-met-cys at 30°C to mid-log phase before the culture was split in six parts and further 
cultivated in SCD-met-cys either in the absence or in the presence of rapamycin (200 ng/ml) or cycloheximide (0.1 µg/ml; 
1 µg/ml; 10 µg/ml; 100 µg/ml). After 15 min of treatment, same amounts of cells were pulsed for 5 min with [35S]-
methionine/cysteine. Total protein was extracted and subjected to SDS-PAGE with subsequent coomassie staining and 
autoradiography. A sample containing purified 80S ribosomes was included as a marker for r-proteins. The protein bands 
which were migrating with the putative mobility of ribosomal proteins and which were therefore analyzed by mass 
spectrometry are indicated on the left with numbers 1-8.  
(B) Incorporation of [35S]-methionine/cysteine into the protein band marked in Figure 20A was determined by excision of 
the respective band from the coomassie-stained gel and analysis by liquid scintillation counting. The values obtained 
were normalized to the values of the coomassie-stained bands obtained with the Multi Gauge software (Fujifilm). The 
level of incorporation of [35S]-methionine/cysteine into the respective protein band of the cells grown for 15 min in YPD 
was arbitrarily set to 100%. The data represent the mean of at least two independent experiments.  
(C) Experiment was essentially performed as described in the legend to Figure 20A, except for using yeast strains Y2172 
and Y2171.  
 
The fact that only moderate changes in the level of one single r-protein in the context of gene 
haploinsufficiency in human disease (Farrar et al., 2008; Lipton and Ellis, 2009, 2010) or in yeast 
mutants (Abovich et al., 1985; Lucioli et al., 1988; Song et al., 1996; Léger-Silvestre et al., 2005; 
Deutschbauer et al., 2005) are sufficient to cause pre-rRNA processing and growth defects indicates 
how drastically a strong reduction of most if not all ribosomal proteins affects yeast cell growth.  
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Figure 21. The moderate reduction of the expression level of one single ribosomal protein to approximately 50% 
results in a significant growth defect.  
Diploid yeast strains Y208 and Y990, the latter of which bears a deletion of one RPL25 allele, and two derivatives of strain 
Y990 which carry either a control plasmid (YCplac111GAL) or a plasmid expressing the ribosomal protein Rpl25p under 
the control of a galactose-dependent promoter (pGAL1-RPL25) were grown at 30°C in YPG (Y208) or YPG + geneticin 
(Y990 + derivatives). Growth was monitored for 10 h by measuring the OD600 of the cultures.  
 
To confirm the effect of the reduction of one specific r-protein to presumably 50%, growth of the 
RPL25 haploinsufficient diploid yeast strain RPL25/rpl25∆  was monitored. The isogenic wild type 
strain BY4743 was included in the experiment as an appropriate control. As shown in Figure 21, the 
growth rate of the mutant strain was significantly lower than that of the corresponding wild type 
strain. Transforming the mutant strain with a plasmid for galactose-dependent expression of RPL25 
(pGAL1-RPL25) completely rescued growth to wild type rate. However, no significant changes with 
respect to the growth rate could be observed when this mutant strain is transformed with an 
identical control plasmid lacking the RPL25 insert (YCplac111-pGAL1). These results underlined well 
the importance of maintaining a certain level of this individual ribosomal protein for yeast cell 
growth.  
 
3.1.6 Nucleolar entrapment of ribosome biogenesis factors in yeast cells is 
mediated by both rapamycin and cycloheximide treatment as well as by 
conditional shut-down of ribosomal protein expression 
Recently, TOR signaling was reported to be involved in late steps of ribosome maturation, co-
transcriptional ribosome assembly and pre-40S ribosome export (Honma et al., 2006; Vanrobays et 
al., 2008). Rapamycin treatment triggers the nucleolar entrapment of Rrp12p, a cytoplasmic HEAT-
repeat/Armadillo-domain and export factor (Oeffinger et al., 2004), and Nog1p, a GTP-binding 
protein, thereby generating defects in the above processes.  
Since the severe impact of TOR inactivation upon ribosome production and cell growth appears to 
derive from impaired translation and especially from a fast depletion of the free pool of ribosomal 
proteins, an attempt was made to reproduce the above results and to test in parallel whether 
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cycloheximide treatment influences the cellular localization of these two ribosome biogenesis 
factors as well.  
Hence, yeast strains RRP12-GFP and NOG1-GFP expressing either GFP-tagged Rrp12p or Nog1p, 
respectively, were grown in YPD at 30°C to mid-log phase before the cultures were split in three 
parts and further cultivated either in the absence or in the presence of rapamycin (200 ng/ml) or 
cycloheximide (100 µg/ml). After 15 min and 30 min, samples were withdrawn, cells were washed, 
and immediately subjected to live cell imaging. Indeed, in both rapamycin and cycloheximide 
treated cells a concentration of the GFP-signal to a crescent-shaped region of the nucleus, very 
likely representing the nucleolus, could be detected, whereas the signal remained dispersed in 
untreated cells (Figure 22, row 2, 4, 6, and 8, compare central and lower panel with upper panel). 
The concentration in the nucleolus was more obvious for Rrp12p-GFP, since this factor is 
distributed all over the cell in normal conditions, whereas Nog1p-GFP is already nuclear in cells 
cultivated in YPD (Figure 22, row 4 and 8, compare upper and central panel). Furthermore, it 
appeared that in cells treated with cycloheximide, the subcellular redistribution of the ribosome 
biogenesis factors occurred even faster than in cells treated with rapamycin (Figure 22, row 2 and 
6, compare central and lower panel).  
These results suggest that biogenesis factors Rrp12p and Nog1p are no direct targets of the TOR 
signaling cascade, but their entrapment in the nucleolus is rather a consequence of rapamycin-
induced inhibition of protein synthesis, because cycloheximide treatment, which is not reported to 
affect the TOR pathway, provokes the identical effects.  
 
 
Figure 22. Both rapamycin and cycloheximide treatment result in nucleolar entrapment of ribosome biogenesis 
factors Rrp12p and Nog1p in yeast cells.  
Yeast strains Y1809 and Y1807 expressing either GFP-tagged Rrp12p or Nog1p were grown in YPD at 30°C to mid-log 
phase before the cultures were split in three parts and further grown in YPD either in the absence or in the presence of 
rapamycin (200 ng/ml) or cycloheximide (100 µg/ml). At the time points indicated on top of the panels, a sample was 
withdrawn, washed with SCD, and immediately analyzed by fluorescence microscopy (GFP). Yeast cell morphology was in 
parallel visualized by differential contrast (DIC).  
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Next, the hypothesis of rapidly depleted r-proteins generating the observed concentration effects 
of these ribosome biogenesis factors was tested. Therefore, yeast strains deleted in the 
chromosomal copies of RPS5, RPS14 or RPL25 and conditionally expressing the respective wild type 
allele under the control of the glucose repressible GAL1 promoter were employed (Ferreira-Cerca et 
al., 2005; Pöll et al., 2009). Whereas growth of these strains is supported in YPG due to occurring 
expression of the corresponding ribosomal proteins, a shift of the cells to glucose containing 
medium inhibits this expression and leads to strong and selective defects in nuclear maturation 
steps of ribosomal subunit precursors (van Beekvelt et al., 2000, 2001; Ferreira-Cerca et al., 2005, 
2007; Pöll et al., 2009). The above strains and the corresponding wild type strains, which served as 
controls, were genetically modified for constitutive expression of either GFP-tagged Rrp12p or 
GFP-tagged Nog1p.  
 
 
 
Figure 23. Conditional shut-down of individual ribosomal proteins results in nucleolar entrapment of ribosome 
biogenesis factors Rrp12p and Nog1p in yeast cells.  
(A) Yeast strains Y1809, Y1805, and Y1806 expressing GFP-tagged Rrp12p and expressing ribosomal protein Rps5p or 
Rps14p either from their respective genomic loci (WT) or from a plasmid under the control of a galactose-dependent 
promoter (pGAL1-RPS5, pGAL1-RPL25) were grown in YPG at 30°C to mid-log phase before the cultures were split in two 
parts. Cells were collected, washed, and further cultivated in either YPG or YPD. After 90 min, a sample was withdrawn, 
washed with SCG or SCD, and immediately analyzed by fluorescence microscopy as described in the legend to Figure 22.  
(B) Yeast strains Y1807 and Y1804 both expressing GFP-tagged Nog1p and expressing ribosomal protein Rpl25p either 
from their respective genomic loci (WT) or from a plasmid under the control of a galactose-dependent promoter (pGAL1-
RPL25) were analyzed as described in the legend to Figure 23A.  
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For the experiment, these yeast strains, RRP12-GFP, NOG1-GFP, pGAL1-RPS5-RRP12-GFP, pGAL1-
RPS14-RRP12-GFP, and pGAL1-RPL25-NOG1-GFP, were grown in YPG at 30°C to mid-log phase 
before the cultures were split in two parts. Cells were collected, washed, and further cultivated 
either in YPG or YPD. After 90 min, samples were withdrawn, cells were washed, and immediately 
subjected to live cell imaging. The images obtained showed clearly that the depletion of individual 
ribosomal proteins in mutant cells grown for 90 min in YPD indeed resulted in nucleolar 
entrapment of the factors Rrp12p and Nog1p, in contrast to wild type cells (Figure 23A and 23B, 
row 2, 4 and 6 or row 2 and 4, respectively, compare lower panel with upper panel).  
These observations demonstrate that the specific reduction in the abundance of a single ribosomal 
protein is sufficient to provoke the same effects concerning the subcellular localization of these 
ribosome biogenesis factors in yeast cells as does rapamycin or cycloheximide treatment.  
In summary, the nucleolar entrapment of Rrp12p and Nog1p is obviously not a direct consequence 
of impaired TOR signaling, but is rather caused indirectly by the rapid and specific depletion of the 
free pool of ribosomal proteins in this situation which is presumably due to the down-regulation of 
both transcription of r-protein genes and general translation.  
 
3.2 Effects of overexpression of Rrn3p on RNA polymerase I 
transcription 
3.2.1 GAL1-dependent overexpression of Rrn3p results in defects of yeast cell 
growth 
During the preceding studies, it has become obvious that the level of RNA Pol I transcription 
initiation factor Rrn3p indeed influences transcription of ribosomal RNA genes by RNA polymerase 
I in yeast. Furthermore, it appeared that enhanced expression of Rrn3p, leading to a larger amount 
of Pol I-Rrn3p complexes (Figure 12), is accompanied with a decrease in yeast growth rate (Figure 
10) (Philippi, 2008). The question arose as to whether and how the overexpression of Rrn3p affects 
the Pol I system and in turn ribosome production and yeast cell growth or whether the defect in 
cell growth is mediated by increased Rrn3p-levels in a Pol I-independent manner.  
To further elucidate this issue, yeast strain RRN3-Prot.A-A190-HA3 was used expressing Prot.A-
tagged Rrn3p and HA3-tagged Pol I subunit A190 both from their genomic loci. The tags are 
important to allow the analysis of possible alterations in the association of the respective protein 
with the rDNA locus by chromatin immunoprecipitation experiments.  
Transformation of the strain RRN3-Prot.A-A190-HA3 with plasmids pGAL1-RRN3-Prot.A (A/C) or 
pGAL1-RRN3-Prot.A (2µ) both results in the formation of mutant strains harboring the possibility of 
a galactose-inducible overexpression of Prot.A-tagged Rrn3p in a co-expression situation. 
Overexpression from the latter, however, should produce an even higher level of Rrn3p than from 
the first due to carrying a multi-copy (2µ) and not a single-copy (A/C) plasmid. Another 
transformation of the above strain with the single-copy plasmid pRRN3-Prot.A (A/C) results in the 
formation of a mutant strain constitutively expressing Prot.A-tagged Rrn3p under the control of its 
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endogenous promoter in the same co-expression situation. In the following experiments this 
strain, hereafter called pRRN3-Prot.A (A/C), was included as a control to be able to monitor the 
effects of Rrn3p overexpression in the corresponding mutant strains, hereafter called pGAL1-RRN3-
Prot.A (A/C) and pGAL1-RRN3-Prot.A (2µ).  
The three strains were commonly grown in minimal medium depleted of the amino acid leucine in 
order to prevent the loss of the plasmids by maintaining selective conditions and containing 
raffinose as carbon source (SCR-leu) to either permit induction or inhibition of Rrn3p 
overexpression by adding galactose or glucose to the medium, respectively.  
To reproduce the observation that abnormal excess of Rrn3p indeed results in a significant growth 
defect, pre-cultures of these three strains were grown overnight in SCR-leu at 30°C before different 
dilutions of the cells were spotted either on SCD-leu (glucose) or SCG-leu (galactose) plates and 
incubated for 2-4 days at different temperatures (Figure 24).  
 
 
Figure 24. Overexpression of Rrn3p results in defects of yeast cell growth.  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 both from their genomic loci was 
transformed either with the single-copy plasmid pRRN3-Prot.A (A/C), with the single-copy plasmid pGAL1-RRN3-Prot.A 
(A/C), or with the multi-copy plasmid pGAL1-RRN3-Prot.A (2µ), all of them expressing additionally Prot.A-tagged Rrn3p 
under the control of the endogenous promoter or the GAL1 promoter, respectively. Cells were grown overnight in SCR-
leu at 30°C before different dilutions were spotted on SCD-leu or SCG-leu plates containing either glucose or galactose as 
carbon source and incubated for 3-4 days at the temperatures indicated on top of the panels.  
 
Indeed, growth defects occurred when overexpression of Rrn3p was induced by growth on 
galactose-containing plates (Figure 24, lower panels) in contrast to plates with the carbon source 
glucose (Figure 24, upper panels), where the additional expression of Rrn3p is impaired. However, 
moderate overexpression of this factor in cells harboring the single-copy plasmid pGAL1-RRN3-
Prot.A (A/C) was at most slightly affected (Figure 24, lower panel, central spots), whereas strong 
overexpression in cells with the corresponding multi-copy plasmid pGAL1-RRN3-Prot.A (2µ) caused 
a significant reduction of the growth rate (Figure 24, lower panel, lower spots). Additionally, it 
appeared that the effect was more severe when cells were grown at 24°C compared to cells grown 
at 30°C or 37°C (Figure 24, lower panels, compare left panel with central and right panel). For this 
reason, in the following experiments cells were grown at 24°C when overexpression of Rrn3p was 
induced by galactose addition. Additionally, the overexpression of Rrn3p was induced for at least 
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8 h, since preliminary experiments showed that after this time the growth defect became 
detectable by monitoring the optical density of liquid cultures (data not shown).  
To get a quantitative estimate, Rrn3p-levels of the three strains were analyzed by Western blotting 
after cells were grown in SCR-leu+gal for 8 h at 24°C. The cultures were always kept in the 
logarithmic growth phase (OD600 ∼ 0.1-0.7) by dilution with SCR-leu+gal.  
 
 
Figure 25. Galactose-dependent expression of Rrn3p in the strain RRN3-Prot.A-A190-HA3 harboring either 
plasmid pRRN3-Prot.A (A/C) or plasmids pGAL1-RRN3-Prot.A (A/C) and pGAL1-RRN3-Prot.A (2µ).  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) was grown in SCR-leu at 30°C to mid-log phase 
before galactose was added to a final concentration of 2% (w/v) and the cultures were shifted to 24°C. The cultures were 
further grown for 8 h, always keeping the cells in the logarithmic growth phase by dilution with SCR-leu+gal. Cells were 
collected, lyzed, and same amounts of WCE (9 µg) were analyzed by Western blotting using antibodies directed against 
the Prot.A-tag of Rrn3p and the HA3-tag of the Pol I subunit A190, respectively. Quantitative analysis of corresponding 
signals was performed with the Multi Gauge software (Fujifilm). Rrn3p-Prot.A signals were calculated and normalized to 
the signals of A190-HA3, which served as a loading control. The level of Rrn3p of the control strain was arbitrarily set to 
100%.  
 
Relative to the level of Pol I subunit A190, the level of Rrn3p could be enhanced 20 fold in the 
moderate overexpression situation, whereas under strong overexpression conditions even a 60 
fold increase could be achieved (Figure 25), which seems to be a critical amount for yeast cell 
growth (Figure 24, lower panel, lower spots).  
 
3.2.2 Overexpression of Rrn3p leads to increased amounts of Pol I-Rrn3p complexes 
in yeast cells 
As shown before (see section 3.1.2), artificially increased levels of Rrn3p triggers the production of 
more Pol I-Rrn3p complexes in the cell. To reproduce and to corroborate the results of the 
preceding experiment, this issue is analyzed here in more detail by handling the examination in a 
more quantitative way.  
To this end, co-immunoprecipitation (CoIP) experiments were performed with the strains pRRN3-
Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), and pGAL1-RRN3-Prot.A (2µ). As described, cells were 
grown in SCR-leu at 30°C to mid-log phase before galactose was added to the medium and cells 
were further cultivated for 8 h at 24°C while keeping them always in the logarithmic growth phase 
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by dilution with SCR-leu+gal. Since only about 2% of all RNA Pol I molecules in a logarithmically 
growing wild type cell are bound to Rrn3p and therefore competent for transcription initiation 
(Milkereit and Tschochner, 1998), formaldehyde crosslinking for 15 min was necessary to get co-
precipitation of detectable amounts of Rrn3p. Cells were collected, lyzed, and sonified before the 
Pol I-specific subunit A190 was immunoprecipitated via its HA3-tag from the chromatin extracts. 
The associated proteins were eluted with SDS sample buffer and incubated for 30 min at 99°C to 
reverse the formaldehyde crosslink. Same amounts of the input (3%) and IP fractions (90%) were 
analyzed by Western blotting. An identical CoIP experiment, except for omitting the required 
antibodies, was performed and included as an appropriate control.  
 
 
 
Figure 26. Increased levels of Rrn3p result in elevated levels of Pol I-Rrn3p complexes.  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) was grown in SCR-leu at 30°C to mid-log phase 
before galactose was added to a final concentration of 2% (w/v) and the cultures were shifted to 24°C. The cultures were 
further grown for 8 h, always keeping the cells in the logarithmic growth phase by dilution with SCR-leu+gal. Cells were 
crosslinked with 1% formaldehyde, harvested, lyzed, and sonified. The HA3-tagged Pol I subunit A190 was 
immunoprecipitated from the chromatin extracts. Proteins were eluted with SDS sample buffer and the formaldehyde 
crosslink was reversed by incubation for 30 min at 99°C. 3% of the input and 90% of the IP fraction were analyzed by 
Western blotting using antibodies directed against the Prot.A-tag of Rrn3p and the HA3-tag of the Pol I subunit A190, 
respectively. Quantitative analysis of corresponding signals was performed with the Multi Gauge software (Fujifilm). The 
ratio of the IP-signals of Rrn3p-Prot.A and A190-HA3 were calculated and the Rrn3p/A190 ratio of the control strain was 
arbitrarily set to 100%.  
 
The increasing signal intensities of Rrn3p in the respective input fractions relative to Pol I subunit 
A190 demonstrate again the occurring overexpression of this factor in the mutant strains upon 
growth on galactose (Figure 26, left panel).  
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Regarding the amount of Rrn3p co-precipitating with Pol I subunit A190, it is obvious that 
increasing Rrn3p-levels are actually accompanied by elevated levels of Pol I-Rrn3p complexes 
(Figure 26, central panel). By quantification of corresponding signals of the identical samples (data 
not shown) and subsequent calculation, it could be measured that, by artificially raising the levels 
of Rrn3p 60 fold, an increase in Pol I-Rrn3p complex formation of more than 25 fold could be 
generated (Figure 26, quantification).  
Importantly, in the control experiment no precipitation of both Pol I and Rrn3p could be detected 
indicating the high binding specificity of Rrn3p to A190 in the actual experiment (Figure 26, 
compare right panel with central panel).  
 
3.2.3 ChIP experiments reveal no increase in the association of Pol I with the rDNA 
locus, but an enhanced level of Rrn3p crosslinking to the rDNA locus when 
Rrn3p is overexpressed in yeast cells 
The next investigation step was to analyze whether the artificially elevated amount of Pol I-Rrn3p 
complexes by overexpression of Rrn3p leads in turn to an augmented recruitment rate of Pol I 
and/or Rrn3p to the rRNA genes.  
Therefore, ChIP experiments were performed to examine both the crosslinking of Pol I and Rrn3p 
to the rDNA locus. Yeast strains pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), and pGAL1-RRN3-
Prot.A (2µ) were grown as previously mentioned in SCR-leu at 30°C to mid-log phase before 
galactose was added to the medium and cells were further cultivated for 8 h at 24°C while keeping 
them always in the logarithmic growth phase by dilution with SCR-leu+gal. Cells were crosslinked 
with 1% formaldehyde for 15 min, harvested, lyzed, and sonified. The chromatin extracts were split 
in two parts and either the HA3-tagged Pol I subunit A190 or the Prot.A-tagged Rrn3p were 
immunoprecipitated. After DNA isolation, the relative amounts of specific DNA fragments co-
purifying with the respective protein were measured in triplicate real-time PCR reactions using 
different sets of primer pairs for each of the two proteins. Crosslinking of RNA Pol I was examined 
to the 35S rRNA gene promoter region and to two regions coding for the 18S rRNA and the 25S 
rRNA. Crosslinking of Rrn3p was investigated in a similar way to the 35S rDNA promoter region and 
to one and to two regions coding for the 18S rRNA and the 25S rRNA, respectively. The 5S rRNA-
coding region was included in both analyses as an internal control.  
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Figure 27. Increased levels of Rrn3p do not lead to an enhanced association of Pol I with the rDNA locus in ChIP 
experiments.  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) was grown in SCR-leu at 30°C to mid-log phase 
before galactose was added to a final concentration of 2% (w/v) and the cultures were shifted to 24°C. The cultures were 
further grown for 8 h, always keeping the cells in the logarithmic growth phase by dilution with SCR-leu+gal. Cells were 
crosslinked with 1% formaldehyde for 15 min, harvested, lyzed, and sonified. The HA3-tagged Pol I subunit A190 was 
immunoprecipitated from the chromatin extracts. After DNA isolation, the relative amounts of specific DNA fragments 
co-purifying with the protein were measured in triplicate real-time PCR reactions using primers specific for the rDNA 
promoter (Prom I), the 18S (18S II) and 25S (25S III) rRNA-coding region as well as for the 5S rRNA gene (5S), which served 
as an internal control. The data represent the mean of at least three independent ChIP experiments. The positions of the 
amplified rDNA regions are indicated in a sketch on the bottom of the figure.  
 
The results of the Pol I-ChIP experiment indicated that there was no enhanced recruitment of Pol I, 
neither to the rDNA promoter region nor to the transcribed region of the rRNA gene, even though 
more Pol I-Rrn3p complexes were available. Yet, a slight decrease in Pol I association with the rDNA 
appeared to occur in the situation with strong overexpression of Rrn3p (Figure 27). However, this 
difference was not drastic and could therefore just be due to measurement inaccuracy. As 
mentioned before (see section 3.1.2), there are certain limitations of the chromatin 
immunoprecipitation method in this special case, possibly concealing the existence of increased 
Pol I occupancy at the rDNA locus. Corresponding ChEC experiments or the Miller chromatin 
spreading technique might help to overcome this problem.  
In contrast to Pol I, a significant increase in the association of Rrn3p with the rRNA gene promoter 
region but also elevated crosslinking to the transcribed sequence could be detected (Figure 28). 
However, increased levels of Rrn3p crosslinking to the region coding for the 5S rRNA, which is 
transcribed by RNA polymerase III, indicated a rise in unspecific binding of the overexpressed 
protein as well. Nevertheless, when the levels of specific binding were corrected by the respective 
level of unspecific binding, still a significant increase in the crosslinking of Rrn3p both to the rDNA 
promoter region and the transcribed sequence could be detected in the course of its 
overexpression.  
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Figure 28. Increased levels of Rrn3p lead to a significantly enhanced association of Rrn3p with the rDNA locus in 
ChIP experiments.  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) was grown as described in Figure 27. Cells 
were crosslinked with 1% formaldehyde for 15 min, harvested, lyzed, and sonified. The Prot.A-tagged Rrn3p was 
immunoprecipitated from the chromatin extracts. After DNA isolation, the relative amounts of specific DNA fragments 
co-purifying with the protein were measured in triplicate real-time PCR reactions using primers specific for the rDNA 
promoter (Prom II), the 18S (18S I) and 25S (25S I and 25S II) rRNA-coding region as well as for the 5S rRNA gene (5S), 
which served as an internal control. The data represent the mean of at least three independent ChIP experiments. The 
positions of the amplified rDNA regions are indicated in a sketch on the bottom of the figure.  
 
Although the possibility of Rrn3p-binding to the rDNA locus independently of Pol I under these 
overexpression conditions cannot be excluded, Rrn3p was so far described to bind to the promoter 
region of the rDNA in yeast exclusively when existing in a complex with RNA polymerase I. 
Therefore, the results obtained from the Rrn3p-ChIP might indicate a higher proportion of Pol I 
molecules being recruited to the rRNA genes when Rrn3p is overexpressed.  
It has been previously demonstrated that Rrn3p dissociates from Pol I when the enyzme switches 
from initiation to elongation (Schnapp et al., 1993; Brun et al., 1994; Milkereit and Tschochner, 
1998; Bier et al., 2004). A large excess of Rrn3p might interfere with this dissociation step leading to 
problems of Rrn3p-bound Pol I in proper pre-rRNA synthesis and in turn to growth defects as 
observed in strain pGAL1-RRN3-Prot.A (2µ). A recent study showed that a correlation between a 
defect in Pol I-Rrn3p complex dissociation and both cell growth and sensitivity to drugs affecting 
transcription elongation might exist (Beckouet et al., 2008).  
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Figure 29. Overexpression of Rrn3p does not lead to a significant alteration in the rDNA copy number.  
Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) and yeast strains Y353 and Y352, carrying 
approximately 25 or 190 rDNA repeats, respectively, were analyzed as described in Figure 27. After DNA isolation, the 
content of rDNA was measured in triplicate real-time PCR reactions using primers specific for the 25S rRNA-coding region 
and normalized to the content of DNA using primers specific for the single copy gene locus NOC1.  
 
As described before (see section 3.1.2), artificial variations in the level of Rrn3p did not lead to a 
significant alteration in the rDNA copy number in yeast cells. This result could be reproduced, since 
overexpression of Rrn3p showed no substantial impact on the number of rDNA repeats (Figure 29). 
Yeast strains NOY1071 and NOY1064, carrying approximately 25 or 190 rDNA repeats, respectively, 
served again as internal controls (Cioci et al., 2003).  
 
3.2.4 Overexpression of Rrn3p does not lead to severe pre-rRNA processing defects 
or changes in mature rRNA production in yeast cells 
Since Rrn3p overexpression might lead to an increased rate of Pol I transcription due to enhanced 
polymerase loading, the question arose as to whether the presumably thereby generated 
imbalance between 35S pre-rRNA synthesis and r-protein synthesis leads to pre-rRNA processing 
defects. Additionally, it is not clear whether there is indeed a problem in Pol I-Rrn3p complex 
dissociation in this situation which can lead to defects in transcription elongation and pre-rRNA 
processing as well.  
Pulse-chase experiments with [3H]-uracil were performed to directly analyze the effects of Rrn3p 
overexpression on rRNA neo-synthesis in yeast cells. Therefore, yeast strains pRRN3-Prot.A (A/C), 
pGAL1-RRN3-Prot.A (A/C), and pGAL1-RRN3-Prot.A (2µ) were grown as described (see section 3.2.3) 
before same amounts of cells were pulsed for 20 min with [3H]-uracil and chased with an excess of 
unlabeled uracil for 60 min. Total RNA was isolated and analyzed by denaturing agarose gel 
electrophoresis with subsequent Northern blotting and autoradiography.  
Strikingly, rRNA synthesis seemed not to be critically affected by Rrn3p overexpression. Regardless 
of the level of Rrn3p, 35S pre-rRNA production and subsequent processing first to the intermediate 
27S and 20S rRNA and finally to the mature 25S and 18S rRNA was very comparable in all three 
strains (Figure 30A). Nevertheless, to reveal potential pre-rRNA processing defects, the ratio of 35S 
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rRNA to 27S rRNA was calculated and normalized to the corresponding ratio in cells of the control 
strain. Only slight differences could be observed indicating the absence of severe maturation 
defects (Figure 30B, compare with Figure 18B). Additionally, the incorporation of [3H]-uracil into the 
mature 25S rRNA was quantified as a measure of ribosome neo-production. Again, no significant 
difference between the three strains could be detected (Figure 30C). The neo-synthesis of 
ribosomes was unaffected by Rrn3p overexpression.  
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Figure 30. Overexpression of Rrn3p does not result in severe pre-rRNA processing defects or alterations in mature 
rRNA synthesis.  
(A) Yeast strain Y2127 expressing Prot.A-tagged Rrn3p and HA3-tagged Pol I subunit A190 and harboring either plasmid 
pRRN3-Prot.A (A/C), pGAL1-RRN3-Prot.A (A/C), or pGAL1-RRN3-Prot.A (2µ) was grown as described in Figure 27. Pulse 
labeling with [3H]-uracil was performed for 20 min followed by a chase with an excess of unlabeled uracil (final 
concentration 1 mg/ml) for the times indicated above the panel. RNA was isolated, separated in a denaturing agarose gel, 
and transferred to a positively charged nylon membrane. The autoradiogram shown was obtained after exposure of the 
membrane treated with EN3HANCE solution. Positions of the different rRNA processing products are indicated on the 
right.  
(B) Quantitative analysis of [3H]-signals presented in Figure 30A was performed prior to EN3HANCE treatment. The ratio of 
the [3H]-signals of the 35S and 27S pre-rRNAs was calculated after 20 min pulse (0) of each experiment. The 35S/27S rRNA 
ratio of the control strain was arbitrarily set to 1.  
(C) Incorporation of [3H]-uracil into 25S rRNA was determined by excision of the 25S rRNA bands from an identical blot 
and analysis by liquid scintillation counting. The values obtained were normalized to the value after 20 min pulse (0) of 
the control strain, which was arbitrarily set to 1, and plotted against the time of the chase.  
 
If artificially raised levels of Rrn3p indeed generate problems in Pol I-Rrn3p complex dissociation, 
this will obviously not lead to significant defects in pre-rRNA maturation.  
Yet, it seemed that there is a slight increase in 35S pre-rRNA-levels in cells with moderate 
overexpression of Rrn3p which is even further enhanced under strong overexpression conditions. 
However, this observation has to be confirmed in additional experiments.  
In summary, these results do not explain the growth phenotype of strain pGAL1-RRN3-Prot.A (2µ) 
cultivated in galactose-containing medium. Besides the probable role of overexpressed Rrn3p in 
affecting Pol I transcription and ribosome production, definitely other cellular processes could be 
negatively influenced as well. The question remains open whether the observed growth defect 
derives indeed from problems in the ribosome synthesis machinery due to an excess of Rrn3p or 
whether this overexpression impairs different processes in the cell.  
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3.3 Pol5p, which plays an important role in rRNA synthesis, is a 
putative interaction partner of Rrn3p 
3.3.1 Co-purification of Pol5p in the course of phosphorylation analyses of Rrn3p 
indicates interaction between the two proteins 
As already mentioned, the level of Rrn3p influences Pol I transcription by modulating the formation 
of Pol I-Rrn3p complexes. However, posttranslational modifications of both Rrn3p and RNA 
polymerase I, predominantly phosphorylation and/or dephosphorylation events, are important for 
Pol I transcription regulation as well. Various studies already revealed the positions and roles of 
diverse phosphorylation sites of different RNA polymerase I subunits and TIF-IA, the mouse 
homologue of yeast Rrn3p (Paule et al., 1984; Fath et al., 2001, 2004; Schlosser et al., 2002; 
Cavanaugh et al., 2002; Yuan et al., 2002; Hirschler-Laszkiewicz et al., 2003; Zhao et al., 2003; Mayer 
et al., 2004, 2005; Gerber et al., 2008; Hoppe et al., 2009). However, no phosphorylation sites of 
yeast Rrn3p could be discovered up to now.  
Hence, a further objective of this PhD thesis was the continuation of a project from my diploma 
thesis in order to reveal such sites of this transcription factor in yeast. To this end, several different 
large scale affinity purifications of Rrn3p were performed and the fractions containing the enriched 
protein were mostly subjected to SDS-PAGE to further separate the target protein. The prominent 
band of Rrn3p and the other dominant protein bands were excised and analyzed by mass 
spectrometry with respect to either the phosphorylation status in the case of Rrn3p or the protein 
identity in the case of these putative co-purified interaction partners of Rrn3p. Despite multiple 
attempts and varying strategies, only the single phosphorylation site of Rrn3p at serine 102 could 
be confirmed, which I first described in my diploma thesis (see section 4.3) (Steinbauer, 2006). 
Nevertheless, the protein Pol5p could be identified among the co-purified proteins in two 
independent multi-step affinity purifications of TAP-tagged Rrn3p during my diploma thesis 
(Figure 31) (Steinbauer, 2006). Pol5p is shown to play an essential role in the synthesis of ribosomal 
RNA, presumably by influencing Pol I transcription and/or pre-rRNA processing, since both binding 
of Pol5p to various sites within the rDNA locus and recruitment of this protein to the 35S pre-rRNA 
were reported (Shimizu et al., 2002; Yang et al., 2003; Krogan et al., 2004; Nadeem et al., 2006; Wery 
et al., 2009). Therefore, Pol5p constitutes a bona fide interaction partner of Rrn3p. Among the other 
co-purifying proteins, only the two FACT complex components Spt16p and Pob3p were identified 
in one of these purification approaches, likewise exhibiting a direct link to rRNA synthesis due to 
promoting Pol I transcription elongation (Birch et al., 2009). The question, however, whether this 
complex indeed interacts with Rrn3p was not investigated further in this thesis.  
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Figure 31. Pol5p is identified in the eluate of two independent multi-step affinity purifications of Rrn3p.  
Yeast strain Y2182 expressing TAP-tagged Rrn3p was grown in YPD at 30°C to mid-log phase before cells were collected 
and lyzed. Rrn3p was affinity precipitated from WCE via its CBP-part of the tag and further purified by anion exchange 
chromatography using a Mono Q column before the peak fractions were subjected to SDS-PAGE with subsequent 
coomassie staining. The bands of the respective proteins identified by mass spectrometry were shown in two 
independent experiments.  
 
In my PhD thesis, the putative interaction between Rrn3p and Pol5p should be further 
investigated. Thus, co-purification of the two proteins was monitored with the adequate yeast 
strain POL5-HA3-RRN3-TAP. Strain POL5-HA3 was included in the experiment as an appropriate 
control to look for possible unspecific binding of Pol5p to the calmodulin affinity resin. The strains 
were grown in YPD at 30°C to mid-log phase before cells were harvested and lyzed. TAP-tagged 
Rrn3p was affinity precipitated from WCE via the attached calmodulin-binding peptide (CBP) and 
further purified by anion exchange chromatography and subsequent gel filtration. It was quite 
obvious that Pol5p co-purified with Rrn3p in all of the three steps of the purification indicating 
indeed an interaction between the two proteins (Figure 32, upper panel, right hand side, central 
panel and lower panel). Importantly, no unspecific binding of Pol5p to the calmodulin affinity resin 
could be detected in the control strain (Figure 32, upper panel, left hand side). The observation that 
HA3-tagged Pol5p with a molecular weight of approximately 120 kDa and TAP-tagged Rrn3p with a 
molecular weight of approximately 90 kDa co-eluted from the gel filtration column in higher 
molecular weight fractions (∼ 250 kDa) than expected for the single proteins provided additional 
evidence for an existing interaction between the two proteins, probably forming a heterodimer.  
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Figure 32. Specific co-purification of Pol5p with Rrn3p within three subsequent purification steps.  
Yeast strains Y2179 and Y1798, both expressing HA3-tagged Pol5p and either untagged or TAP-tagged Rrn3p were 
grown in YPD at 30°C to mid-log phase before cells were harvested and lyzed. Same amounts of WCE (1.2 g) were 
incubated with 500 µl calmodulin affinity resin. After washing, proteins bound to the beads were eluted with EGTA. 
0.004% of load (L) and flow through (FT) and 0.4% of the eluate (E1/E2) were analyzed by Western blotting using 
antibodies directed against the HA3-tag of Pol5p and the Prot.A-tag of Rrn3p, respectively. Pooled eluates were bound to 
a Mono Q column and eluted with a linear gradient of 0-1 M sodium chloride. 0.2% of load (L) and flow through (FT) and 
3% of every second fraction (19/21) were analyzed by Western blotting using the above antibodies. Pooled peak fractions 
were separated on a Superose 6 column in a buffer containing 200 mM sodium chloride. 5% of load (L) and 5% of every 
second fraction (3/5/7/9) were analyzed by Western blotting using the above antibodies.  
 
 
Figure 33. Specific co-precipitation of Pol5p with Rrn3p and vice versa.  
Yeast strains Y2179 and Y1798 and yeast strains Y653 and Y1799 either both expressing HA3-tagged Pol5p and untagged 
or TAP-tagged Rrn3p or both expressing HA3-tagged Rrn3p and untagged or TAP-tagged Pol5p were grown in YPD at 
30°C to mid-log phase before cells were harvested and lyzed. Rrn3p or Pol5p, respectively, was immunoprecipitated from 
WCE via its Prot.A-part of the tag. After washing, proteins bound to the beads were eluted with SDS sample buffer. 0.5% 
of the input (IN) and 50% of the IP (IP) were analyzed by Western blotting using antibodies directed against the HA3-tag 
or the Prot.A-tag of the respective protein.  
 
Additional co-immunoprecipitation experiments were performed to further confirm the above 
results. Both, the ability of Pol5p to pull-down Rrn3p and vice versa was assayed. To this end, yeast 
strains POL5-HA3-RRN3-TAP and POL5-HA3 as well as strains RRN3-HA3-POL5-TAP and RRN3-HA3 
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were grown in YPD at 30°C to mid-log phase before cells were harvested and lyzed. TAP-tagged 
Rrn3p or Pol5p, respectively, was immunoprecipitated from WCE. The associated proteins were 
eluted with SDS sample buffer and same amounts of the input (IN) and IP fractions (IP) were 
analyzed by Western blotting.  
The obtained results confirmed an interaction between the corresponding proteins, however, the 
intensity of the Western blot signals of the HA3-tagged proteins was relatively low (Figure 33, lane 2 
and 6). Nevertheless, co-precipitation of Pol5p with Rrn3p and vice versa was detectable, whereas 
in the corresponding control experiments the signals representing unspecific binding were 
significantly lower than in the actual experiments (Figure 33, lane 4 and 8).  
 
3.3.2 ChIP experiments reveal no association of Pol5p with the rDNA locus 
Since Pol5p was reported to bind to the rRNA gene promoter, the 25S rRNA-coding region and the 
rDNA enhancer region (Shimizu et al., 2002; Nadeem et al., 2006; Wery et al., 2009), additional 
association of Pol5p to other rDNA regions was assayed by ChIP experiments simultaneously trying 
to reproduce the published results. Crosslinking of Rrn3p and Pol I subunit A43 to the rDNA locus 
was explored in parallel, serving as positive controls. Yeast strains POL5-HA3-RRN3-TAP, RRN3-HA3-
POL5-TAP, and RRN3-HA3-A43-TAP were grown in YPD at 30°C to mid-log phase before cells were 
crosslinked with 1% formaldehyde for 15 min, harvested, lyzed, and sonified. The respective TAP-
tagged protein was immunoprecipitated from the chromatin extracts. After DNA isolation, 
crosslinking of these proteins to the 35S rDNA promoter, to the 18S and the 25S rRNA-coding 
region and to the enhancer elements EI and EII was examined in triplicate real-time PCR reactions. 
The 5S rRNA-coding region was included as an internal control at least for the Rrn3p- and Pol I-
ChIPs.  
Surprisingly, despite investigating Pol5p crosslinking to the regions for which binding was 
described and even despite using the identical pair of primers for one of these amplicons (25S II), 
no association of Pol5p could be confirmed with any of the corresponding regions (Figure 34). In 
summary, no evidence for Pol5p-binding to the rDNA locus was provided in this analysis. 
Differences in the ChIP protocols of the respective groups could be a possible explanation for the 
discrepancy of the obtained data. However, Rrn3p crosslinking exclusively to the rRNA gene 
promoter and Pol I subunit A43-binding to the promoter and the transcribed region was detected 
as expected (Figure 34).  
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Figure 34. ChIP experiments reveal no association of Pol5p with the rDNA locus.  
Yeast strains Y1798, Y1799, and Y2184 expressing either TAP-tagged Rrn3p, Pol5p, or Pol I subunit A43 were grown in 
YPD at 30°C to mid-log phase before cells were crosslinked with 1% formaldehyde for 15 min, harvested, lyzed, and 
sonified. Rrn3p, Pol5p, or Pol I subunit A43, respectively, was immunoprecipitated from the chromatin extracts via the 
Prot.A-part of the tag. After DNA isolation, the relative amounts of specific DNA fragments co-purifying with the protein 
were measured in triplicate real-time PCR reactions using primers specific for the rDNA promoter (Prom I), the 18S rRNA-
coding region (18S II), the 25S rRNA-coding region (25S II and 25S III), the enhancer elements EI and EII (Enh1 and Enh2) 
as well as for the 5S rRNA gene (5S), which served as an internal control at least for the Rrn3p- and Pol I-ChIPs. The data 
represent the mean of at least three independent ChIP experiments. The positions of the amplified rDNA regions are 
indicated in a sketch on the bottom of the figure.  
 
In summary, it is quite obvious that an interaction between at least subpopulations of Pol5p and 
Rrn3p exists, however, further investigation is required to elucidate the putative binding of Pol5p 
to the rDNA locus and its role in regulating rRNA synthesis.  
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4 DISCUSSION 
4.1 The role of the proteasome in the down-regulation of Rrn3p-levels 
upon TOR inactivation 
Eukaryotic cells had to evolve several mechanisms to ensure a tight and sensitive regulation of 
complex processes like ribosome biogenesis. One of these control points is the transcription 
initiation rate of RNA polymerase I.  
In the present PhD thesis, evidence could be obtained suggesting that the yeast ubiquitin-
proteasome system is in part involved in the regulation of RNA polymerase I transcription initiation 
by influencing the abundance of the essential transcription factor Rrn3p (see section 3.1.1).  
Ubiquitylation of Rrn3p targets this protein for degradation by the proteasome which contributes 
to the quick down-regulation of both cellular Rrn3p-levels and Pol I transcription initiation rates 
following TOR inactivation by rapamycin. Interestingly, Rrn3p appears to be ubiquitylated also in 
growing cells indicating a constitutive degradation of the protein rather than an induced 
destruction due to unfavorable growth conditions (Muratani and Tansey, 2003). This hypothesis 
would implicate a significant reduction in the expression rate of Rrn3p upon TOR inactivation. 
Indeed, a decrease in RRN3 mRNA-levels to about 30% of the initial value could be detected within 
20 min of rapamycin treatment (Philippi et al., 2010), an observation also described by others 
(Jorgensen et al., 2004; Huang et al., 2004). Moreover, general translation is reported to decline to 
roughly 50% of the initial value within 15 min of rapamycin-induced TOR inactivation (Barbet et al., 
1996). Consistently, preventing the cellular supply of Rrn3p, either by inhibiting the production of 
RRN3 mRNAs in a conditional Pol II mutant strain or by eliminating the translation of RRN3 mRNAs 
by cycloheximide, leads to a reduction in the level of Rrn3p with similar kinetics as TOR 
inactivation. Thus, these observations along with a presumably short half-life of the protein 
strongly argue for this hypothesis implicating that TOR inactivation affects cellular Rrn3p-levels 
most probably at the stage of or prior to protein production.  
It should be mentioned, however, that the C-terminal Prot.A-tag of Rrn3p could not be entirely 
excluded to constitute a substrate of the ubiquitylation machinery.  
In a different approach, the levels of Rrn3p could be stabilized despite TOR inactivation by shifting 
cells of the temperature-sensitive proteasome mutant strain cim3-1 to the restrictive temperature 
(Philippi et al., 2010). Though, this result contributes to the view of Rrn3p being a genuine target of 
the ubiquitin-proteasome system, the possible involvement of the tag of Rrn3p in the degradation 
process could still not be eliminated completely.  
Strikingly, TIF-IA, the mouse homologue of Rrn3p, was recently shown to be ubiquitylated as well 
(Fátyol and Grummt, 2008). This result further corroborates the status of Rrn3p as a direct substrate 
for ubiquitylation, concomitantly suggesting that ubiquitylation is an evolutionary conserved 
feature of these proteins. However, contrary to the yeast Rrn3p, the mouse TIF-IA is not degraded 
upon TOR inactivation but rather redistributed to the cytoplasm (Mayer et al., 2004). This 
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observation indicates that these proteins are differently regulated in their organisms, although 
fulfilling a very similar function in the cell.  
 
4.2. The role of Rrn3p-levels in the formation of Pol I-Rrn3p complexes 
upon TOR inactivation 
Experiments with a strain whose Rrn3p-levels could artificially be up- or down-regulated showed 
that there is in fact a correlation between the level of the transcription factor Rrn3p and the 
amount of initiation-competent Pol I-Rrn3p complexes and their recruitment to the rDNA locus 
(see section 3.1.2). Similar results could be obtained using strains in which the overexpression of 
this factor is dependent on galactose (see section 3.2.2).  
Several studies showed that the TOR pathway regulates the recruitment of RNA polymerase I to the 
promoters of active rRNA genes in an Rrn3p-dependent manner (Claypool et al., 2004; Oakes et al., 
2006; Philippi et al., 2010). Regardless of whether using the Miller chromatin spreading technique 
or chromatin immunoprecipitation analysis, the general consensus of this work was that 
rapamycin-induced TOR inactivation leads to a similar decrease both in Pol I occupancy at the 
promoter and the transcribed region of the rDNA locus and in Rrn3p occupancy at the rDNA 
promoter region. In parallel, this down-regulation is accompanied with a decrease in the level of 
Pol I-Rrn3p complexes (Claypool et al., 2004; Philippi et al., 2010). Thus, this observation suggests 
that the reduction in the recruitment of Pol I and Rrn3p to the promoter by rapamycin is caused 
largely, if not entirely, by a decrease in the amount of initiation-competent Pol I-Rrn3p complexes. 
Concomitantly, a decline in the Rrn3p-levels with similar kinetics could be detected, which is 
obtained by the combination of a constitutive degradation and a shut-down in the neo-synthesis 
of the protein (see section 4.1) (Philippi et al., 2010). It is tempting to speculate that the decrease in 
Pol I-Rrn3p complexes derived exclusively from the respective decrease in Rrn3p-levels. However, 
although the degradation of Rrn3p contributes definitely to the reduction of Pol I-Rrn3p 
complexes, there are other mechanisms which play a significant role in this process as well.  
Recently, advantage was taken of a strain, referred as to the ∆N strain whose cells express a mutant 
version of Rrn3p bearing an N-terminal truncation which along with a C-terminal Prot.A-tag confers 
resistance to rapamycin-induced degradation of the protein. Following TOR inactivation in these 
cells, the down-regulation of Pol I-Rrn3p complexes, of both Pol I and Rrn3p occupancy at the 
rDNA locus and of 35S pre-rRNA synthesis could be attenuated, but not completely inhibited 
(Philippi et al., 2010). Thus, since wild type levels of Rrn3p are maintained in this strain, TOR 
inactivation must affect complex formation and subsequently Pol I transcription additionally by 
other means.  
The above results indicate that keeping a higher proportion of Pol I-Rrn3p complexes in the cell 
despite TOR inactivation results in a corresponding higher association of Pol I with the rDNA locus. 
However, this assumption turned out to be just partially true regarding results obtained from the 
CARA strain expressing a non-dissociable Pol I-Rrn3p fusion protein (CARA for Constitutive 
Association of Rrn3 and A43) (Laferté et al., 2006). These cells harbor exclusively Pol I molecules 
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which mimic constitutively active, rapamycin-resistant Pol I-Rrn3p complexes. Similar to the ∆N 
strain, the CARA strain exhibits elevated levels of Pol I occupancy at the rDNA locus, however, to a 
larger extent than in the ∆N strain, probably due to preventing both degradation of Rrn3p and its 
dissociation from RNA polymerase I in this mutant. Yet, a slight but significant decrease in the 
occupancy of these mutant polymerases at the rDNA locus could still be observed indicating that 
Pol I-Rrn3p complex formation is not the only mechanism determining the recruitment of the 
polymerase to the gene. Strikingly, also in CARA cells 35S pre-rRNA synthesis is substantially 
reduced upon prolonged rapamycin treatment despite maintaining the increased level of Pol I 
occupancy at the rDNA locus. These results suggest the existence of other mechanisms regulating 
rRNA production independent from the formation of the Pol I-Rrn3p complex.  
 
4.3. The role of phosphorylation in the formation of Pol I-Rrn3p 
complexes 
Since TOR shows kinase activity, it very likely influences the formation of Pol I-Rrn3p complexes via 
protein phosphorylation-dephosphorylation cascades. In fact, both in the yeast and the 
mammalian system, phosphorylation events of Pol I and/or Rrn3p were reported to play essential 
roles in the regulation of Pol I transcription by affecting the interaction between Pol I and its 
recruiting factor Rrn3p (Fath et al., 2001; Cavanaugh et al., 2002; Yuan et al., 2002; Hirschler-
Laszkiewicz et al., 2003; Zhao et al., 2003; Mayer et al., 2005). Additionally, phosphorylation of TIF-IA 
was shown to be crucial for mediating the contact between the initiation-competent Pol I complex 
and the promoter-bound SL1 (Hoppe et al., 2009). Whereas in yeast no reports are published to 
date describing a TOR-dependent phosphorylation site of either Pol I or Rrn3p, in mammals two 
serine residues of TIF-IA were found to be posttranslationally modified in a mTOR-dependent 
manner, thereby affecting complex formation (Mayer et al., 2004).  
Interestingly, a recent study in yeast demonstrated that the nuclear localization of Tor1p is critical 
for 35S pre-rRNA synthesis and that this kinase associates with the promoter region of rRNA genes. 
Importantly, both the nuclear localization of Tor1p and its association with the rDNA occur in a 
rapamycin- and starvation-sensitive manner (Li et al., 2006). This observation corroborates the 
possibility of TORC1-dependent phosphorylation events at the rDNA locus which modulate the 
transcription initiation rate of RNA polymerase I.  
Although diverse phosphorylation sites of the five in vivo phosphorylated subunits of yeast Pol I 
could be identified yet, all of them appear to be non-essential posttranslational modifications 
(Buhler et al., 1976; Bréant et al., 1983; Gerber et al., 2008). Just the mutation of serine 685 of the 
largest Pol I subunit A190 to aspartate, which mimics a constitutively phosphorylated state, 
exhibits synthetic lethality with the deletion of the non-essential Pol I subunit A12.2 (Gerber et al., 
2008). The unexpected absence of more severe phenotypes from these mutational analyses could 
be explained by the possible existence of a cooperation between two or even clusters of 
phosphorylation sites.  
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Nevertheless, since Rrn3p was also shown both to be phosphorylated in vivo (Fath et al., 2001) and 
to be a key player in the regulation of Pol I transcription, several phosphorylation analyses were 
performed in order to identify phosphorylation sites of this protein as it was done previously with 
RNA polymerase I (Gerber et al., 2008). Despite various attempts and strategies, no additional 
phosphorylation sites of Rrn3p could be revealed apart from that at serine 102 which I already 
described in my diploma thesis (Steinbauer, 2006).  
 
 
Figure 35. Mutation of phosphorylation site S102 of Rrn3p does not result in defects of yeast cell growth.  
Yeast strains Y2176, Y2177, and Y2178 expressing either wild type Rrn3p or mutant Rrn3p whose serine at position 102 is 
either substituted by alanine (S102A) or aspartate (S102D) were grown overnight in YPD at 30°C before different dilutions 
were spotted on YPD plates and incubated for 3-4 days at the temperatures indicated on top of the panels.  
 
Identically to the mutational analyses performed for Pol I, the amino acids alanine or aspartate 
were chosen to substitute serine 102 to mimic either a constitutively unphosphorylated or 
phosphorylated state, respectively (Gerber et al., 2008). The resulting mutant strains were 
investigated with respect to their growth ability by performing spot tests on YPD plates at various 
temperatures in comparison to the control strain. However, regardless of the incubation 
temperature, the growth behavior of the two mutant strains was indistinguishable from the parent 
strain (Figure 35) arguing for no essential function of this phosphorylation site.  
Despite the above observation, this site, maybe in combination with putative other, yet undefined 
phosphorylation sites of Rrn3p or with respective sites of RNA polymerase I, still can play a role in 
the regulation of Pol I transcription.  
 
4.4 Uncoupling RNA polymerase I transcription and mature rRNA 
production after short-term TOR inactivation 
As already mentioned, the cellular level of the transcription factor Rrn3p significantly influences 
RNA polymerase I transcription and thus the rate of rRNA synthesis. A wild type expression level of 
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this factor promotes growth best, whereas both artificially increased and decreased levels of Rrn3p 
result in distinct growth phenotypes (see sections 3.1.2 and 3.2.1). Importantly, regardless of the 
level of Rrn3p, even if it is artificially decreased below that of cells treated with rapamycin, all these 
strains do not cease ribosome production and growth completely. Additional rapamycin treatment 
of these cells, however, led in all cases to a fast termination of both growth with similar kinetics and 
mature rRNA production (see section 3.1.2) (Philippi et al., 2010). These results point to another, 
more drastic and rapid effect of rapamycin- or starvation-induced TOR inactivation on the cells 
besides down-regulating Pol I transcription via reducing the amount of Rrn3p. Controlling the level 
of Rrn3p might serve as a tool for the cell to adjust the rate of ribosome synthesis in the long term. 
At early stages of TOR inactivation, however, a target very likely downstream of Pol I transcription 
initiation must be affected whose aftermaths dominate and are more severe.  
In order to elucidate this issue, the short-term effects of TOR inactivation upon Pol I transcription 
and rRNA production were investigated. Interestingly, neither the level of Rrn3p nor the association 
of Pol I with the rDNA locus were substantially decreased after 15 min of rapamycin-induced TOR 
inactivation (see section 3.1.3). Additionally, the possibility for RNA Pol I of being stalled at the 
rDNA locus in the course of transcription upon rapamycin treatment could be excluded (see 
section 3.1.3). At least after 15 min of rapamycin action, polymerase molecules engaged in 
transcription elongation were still able to quit their started cycle. It should be mentioned, however, 
that no statements could be made regarding the elongation rate or the processivity of the Pol I 
molecules following the treatment with rapamycin.  
Strikingly, despite the maintenance of 35S pre-rRNA production, there is a drastic decrease in the 
level of intermediate and mature rRNAs detectable already after 15 min of rapamycin treatment 
compared to untreated cells (see section 3.1.4). Since TOR inactivation affects not only rRNA gene 
transcription by Pol I but also very fast translation initiation and pre-rRNA maturation (Barbet et al., 
1996; Powers and Walter, 1999), the protein synthesis inhibitor cycloheximide was used to analyze 
whether a sharp drop in the neo-production of proteins causes the observed pre-rRNA processing 
defects following TOR inactivation. In fact, 15 min of cycloheximide treatment was sufficient to 
generate even more severe pre-rRNA maturation defects (see section 3.1.4), a result consistent with 
diverse earlier reports (de Kloet, 1966; Udem and Warner, 1972; Warner and Udem, 1972). Similar to 
rapamycin, 15 min of cycloheximide treatment has almost no effect on both cellular Rrn3p-levels 
and Pol I occupancy at the promoter region of the rDNA locus. It appears that even more Pol I 
molecules are associated with the transcribed region of the rRNA genes following 15 min of 
cycloheximide action compared to the untreated situation (see section 3.1.4). A scenario which 
might account for the observed increase in Pol I crosslinking to the transcribed region could be an 
improved accessibility of the epitope under these conditions due to enhanced co-transcriptional 
degradation of nascent transcripts which leads to an elevated precipitation rate in the ChIP 
experiments. Furthermore, the possibility of an attenuated elongation rate of the Pol I molecules 
producing similar results could not be excluded.  
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In summary, TOR-dependent inhibition of protein neo-expression appears to play the dominant 
role in the drastic down-regulation of ribosome production rather than the decrease in Pol I 
transcription.  
Since ribosomal proteins have to be produced in at least stoichiometric amounts with the 
ribosomal RNAs in the cell to support proper assembly, processing, and maturation of the 
ribosomal subunits (Warner, 1999), an impairment in the production of these structural 
components very likely provokes drastic effects on the neo-synthesis of ribosomes. The occurrence 
of pre-rRNA processing defect upon depletion of individual r-proteins underline the significance of 
the above hypothesis (Ferreira-Cerca et al., 2005, 2007; Robledo et al., 2008; Pöll et al., 2009). 
Further evidence for this statement derives from a yeast strain which exhibits severe growth 
defects due to an only moderate reduction in the level of a single ribosomal protein in the context 
of gene haploinsufficiency (see section 3.1.5), an observation already described by others (Abovich 
et al., 1985; Lucioli et al., 1988; Deutschbauer et al., 2005).  
Interestingly, the impact of rapamycin treatment for 15 min is indeed predominantly directed 
towards the neo-expression of most probably all ribosomal proteins, whereas cycloheximide 
treatment for the same time affects the overall expression of proteins in the cell (see section 3.1.5). 
By using limited cycloheximide concentrations, which have a similar impact on the synthesis of 
ribosomal proteins as rapamycin treatment, a virtually identical defect in the production of mature 
rRNAs could be obtained (Reiter et al., accepted). Although the CARA strain, when compared to the 
wild type strain, displays an attenuated decrease in the mRNA-levels specifically of r-proteins upon 
TOR inactivation (Laferté et al., 2006), their neo-production is equally decreased in both the mutant 
and the wild type cells after 15 min of rapamycin treatment (see section 3.1.5). Consistent with this 
finding, in both strains the same drastic defects in pre-rRNA processing and mature rRNA synthesis 
could be observed under these conditions (data not shown). It should be noted, however, that the 
decrease in the mRNA-levels of r-proteins in the CARA mutant is only slightly delayed compared to 
the wild type strain after 15 min of rapamycin treatment. Only after prolonged drug treatment a 
significant difference between the levels of these mRNAs is established in the two strains.  
Further evidence for an early shortage of ribosomal proteins derives from a recent study showing 
that amino acid starvation leads to a very rapid inhibition of mRNA-splicing in yeast which 
predominantly affects the expression of r-protein genes (Pleiss et al., 2007). A general depletion of 
the cellular r-protein-pool was already speculated to link impairments in the nuclear pre-mRNA 
splicing machinery to ribosome biogenesis defects, since ribosomal protein genes account for 
almost 50% of the intron-containing genes and about 90% of mRNA splicing is devoted to 
r-protein transcripts in yeast (Hartwell et al., 1970; Warner and Udem, 1972; Rosbash et al., 1981; 
Spingola et al., 1999; Warner, 1999).  
These observations indicate that the drastic reduction in ribosomal proteins following rapamycin 
or cycloheximide treatment is sufficient to provoke severe defects in the processing and 
maturation steps of pre-rRNAs, which are then obviously rapidly degraded.  
In this context, the investigation of a recently described TOR1 mutant strain would be interesting 
(Li et al., 2006). In this strain, the rapamycin-induced pre-rRNA processing phenotype can be 
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uncoupled from the inhibition of r-protein mRNA synthesis. These observations contradict not 
necessarily the model of depleted r-proteins generating the immediate shut-off of ribosome 
production, as it is not clear yet whether or not rapamycin still prevents the translation of the 
r-protein mRNAs and thus the expression of the ribosomal proteins (Barbet et al., 1996).  
Treatment of the yeast cells with rapamycin or cycloheximide not only provokes very related pre-
rRNA processing and growth defects, but also the cellular localization of two ribosome biogenesis 
factors is influenced in a strikingly similar manner (see section 3.1.6). Although the nucleolar 
entrapment of Rrp12p and Nog1p is described to be caused primarily by the inhibition of the TOR 
pathway (Honma et al., 2006; Vanrobays et al., 2008), cycloheximide treatment, which affects 
instantaneously the translation machinery, led to an even accelerated redistribution of these 
factors to the nucleolus. Considering the depletion of the r-protein-pool to be the reason for the 
nucleolar entrapment of the two proteins, the observation of this process to occur even faster 
upon cycloheximide treatment than upon rapamycin treatment is compatible with the differing 
intensity the two drugs display on the translation machinery. The above speculation of r-protein-
levels influencing the localization of these factors could indeed be evidenced, since the conditional 
depletion of individual r-proteins resulted in the same phenotype as seen for rapamycin and 
cycloheximide treatment (see section 3.1.6).  
 
4.5 A model for the drastic down-regulation of ribosome production 
upon TOR inactivation 
In summary, the obtained results led to the conclusion that rRNA synthesis and consequently 
ribosome production in yeast is affected on several levels when TOR signaling is impaired upon 
rapamycin treatment or starvation.  
Firstly, RNA Pol I transcription initiation is negatively influenced. The decrease in the level of the 
transcription initiation factor Rrn3p leads to a decline in Pol I-Rrn3p complex formation. This in turn 
results in a corresponding reduction of Pol I transcription. However, the above mechanism 
represents a rather long-term form of regulation, since only relatively moderate and slow changes 
in the association of RNA Pol I with the rDNA locus could be detected (Figure 36).  
Secondly, RNA Pol I transcription elongation might be affected to a certain extent. The possibility 
that the Pol I molecules, which are engaged in transcription, are slowed down by TOR inactivation 
could not be excluded. However, it is clear that these molecules are not stalled on the rDNA 
template, since they are able to finish their transcription cycle even after approximately 100 min of 
rapamycin treatment (Figure 36).  
Thirdly, and most importantly, pre-rRNA processing is affected very severely and quickly by TOR 
inactivation. The free pool of ribosomal proteins is very rapidly depleted in cells treated with 
rapamycin due to a strong and specific down-regulation of r-protein expression. Apparently, this 
lack causes drastic pre-rRNA processing defects, since ribosomal proteins are indispensable for 
proper subunit maturation. The incorrectly processed rRNAs are obviously rapidly degraded 
(Figure 36).  
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Figure 36. A model for the drastic down-regulation of ribosome production upon TOR inactivation in yeast cells.  
Nutrient deprivation affects ribosome production on several levels. Pol I transciption initiation is clearly down-regulated 
upon TOR inactivation due to a decrease in the level of Rrn3p. Transcription elongation by Pol I might also be affected to 
some extent, however, the dominant event in the immediate shut-off of ribosome production upon TOR inactivation is 
the drastic inhibition of pre-rRNA processing mediated by the rapid depletion of ribosomal proteins.  
 
Taken together, these results led to the model that the immediate inhibition of r-protein synthesis 
is sufficient to explain the drastic pre-rRNA processing defects inducing the acute decline in 
ribosome neo-production, which in turn is presumably responsible for the observed growth defect 
in yeast cells upon short-term TOR inactivation.  
 
4.6 Overexpression of Rrn3p and its impact on ribosome biogenesis 
and yeast cell growth 
Since previous observations and the experiments with a strain whose Rrn3p-levels are artificially 
adjustable indicated that elevated amounts of this factor negatively influence the growth rate of 
yeast cells, the significance of the overexpression of Rrn3p in the context of Pol I transcription 
should be further investigated.  
Indeed, strong overexpression of this transcription factor led to a substantially decreased growth 
rate, whereas moderately increased levels of Rrn3p resulted at most in a very slight growth defect if 
any compared to the control strain (see section 3.2.1). Subsequent analysis revealed that higher 
levels of Rrn3p generated in fact higher levels of initiation-competent Pol I-Rrn3p complexes (see 
section 3.2.2), a correlation also true for decreasing amounts of Rrn3p (see section 3.1.2).  
The question, however, whether the enlarged pool of Pol I-Rrn3p complexes leads to an 
augmented recruitment of polymerases to the rDNA locus giving rise to surplus 35S pre-rRNAs 
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could not be answered definitely. Respective ChIP experiments provided ambiguous results. 
Regardless of the level of Rrn3p, Pol I crosslinking to the promoter and the transcribed region of 
the rDNA locus was more or less undistinguishable suggesting for no additional polymerases 
engaged in transcription (see section 3.2.3). Albeit, the corresponding Rrn3p-ChIP indicated that 
there is indeed an enhanced recruitment of this factor to the rDNA promoter with increasing 
cellular amounts of Rrn3p (see section 3.2.3). It should be mentioned that unspecific binding of 
Rrn3p to the 5S rRNA gene is also enhanced. Nevertheless, considering the Rrn3p occupancy at the 
5S rDNA region to be background, still a significant increase of specific Rrn3p crosslinking both to 
the promoter and the transcribed region of the rRNA gene locus could be detected.  
Although evidence exist suggesting that hRRN3 is capable of binding to the SL1 and the rRNA gene 
promoter independently of Pol I in the mammalian system (Miller et al., 2001; Cavanaugh et al., 
2002, 2008), corresponding in vitro studies showed that Pol I is important for the binding of the CF 
and thus of Rrn3p to the rDNA promoter in the yeast system (Aprikian et al., 2001). Therefore, the 
outcome of the Rrn3p-ChIP might argue also for an elevated Pol I occupancy at the rDNA locus. 
A possible explanation for the failure of detecting more polymerases at the template might be due 
to certain limitations of the chromatin immunoprecipitation method in this special case. 
Decreasing occupancy of the enzyme on a distinct rDNA fragment is detectable without 
limitations, since the amount of the fragment co-precipitating with Pol I gradually declines (see 
section 3.1.2). However, this is not absolutely true for the opposite case. Both one or five 
polymerase molecules crosslinked to the same rDNA fragment will just result in the precipitation of 
this single fragment, thereby masking the assumed fivefold increase in Pol I loading on the rDNA 
locus (see sections 3.1.2 and 3.2.3).  
The appearance of additional rDNA repeats or the activation of further rDNA repeats for 
transcription would relieve this possible detection problem. However, overexpression of Rrn3p did 
not result in a significant change in the rDNA copy number (see section 3.2.3). Unfortunately, no 
clear statements regarding the ratio of actively transcribed to transcriptionally inactive rDNA 
repeats could be made due to analytical problems, but it seemed that this ratio is not substantially 
altered as well.  
Rrn3p is described to dissociate from Pol I during promoter clearance in order to allow efficient 
transcription elongation by the enzyme (Schnapp et al., 1993; Brun et al., 1994; Milkereit and 
Tschochner, 1998; Bier et al., 2004). A possible consequence of strongly increased Rrn3p-levels 
might be an impairment of this dissociation event leading to problems of Pol I in the elongation 
cycle. This would be consistent with enhanced Rrn3p crosslinking to the transcribed region of the 
rDNA locus as seen in the Rrn3p-ChIP. Strikingly, a recently published study proposed that there is 
a connection between the impaired dissociation of the Pol I-Rrn3p complex and problems in both 
cell growth and transcription elongation (Beckouet et al., 2008).  
Interestingly, neither significant pre-rRNA processing defects nor other abnormalities in the 
production and maturation of ribosomal RNAs were detectable following strong overexpression of 
Rrn3p which could account for the observed growth phenotype of the respective yeast strain (see 
section 3.2.4). Only a stepwise increase in the level of 35S pre-rRNA was observed which correlated 
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with rising amounts of Rrn3p. It is difficult to state whether this is the consequence of enhanced 
Pol I transcription and thus 35S pre-rRNA production or of a minor pre-rRNA processing defect, 
since 35S pre-rRNA-levels are established by the balanced interplay of pre-rRNA production, pre-
rRNA processing, and pre-rRNA degradation.  
In any case, further investigation is required, using for instance the Miller chromatin spreading 
technique or the ChEC method, to clarify the question whether or not Pol I transcription and 35S 
pre-rRNA production is stimulated by the overexpression of Rrn3p.  
It should be noted that the possibility of increased Rrn3p-levels generating defects in processes 
completely different from ribosome biogenesis cannot be excluded.  
 
4.7 The role of Pol5p in ribosome biogenesis and yeast cell growth 
Previous results from my diploma thesis showing twice independently the presence of the factor 
Pol5p in cellular fractions purified for Rrn3p prompted for a closer investigation of a possible 
interaction between the two proteins (see section 3.3.1) (Steinbauer, 2006). In fact, at least an 
interaction between subpopulations of these factors appears to exist, since Pol5p specifically co-
purified with Rrn3p within three consecutive purification steps (see section 3.3.1).  
Strong evidence exist that Mybbp1a, the corresponding mammalian homologue of Pol5p (Shimizu 
et al., 2002), interacts likewise with the mammalian RNA Pol I transcription machinery (Hochstatter 
et al., submitted). However, Mybbp1a was described to bind directly to the Pol I subunit 
hPAF53/A49. The question whether Pol5p or Mybbp1a additionally interacts with any of the yeast 
Pol I subunits or the mammalian hRRN3/TIF-IA, respectively, remains open and requires further 
investigation.  
Consistently, an essential role in the synthesis of ribosomal RNA was assigned for both Pol5p and 
Mybbp1a indicating a conservation of regulatory mechanisms throughout evolution (Shimizu et al., 
2002; Nadeem et al., 2006). Both proteins seem to fulfill a dual function in the rDNA metabolism. On 
the one hand, Pol5p was found to associate with the promoter region, the 25S rRNA-coding region, 
and the enhancer region of the rDNA locus, thereby presumably influencing Pol I transcription 
(Shimizu et al., 2002; Nadeem et al., 2006; Wery et al., 2009). On the other hand, this protein could 
be identified to be a part of a complex required for early pre-rRNA processing events (Krogan et al., 
2004). In a related manner, Mybbp1a appears to play both a negative role in Pol I transcription and 
a positive role in pre-rRNA processing (Hochstatter et al., submitted).  
Interestingly, the homologue of Pol5p in the fission yeast Saccharomyces pombe appears to interact 
with a subunit of the cell cycle-regulating complex MBF suggesting a possible role for Pol5p in the 
coordination of ribosome biogenesis and cell cycle progression (Nadeem et al., 2006).  
Mybbp1a, meaning Myb-binding protein 1a, was originally designated due to its ability to bind to 
the mammalian transcription factor c-Myb (Favier and Gonda, 1994). Being the putative 
homologue of c-Myb, yeast Reb1p might enable Pol5p to function in Pol I transcription by 
recruiting the protein to the enhancer region of the rDNA locus where Pol5p crosslinking is actually 
detected.  
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Surprisingly, despite investigating the association of Pol5p with the same regions of the rDNA locus 
where binding was reported, these positive results could not be reproduced (see section 3.3.2) 
(Shimizu et al., 2002; Nadeem et al., 2006; Wery et al., 2009). Variations in the protocols used for 
chromatin immunoprecipitation experiments by the different groups provide a possible 
explanation for this discrepancy.  
Although the functional outcome of the depletion of either Pol5p or Mybbp1a is quite similar, 
being pre-rRNA processing defects and cessation of growth and proliferation (Shimizu et al., 2002; 
Peng et al., 2003; Hochstatter et al., submitted), further investigation is required to elucidate the 
conservation of their functions in regulating and/or coordinating ribosome biogenesis, cell growth, 
and maybe cell cycle progression.  
 
4.8 Outlook 
One of the major objectives of this PhD thesis was the investigation of the mechanism(s) regulating 
the complex formation between RNA polymerase I and Rrn3p. In contrast to the mammalian 
system, in yeast the parameters involved in the control of this switch essential for RNA polymerase I 
transcription remain largely uncharacterized. Strikingly, although both Pol I and Rrn3p are present 
in sufficient amounts in the cell, only a minor fraction of these molecules is assembled into Pol I-
Rrn3p complexes.  
Alterations in the level of Rrn3p appear to play a distinct role in Pol I-Rrn3p complex formation, 
however, there are definitely other mechanisms which contribute. Since Rrn3p is a 
phosphoprotein, changes in the phosphorylation pattern very likely influence its binding affinity to 
Pol I, a hypothesis already proposed by others (Fath et al., 2001). However, serine 102, the only 
phosphorylation site of Rrn3p identified so far, turned out to be not essential for yeast cell growth. 
This is reminiscent to Pol I whose established phosphorylation sites appear likewise to constitute 
non-essential posttranslational modifications (Gerber et al., 2008).  
Nevertheless, the identification and investigation of additional phosphorylation sites and/or other 
posttranslational modifications of both Pol I and Rrn3p is important to further elucidate their role 
in the regulation of Pol I-Rrn3p complex formation. Crystallization and subsequent X-ray structure 
analysis of Rrn3p and/or electron microscopy analysis of the Pol I-Rrn3p complex might provide 
invaluable structural information presumably leading to an improved understanding of Pol I-Rrn3p 
complex formation.  
Finally, the identification of additional interaction partners of Rrn3p and/or Pol I might also 
contribute to the knowledge of how Pol I-Rrn3p complex formation and thus Pol I transcription is 
regulated in yeast cells.  
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5 MATERIAL AND METHODS 
5.1 Material 
5.1.1 Saccharomyces cerevisiae strains 
No. Name Genotype Background Comment Origin 
Y6 W303-1A ade2-1 can1-100 his3-
11,-15 leu2-3,112 trp1-
1 ura3-1 
W303-1A  (Thomas 
and 
Rothstein, 
1989) 
Y652 cim3-1-
RRN3-TAP 
ura3-52 leu2-∆1 his3-
∆200 prc1-1 cim3-1 
RRN3::RRN3-TAP 
(URA3) 
YWO365  (Philippi et 
al., 2010) 
Y658 RRN3-TAP-
A43-HA3 
ura3-52 his3-∆200 
leu2-∆1 trp1∆63 lys2-
801 ade2-101 prc1-1 
RRN3::RRN3-TAP 
(URA3) RPA43::RPA43-
HA3 (HIS3) 
YWO365  (Philippi, 
2008) 
Y2183 RRN3-Prot.A ade2-1 can1-100 his3-
200 leu2-3,112 trp1-1 
ura3-1 RRN3::RRN3-
Prot.A (HIS3) 
BSY420  (Fath et al., 
2001) 
Y2182 RRN3-TAP ade2-1 can1-100 his3-
200 leu2-3,112 trp1-1 
ura3-1 RRN3::RRN3-
TAP (TRP1) 
BSY420  (Fath, 2002) 
Y2189 pRRN3 
(URA) 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
YCplac33-RRN3 (URA3) 
NOY604  (Philippi et 
al., 2010) 
Y667 pTet7-RRN3-
Prot.A 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 pTet7-
RRN3-Prot.A (TRP1) 
NOY604  (Philippi et 
al., 2010) 
Y2180 pNOP1-
RRN3-Prot.A 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
NOY604  (Philippi et 
al., 2010) 
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100 RRN3::HIS3 
pNOP1-RRN3-Prot.A 
(LEU2) 
Y2181 pNOP1-
RRN3-Prot.A 
[pGAL1-
Myc3-UBI4 
[G76A]] 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
pNOP1-RRN3-Prot.A 
(LEU2) pGAL1-Myc3-
UBI4 [G76A] (TRP1) 
NOY604 obtained by 
transformation 
of Y2180 with 
linearized 
plasmid pGAL1-
Myc3-UBI4 
[G76A] 
this study 
Y2176 pRRN3 ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
pRS315-RRN3 (LEU2) 
NOY604 obtained by 
transformation 
of Y2189 with 
pRS315-RRN3 
followed by 
shuffle (see 
section 5.2.1.5) 
this study 
Y2177 pRRN3 
(S102A) 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
pRS315-RRN3 (S102A) 
(LEU2) 
NOY604 obtained by 
transformation 
of Y2189 with 
pRS315-RRN3 
(S102A) followed 
by shuffle (see 
section 5.2.1.5) 
this study 
Y2178 pRRN3 
(S102D) 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
pRS315-RRN3 (S102D) 
(LEU2) 
NOY604 obtained by 
transformation 
of Y2189 with 
pRS315-RRN3 
(S102D) followed 
by shuffle (see 
section 5.2.1.5) 
this study 
Y2113 pRRN3 
(URA)-A43-
HA3 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
YCplac33-RRN3 (URA3) 
RPA43::RPA43-HA3 
(hphNT1) 
NOY604 obtained by 
transformation 
of Y2189 with 
PCR product 
(2174/2175) from 
pYM24 
this study 
Y2186 pRRN3-
Prot.A-A43-
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
NOY604 obtained by 
transformation 
this study 
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HA3 100 RRN3::HIS3 
RPA43::RPA43-HA3 
(hphNT1) pRRN3-
Prot.A (LEU2) 
of Y2113 with 
pRRN3-Prot.A 
followed by 
shuffle (see 
section 5.2.1.5) 
Y2185 pTet7-RRN3-
Prot.A-A43-
HA3 
ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 RRN3::HIS3 
RPA43::RPA43-HA3 
(hphNT1) pTet7-RRN3-
Prot.A (TRP1) 
NOY604 obtained by 
transformation 
of Y2113 with 
pTet7-RRN3-
Prot.A followed 
by shuffle (see 
section 5.2.1.5) 
this study 
Y943 RRN3-A43-
MNase-HA3 
ade5 his7-2 leu2-112 
trp1-289 ura3-52 
RPA43::RPA43-MNase-
HA3 (kanMX6) 
CG379  (Merz et al., 
2008) 
Y936 rrn3-8-A43-
MNase-HA3 
ade5 his7-2 leu2-112 
trp1-289 ura3-52 rrn3-
8 RPA43::RPA43-
MNase-HA3 (kanMX6) 
YCC95  (Merz et al., 
2008) 
Y208 BY4743 his3-1/his3-1 leu2-
0/leu2-0 lys2-0/LYS2 
met15-0/MET15 ura3-
0/ura3-0 
BY4743  Euroscarf 
Y990 RPL25/ 
rpl25∆ 
his3-1/his3-1 leu2-
0/leu2-0 lys2-0/LYS2 
met15-0/MET15 ura3-
0/ura3-0 
YOL127w::kanMX4/YO
L127w 
BY4743  Euroscarf 
Y206 BY4741 his3-1 leu2-0 met15-0 
ura3-0 
BY4741  Euroscarf 
Y207 BY4742 his3-1 leu2-0 lys2-0 
ura3-0 
BY4742  Euroscarf 
Y653 RRN3-HA3 his3-1 leu2-0 met15-0 
ura3-0 RRN3::RRN3-
HA3 (HIS3) 
BY4741  (Philippi, 
2008) 
Y2179 POL5-HA3 his3-1 leu2-0 met15-0 
ura3-0 POL5::POL5-HA3 
BY4741 obtained by 
transformation 
this study 
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(kanMX6) of Y206 with PCR 
product 
(1795/1796) from 
pYM1 
Y1798 POL5-HA3-
RRN3-TAP 
his3-1 leu2-0 met15-0 
ura3-0 POL5::POL5-HA3 
(kanMX6) RRN3::RRN3-
TAP (URA3) 
BY4741 obtained by 
transformation 
of Y2179 with 
PCR product 
(1717/1718) from 
pBS1539 
this study 
Y1799 RRN3-HA3-
POL5-TAP 
his3-1 leu2-0 met15-0 
ura3-0 RRN3::RRN3-
HA3 (HIS3) POL5::POL5-
TAP (URA3) 
BY4741 obtained by 
transformation 
of Y653 with PCR 
product 
(1793/1794) from 
pBS1539 
this study 
Y1807 NOG1-GFP his3-1 leu2-0 met15-0 
ura3-0 NOG1::NOG1-
GFP (HIS3) 
BY4741 obtained by 
transformation 
of Y206 with PCR 
product 
(2049/2050) from 
pYM44 
this study 
Y1809 RRP12-GFP his3-1 leu2-0 met15-0 
ura3-0 RRP12::RRP12-
GFP (HIS3) 
BY4741 obtained by 
transformation 
of Y206 with PCR 
product 
(2051/2052) from 
pYM44 
this study 
Y323 pGAL1-
RPS5 
his3-1 leu2-0 ura3-0 
lys2-0 
YJR123w::kanMX4 
pGAL1-RPS5 (LEU2) 
BY4742  (Ferreira-
Cerca et al., 
2005) 
Y1805 pGAL1-
RPS5-
RRP12-GFP 
his3-1 leu2-0 ura3-0 
lys2-0 
YJR123w::kanMX4 
pGAL1-RPS5 (LEU2) 
RRP12::RRP12-GFP 
(hphNT1) 
BY4742 obtained by 
transformation 
of Y323 with PCR 
product 
(2051/2052) from 
pYM25 
this study 
Y399 pGAL1- his3-1 leu2-0 met15-0 BY4741/  (Ferreira-
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RPS14 lys2-0 ura3-0 
YCR031c::HIS3 
YJL191w::kanMX4 
pGAL1-RPS14 (LEU2) 
BY4742 Cerca et al., 
2005) 
Y1806 pGAL1-
RPS14-
RRP12-GFP 
his3-1 leu2-0 met15-0 
lys2-0 ura3-0 
YCR031c::HIS3 
YJL191w::kanMX4 
pGAL1-RPS14 (LEU2) 
RRP12::RRP12-GFP 
(hphNT1) 
BY4741/ 
BY4742 
obtained by 
transformation 
of Y399 with PCR 
product 
(2051/2052) from 
pYM25 
this study 
Y1026 pGAL1-
RPL25 
his3-1 leu2-0 ura3-0 
YOL127w::kanMX4 
pGAL1-RPL25 (LEU2) 
BY4741/ 
BY4742 
 (Pöll et al., 
2009) 
Y1804 pGAL1-
RPL25-
NOG1-GFP 
his3-1 leu2-0 ura3-0 
YOL127w::kanMX4 
pGAL1-RPL25 (LEU2) 
NOG1::NOG1-GFP 
(hphNT1) 
BY4741/ 
BY4742 
obtained by 
transformation 
of Y1026 with 
PCR product 
(2049/2050) from 
pYM25 
this study 
Y624 A190-HA3 ade2-1 ura3-1 leu2-
3,112 trp1-1 his3-11 
can1-100 
RPA190::RPA190-
MNase-HA3 (kanMX6) 
NOY505  (Merz et al., 
2008) 
Y2127 RRN3-
Prot.A-
A190-HA3 
ade2-1 ura3-1 leu2-
3,112 trp1-1 his3-11 
can1-100 
RPA190::RPA190-
MNase-HA3 (kanMX6) 
RRN3::RRN3-Prot.A 
(HIS3) 
NOY505 obtained by 
transformation 
of Y624 with PCR 
product 
(242/243) from 
pYM10 
this study 
Y2184 RRN3-HA3-
A43-TAP 
ade2-101 ura3-52 lys2-
801 trp1-63 his3-200 
leu2-1 RPA43::RPA43-
TAP (TRP1) 
RRN3::RRN3-HA3 (HIS3) 
YPH499  Philippi, 
Anja 
Y2172 YPH500 ade2-101 his3-200 
leu2-1 lys2-801 trp1-63 
YPH500  (Sikorski 
and Hieter, 
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ura3-52 1989) 
Y2171 CARA ade2-101 his3-200 
leu2-1 lys2-801 trp1-63 
ura3-52 RRN3::HIS5 
RPA43::kan pGEN-
RRN3-A43 (TRP1) 
YPH500  (Laferté et 
al., 2006) 
Y353 NOY1071 ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 FOB1::HIS3 
NOY1071  (Cioci et al., 
2003) 
Y352 NOY1064 ade2-1 ura3-1 his3-11 
trp1-1 leu2-3,112 can1-
100 FOB1::HIS3 
NOY1064  (Cioci et al., 
2003) 
 
5.1.2 Escherichia coli strains 
Name Genotype Origin 
XL1-Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq 
∆(lacZ)M15] hsdR17(rK- mK+) 
Stratagene 
BL21(DE3) F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]) 
Stratagene 
 
5.1.3 Plasmids 
Plasmid Gene Description Derived from Origin 
YCplac33-RRN3 RRN3 URA3, Ampr, ORI, 
ARS1, CEN4 
 (Philippi et al., 
2010) 
pRRN3-Prot.A 
(A/C) 
RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
pNOP1-RRN3-
Prot.A (see 
section 
5.2.3.12.1) 
this study 
pTet7-RRN3-Prot.A  RRN3 TRP1, Ampr, ORI, 
ARS1, CEN4 
 (Philippi et al., 
2010) 
pGAL1-RRN3 (A/C) RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
 Seufert, Wolfgang 
pGAL1-RRN3-
Prot.A (A/C) 
RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
pGAL1-RRN3 
(A/C) (see 
section 
5.2.3.12.2) 
this study 
pGAL1-RRN3 (2µ) RRN3 LEU2, Ampr, ORI, 2µ  Seufert, Wolfgang 
pGAL1-RRN3- RRN3 LEU2, Ampr, ORI, 2µ pGAL1-RRN3 this study 
MATERIAL AND METHODS 
 
87 
Prot.A (2µ) (2µ) (see 
section 
5.2.3.12.2) 
pNOP1-RRN3-
Prot.A 
RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
 (Philippi et al., 
2010) 
pGAL1-Myc3-UBI4 
[G76A] 
UBI4 TRP1, Ampr, ORI  Seufert, Wolfgang 
pRS315-RRN3 RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
 Milkereit, Philipp 
pRS315-RRN3 
(S102A) 
RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
pRS315-RRN3 
(see section 
5.2.3.12.3) 
this study 
pRS315-RRN3 
(S102D) 
RRN3 LEU2, Ampr, ORI, 
ARSH4, CEN6 
pRS315-RRN3 
(see section 
5.2.3.12.3) 
this study 
pGEN-RRN3-A43 RRN3/RPA43 TRP1, Ampr, ORI, 2µ  (Laferté et al., 
2006) 
YCplac111-pGAL1  LEU2, Ampr, ORI, 
ARS1, CEN4 
 (Ferreira-Cerca et 
al., 2005) 
pGAL1-RPS5 RPS5 LEU2, Ampr, ORI, 
ARS1, CEN4 
 (Ferreira-Cerca et 
al., 2005) 
pGAL1-RPS14 RPS14 LEU2, Ampr, ORI, 
ARS1, CEN4 
 (Ferreira-Cerca et 
al., 2005) 
pGAL1-RPL25 RPS25 LEU2, Ampr, ORI, 
ARS1, CEN4 
 (Pöll et al., 2009) 
pYM1 - kanMX6, Ampr, ORI  (Knop et al., 1999) 
pYM10 - HIS3, Ampr, ORI  (Knop et al., 1999) 
pYM24 - hphNT1, Ampr, ORI  (Janke et al., 2004) 
pYM25 - hphNT1, Ampr, ORI  (Janke et al., 2004) 
pYM44 - HIS3, Ampr, ORI  (Janke et al., 2004) 
pBS1539 - URA3, Ampr, ORI  (Puig et al., 2001) 
 
5.1.4 Oligonucleotides 
No. Name Sequence Gene Function 
242 Rrn3-pYM-for GGAGTGAAGCAAGCGGGGA
ATATGAAAGTGATGGGTCGG
ATGACCGTACGCTGCAGGTC
GAC 
RRN3 primer to obtain amplicon of 
pYM10 for genomic integration 
of Prot.A (HIS3) 
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243 Rrn3-pYM-rev TAGTTTGTGACGGGCATGTC
TCGAAGATACCTATGAAAAA
AGACCATCGATGAATTCGAG
CTCG 
RRN3 primer to obtain amplicon of 
pYM10 for genomic integration 
of Prot.A (HIS3) 
710 M1 TGGAGCAAAGAAATCACCGC rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S III) 
711 M2 CCGCTGGATTATGGCTGAAC rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S III) 
712 M3 GAGTCCTTGTGGCTCTTGGC rDNA primer used for qPCR amplifying 
a region in 18S rDNA (18S II) 
713 M4 AATACTGATGCCCCCGACC rDNA primer used for qPCR amplifying 
a region in 18S rDNA (18S II) 
920 5SChIPF1 GCCATATCTACCAGAAAGCA
CC 
rDNA primer used for qPCR amplifying 
a region in 5S rDNA (5S) 
921 5SChIPR1 GATTGCAGCACCTGAGTTTC
G 
rDNA primer used for qPCR amplifying 
a region in 5S rDNA (5S) 
969 PromChIPF2 TCATGGAGTACAAGTGTGAG
GA 
rDNA primer used for qPCR amplifying 
rDNA promoter region (Prom I) 
970 PromChIPR1 TAACGAACGACAAGCCTACT
C 
rDNA primer used for qPCR amplifying 
rDNA promoter region (Prom I) 
1717 fp Rrn3-TAP-
URA3 
GGAATACTACATAGAGTGGA
GTGAAGCAAGCGGGGAATA
TGAAAGTGATGGGTCGGATG
ACTCCATGGAAAAGAGAAG 
RRN3 primer to obtain amplicon of 
pBS1539 for genomic integration 
of TAP (URA3) 
1718 rp Rrn3-TAP-
URA3 
GACTACAGTGTATCATTAGTT
TGTGACGGGCATGTCTCGAA
GATACCTATGAAAAAAGACC
TACGACTCACTATAGGG 
RRN3 primer to obtain amplicon of 
pBS1539 for genomic integration 
of TAP (URA3) 
1793 fp Pol5-TAP-
URA3 
TTCATCAATTGGCTATCTTCA
AAAAAGCAAACTGTAATGGA
TAAGGAATCCATGGAAAAGA
GAAG 
POL5 primer to obtain amplicon of 
pBS1539 for genomic integration 
of TAP (URA3) 
1794 rp Pol5-TAP-
URA3 
GATCAACATACATAATCCGA
TTTTGAGGAGTGATAAAATA
TACTTAGATACGACTCACTAT
AGGG 
POL5 primer to obtain amplicon of 
pBS1539 for genomic integration 
of TAP (URA3) 
1795 fp Pol5-HA3-
kanMX6 
TCATCAATTGGCTATCTTCAA
AAAAGCAAACTGTAATGGAT
AAGGAACGTACGCTGCAGGT
POL5 primer to obtain amplicon of 
pYM1 for genomic integration of 
HA3 (kanMX6) 
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CGAC 
1796 rp Pol5-HA3-
kanMX6 
TCAACATACATAATCCGATTT
TGAGGAGTGATAAAATATAC
TTAGAATCGATGAATTCGAG
CTCG 
POL5 primer to obtain amplicon of 
pYM1 for genomic integration of 
HA3 (kanMX6) 
2049 Nog1-GFP for 
S3 
TTATTCAGTGGTAAGCGTGG
TGTCGGTAAGACAGATTTCC
GTCGTACGCTGCAGGTCGAC 
NOG1 primer to obtain amplicon of 
pYM25/pYM44 for genomic 
integration of GFP (HIS3) 
2050 Nog1-GFP rev 
S2 
TTTTAAAGTACATGCAAAAG
AAAGAATAAGAAGTAGAGA
AAATCGATGAATTCGAGCTC
G 
NOG1 primer to obtain amplicon of 
pYM25/pYM44 for genomic 
integration of GFP (HIS3) 
2051 Rrp12-GFP for 
S3 
CATAATAAGAAAGGTCCAAA
GTTCAAATCTAGAAAAAAAT
TACGTACGCTGCAGGTCGAC 
RRP12 primer to obtain amplicon of 
pYM25/pYM44 for genomic 
integration of GFP (HIS3) 
2052 Rrp12-GFP 
rev S2 
CTCCAGGTGTGTAATTAGCC
ATATTGCTCAGTTTCAATCTT
ATCGATGAATTCGAGCTCG 
RRP12 primer to obtain amplicon of 
pYM25/pYM44 for genomic 
integration of GFP (HIS3) 
2137 RRN3-SOE 
R1A 
CTATCCTGTTGATATTAGCAG
ATAAGATATCCAAA 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2138 RRN3-SOE 
R1D 
CTATCCTGTTGATATTATCAG
ATAAGATATCCAAA 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2139 RRN3-SOE 
F2A 
TTTGGATATCTTATCTGCTAA
TATCAACAGGATAG 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2140 RRN3-SOE 
F2D 
TTTGGATATCTTATCTGATAA
TATCAACAGGATAG 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2141 RRN3-SOE F1 TCGAGGTCGACGGTATCGAT
AAGCT 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2142 RRN3-SOE R2 ATATTCCCCGCTTGCTTCACT
CCAC 
RRN3 primer to obtain phospho-
mutant allele of RRN3 (see 
section 5.2.3.12.3) 
2174 fp A43-HA3-
kanMX6 
GAGATCGTATACGAGGAAAA
CACCAGTGAAAGCAATGATG
GTGAATCGAGTGATAGTGAT
RPA43 primer to obtain amplicon of 
pYM24 for genomic integration 
of HA3 (kanMX6) 
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CGTACGCTGCAGGTCGAC 
2175 rp A43-HA3-
kanMX6 
TTATCCTATATCAATAACGTA
TATCTTTATTTGTTTTGATTTT
TTCTCATTTTTCCCGTCATCG
ATGAATTCGAGCTCG 
RPA43 primer to obtain amplicon of 
pYM24 for genomic integration 
of HA3 (kanMX6) 
2234 RRN3 fo SacI CTCACTATAGGGCGAATTGG
AGCTC 
RRN3 primer to obtain amplicon to 
clone RRN3 promoter 
2235 RRN3 re NdeI CCGCTTGCTTCACTCCACTCT
ATGT 
RRN3 primer to obtain amplicon to 
clone RRN3 promoter 
2472 NdeI fo TCTTTAGCCACTCGACAACA RRN3 primer to obtain amplicon to 
clone Prot.A-tagged RRN3 
2473 HindIII re TACGCCAAGCTCGGAATTAA RRN3 primer to obtain amplicon to 
clone Prot.A-tagged RRN3 
2477 rDNA3 Th fo GTGTGAGGAAAAGTAGTTGG
GAGGTA 
rDNA primer used for qPCR amplifying 
rDNA promoter region (Prom II) 
2478 rDNA3 Th re GACGAGGCCATTTACAAAAA
CATAAC 
rDNA primer used for qPCR amplifying 
rDNA promoter region (Prom II) 
2479 rDNA4 Th fo CTTGTCTCAAAGATTAAGCC
ATGC 
rDNA primer used for qPCR amplifying 
a region in 18S rDNA (18S I) 
2480 rDNA4 Th re ACCACAGTTATACCATGTAG
TAAAGGAACT 
rDNA primer used for qPCR amplifying 
a region in 18S rDNA (18S I) 
2481 rDNA8 Th fo GGTGGTAAATTCCATCTAAA
GCTAAATATT 
rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S I) 
2482 rDNA8 Th re CACGTACTTTTTCACTCTCTTT
TCAAA 
rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S I) 
2483 rDNA11 Th fo AAAGAAGACCCTGTTGAGCT
TGA 
rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S II) 
2484 rDNA11 Th re GTATTTCACTGGCGCCGAA rDNA primer used for qPCR amplifying 
a region in 25S rDNA (25S II) 
817 rDNA-709_for GAGGGACGGTTGAAAGTG rDNA primer to obtain template for 
Southern probe preparation 
from yeast genomic DNA 
818 rDNA-461_re ATACGCTTCAGAGACCCTAA rDNA primer to obtain template for 
Southern probe preparation 
from yeast genomic DNA 
1167 Nup57+759-
for 
TGGATCTAATTTACAGCAGC
A 
NUP57 primer to obtain template for 
Southern probe preparation 
from yeast genomic DNA 
1168 Nup57+1012- CCTGATCCCACTCTTCTTGA NUP57 primer to obtain template for 
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rev Southern probe preparation 
from yeast genomic DNA 
 
5.1.5 Probes 
Name Synthesis Gene Restriction 
Enzyme 
Fragment 
Size 
XcmI-
prom 
PCR from yeast genomic DNA using 
primer 817/818 
rDNA XcmI 4.9 kb 
NUP57 PCR from yeast genomic DNA using 
primer 1167/1168 
RPS23A XcmI 4.2 kb 
 
5.1.6 Antibodies 
Antibody Species Dilution Origin 
α-A43 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 
1980) 
α-A135 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 
1980) 
α-HA (3F10) rat 1:5000 Roche 
α-Myc (9E10) mouse 1:200 E. Kremmer 
α-mouse IgG (H+L) (peroxidase-
conjugated) 
goat 1:5000 Jackson IR/Dianova 
α-rabbit IgG (H+L) (peroxidase-
conjugated) 
goat 1:5000 Jackson IR/Dianova 
α-rat IgG+IgM (H+L) (peroxidase-
conjugated) 
goat 1:5000 Jackson IR/Dianova 
PAP (peroxidase anti-peroxidase) rabbit 1:5000 DakoCytomation 
 
5.1.7 Enzymes 
Enzyme Origin 
Antarctic Phosphatase New England Biolabs 
HotStarTaq DNA Polymerase Qiagen 
iProof High-Fidelity DNA Polymerase Bio-Rad 
Restriction Endonucleases New England Biolabs 
T4 DNA Ligase New England Biolabs 
Taq DNA Polymerase New England Biolabs 
Trypsin, sequencing grade Roche 
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RNase A Invitrogen 
Proteinase K Sigma-Aldrich 
 
5.1.8 Kits 
Kit Origin 
PureLinkTM PCR Purification Kit Invitrogen 
PureLinkTM Quick Gel Extraction Kit Invitrogen 
PureLinkTM Quick Plasmid Miniprep Kit Invitrogen 
RadPrime DNA Labeling System Invitrogen 
 
5.1.9 Media 
Medium Composition 
YPD 
(yeast extract, peptone, dextrose) 
1% (w/v) yeast extract 
2% (w/v) peptone 
2% (w/v) glucose 
YPD+gen/+hyg 
(YPD plus geneticin/hygromycin B) 
YPD + 200 µg/ml geneticin (G418) / + 300 µg/ml 
hygromycin B 
YPAD 
(YPD plus adenine) 
YPD + 100 mg/l adenine 
YPUD 
(YPD plus uracil) 
YPD + 2 mg/ml uracil 
YPD+dox 
(YPD plus doxycycline) 
YPD + 0/0.02/0.1/0.5/1 µg/ml doxycycline 
YPG 
(yeast extract, peptone, galactose) 
1% (w/v) yeast extract 
2% (w/v) peptone 
2% (w/v) galactose 
YPUG 
(YPG plus uracil) 
YPG + 2 mg/ml uracil 
YPG+gen/+hyg 
(YPG plus geneticin/hygromycin B) 
YPG + 200 µg/ml geneticin (G418) / + 300 µg/ml 
hygromycin B 
SCD 
(synthetic complete dextrose) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 100 mg/l L-leucine 
+ 50 mg/l L-tryptophan 
SCD-leu/-trp 0.67% (w/v) YNB + nitrogen 
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(SCD minus leucine/tryptophan) 0.062% (w/v) CSM-his-leu-trp 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 50 mg/l L-tryptophan / + 100 mg/l L-leucine 
SCD-his+gen 
(SCD minus histidine plus geneticin) 
0.17% (w/v) YNB – nitrogen 
0.1% (w/v) proline 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) glucose 
+ 100 mg/l L-leucine 
+ 50 mg/l L-tryptophan 
+ 200 µg/ml geneticin (G418) 
SCD-met-cys 
(SCD minus methionine minus cysteine) 
0.67% (w/v) YNB + nitrogen 
0.051% (w/v) CSM-his-leu-lys-met-trp-ura 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 100 mg/l L-leucine 
+ 50 mg/l L-lysine 
+ 50 mg/l L-tryptophan 
+ 20 mg/l L-uracil 
SCD-leu+5FOA 
(SCD minus leucin plus 5FOA) 
SCD-leu + 0.1% (w/v) 5FOA 
SCD-trp+5FOA 
(SCD minus tryptophan plus 5FOA) 
SCD-trp + 0.1% (w/v) 5FOA 
SCG 
(synthetic complete galactose) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) galactose 
+ 20 mg/l L-histidine 
+ 100 mg/l L-leucine 
+ 50 mg/l L-tryptophan 
SCG-leu 
(SCG minus leucine) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) galactose 
+ 20 mg/l L-histidine 
+ 50 mg/l L-tryptophan 
SCR 
(synthetic complete raffinose) 
0.67% (w/v) YNB + nitrogen 
0.13% AAM-leu-ura-his 
+ 100 mg/l L-leucine 
+ 20 mg/l L-uracil 
+ 20 mg/l L-histidine 
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+ 2% (w/v) raffinose 
SCR-leu 
(SCR minus leucine) 
0.67% (w/v) YNB + nitrogen 
0.13% AAM-leu-ura-his 
+ 20 mg/l L-uracil 
+ 20 mg/l L-histidine 
+ 2% (w/v) raffinose 
SCR-leu+gal 
(SCR minus leucine plus galactose) 
SCR-leu + 2% (w/v) galactose 
LB 
(luria broth) 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
0.5% (w/v) NaCl 
LB+amp 
(LB plus ampicillin) 
LB + 100 µg/ml ampicillin 
SOB 
(super optimal broth) 
2% (w/v) tryptone 
0.5% (w/v) yeast extract 
0.5 g/l NaCl 
0.19 g/l KCl 
2.03 g/l MgCl2 ⋅ 6 H2O 
pH 7.0 with NaOH 
 
AAM-leu-ura-his (amino acid mix minus leucine minus uracil minus histidine) is a mixture of the 
amino acids tyrosine (60 mg/l), isoleucine (80 mg/l), phenylalanine (50 mg/l), glutamic acid 
(100 mg/l), threonine (200 mg/l), aspartic acid (100 mg/l), valine (150 mg/l), serine (400 mg/l), 
arginine (20 mg/l), tryptophan (40 mg/l), methionine (20 mg/l), lysine (30 mg/l), and the 
nucleobase adenine (40 mg/l). Media for agar plates were supplemented with 2% (w/v) agar. All 
growth media were autoclaved for 20 min at 120°C. If required antibiotics, fungicides, 
counterselection drugs, or other chemicals were added after cooling to about 60°C.  
 
5.1.10 Buffers 
Buffer Ingredients Concentration 
10x PBS NaCl 
KCl 
KH2PO4 
Na2HPO4 
pH 7.4 with NaOH 
1.37 M 
27 mM 
18 mM 
0.1 M 
10x PBST NaCl 
KCl 
KH2PO4 
1.37 M 
27 mM 
18 mM 
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Na2HPO4 
Tween 20 
pH 7.4 with NaOH 
0,1 M 
0.5% (v/v) 
4x lower tris Tris 
SDS 
pH 8.8 with HCl 
1.5 M 
0.4% (w/v) 
4x upper tris Tris 
SDS 
bromophenol blue 
pH6.8 with HCl 
0.5 M 
0.4% (w/v) 
4x SDS sample buffer Tris pH 6.8 
glycerol 
SDS 
β-mercaptoethanol 
bromophenol blue 
0.25 M 
40% (v/v) 
8.4% (w/v) 
0.57 M 
HU buffer Tris pH 6.8 
SDS 
EDTA pH 8.0 
β-mercaptoethanol 
urea 
bromophenol blue 
0.2 M 
5% (w/v) 
1 mM 
0.21 M 
8 M 
10x electrophoresis buffer Tris 
glycine 
SDS 
0.25 M 
1.92 M 
1% (w/v) 
transfer buffer (Western Blot) Tris 
glycine 
methanol 
25 mM 
192 mM 
20% (v/v) 
ponceau staining solution Ponceau S 
HOAc 
0.5% (w/v) 
1% (v/v) 
coomassie staining solution Coomassie Brilliant Blue R-250 
methanol 
HOAc 
0.1% (w/v) 
45% (v/v) 
10% (v/v) 
destaining solution methanol 
HOAc 
45% (v/v) 
10% (v/v) 
100x protease inhibitors (PIs) benzamidine 
PMSF 
solvent: ethanol 
store at -20°C 
0.2 M 
0.1 M 
10x DNA loading buffer Tris-HCl pH 8.0 4 mM 
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EDTA pH 8.0 
glycerol 
bromophenol blue 
xylene cyanol 
0.4 mM 
60% (v/v) 
5x TBE buffer Tris 
boric acid 
EDTA pH 8.0 
445 mM 
445 mM 
10 mM 
hybridization buffer sodium phosphate pH 7.2 
SDS 
0.5 M 
7% (w/v) 
AE buffer NaOAc pH 5.3 
EDTA pH 8.0 
50 mM 
10 mM 
RNA solubilization buffer formamide 
formaldehyde 
MOPS buffer 
store at -20°C 
50% (v/v) 
8% (v/v) 
1x 
20x SSC NaCl 
trisodium citrate dihydrate 
pH 7.0 with HCl 
3 M 
0.3 M 
 
10x MOPS buffer sodium acetate trihydrate 
MOPS 
EDTA pH 8.0 
pH 7.0 with NaOH 
20 mM 
0.2 M 
10 mM 
RD buffer glucose 
peptone 
malt extract 
yeast extract 
mannitol 
MgOAc 
store at -20°C 
2% (w/v) 
1% (w/v) 
0.6% (w/v) 
0.01% (w/v) 
12% (w/v) 
17.8 mM 
RG buffer galactose 
peptone 
malt extract 
yeast extract 
mannitol 
MgOAc 
store at -20°C 
2% (w/v) 
1% (w/v) 
0.6% (w/v) 
0.01% (w/v) 
12% (w/v) 
17.8 mM 
TELit Tris pH 8.0 
LiOAc 
EDTA pH 8.0 
10 mM 
100 mM 
1 mM 
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pH 8.0 with HOAc 
LitSorb sorbitol 
solvent: TELit 
sterile filtration 
1 M 
LitPEG polyethylene glycol (PEG3350) 
solvent: TELit 
sterile filtration 
40% (w/v) 
rapamycin stock solution rapamycin 
solvent: DMSO 
store at -20°C 
1 mg/ml 
cycloheximide stock solution cycloheximide 
solvent: ethanol 
store at -20°C 
50 mg/ml 
 
The solvent is H2O, if not indicated otherwise. The pH values were measured at room temperature 
(RT).  
 
5.1.11 Chemicals 
Chemicals were purchased at the highest purity available from Sigma-Aldrich, Merck, Fluka, Roth, 
or J.T.Baker, except 5FOA (Toronto Research Chemicals), electrophoresis-grade agarose 
(Invitrogen), bromophenol blue (Serva), G418/Geneticin (Gibco), milk powder (Sukofin), Nonidet 
P40 (NP40) (USB Corporation), Tris ultrapure (USB Corporation), and Tween 20 (T20) (Serva).  
Ingredients for growth media were purchased from BD Becton, Dickinson and Co. (agar, peptone, 
tryptone and yeast extract), Qbiogene, Bio101, or Sunrise Science Products (complete supplement 
mixtures (CSM), yeast nitrogen base (YNB), amino acids, and adenine), Sigma-Aldrich (D(+)-glucose, 
D(+)-galactose, amino acids, and uracil), PerkinElmer (5’,6’-[3H] uracil), and Hartmann Analytic 
(α-[32P]-ATP, [35S]-met/cys). Water was always purified with an Elga Purelab Ultra device prior to use.  
 
5.1.12 Other materials 
Material Origin 
Protein Marker, Broad Range (2-212 kDa) New England Biolabs 
ColorPlus Prestained Protein Marker, Broad Range (7-175 kDa) New England Biolabs 
1 kb DNA ladder New England Biolabs 
100 bp DNA ladder New England Biolabs 
Salmon Sperm DNA (10 mg/ml) Invitrogen 
yeast genomic DNA (strain S288C) Invitrogen 
Immobilion-P Membrane PVDF 0,45 µm Millipore 
Membrane PositiveTM MP Biomedicals 
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Blotting papers MN 827 B Millipore 
Extra Thick Blot Paper Bio-Rad 
BM Chemiluminescence Blotting Substrate (POD) Roche 
SimplyBlueTM SafeStain Invitrogen 
IgG SepharoseTM 6 Fast Flow GE Healthcare 
Protein G SepharoseTM 4 Fast Flow GE Healthcare 
Protein Assay Dye Reagent Concentrate Bio-Rad 
SYBR Safe DNA Gel Stain Invitrogen 
SYBR Green Roche 
glass beads (∅ 0.75-1 mm) Roth 
Calmodulin Affinity Resin Stratagene 
Glutathione Sepharose 4B GE Healthcare 
BioMax MS Film Sigma-Aldrich 
EN3HANCE Spray Surface Autoradiography Enhancer PerkinElmer 
 
5.1.13 Equipment 
Device Manufacturer 
4700 Proteomics Analyzer MALDI-TOF/TOF Applied Biosystems 
4800 Proteomics Analyzer MALDI-TOF/TOF Applied Biosystems 
Biofuge Fresco refrigerated tabletop centrifuge Hereaus 
Biofuge Pico tabletop centrifuge Hereaus 
C412 centrifuge Jouan 
Centrikon T-324 centrifuge Kontron Instruments 
CT422 refrigerated centrifuge Jouan 
Electrophoresis system model 45-2010-i Peqlab Biotechnologie 
GmbH 
FastPrep Instrument Qbiogene 
FPLC-System (Pumps P-500; Controller LCC-501+; Fraction Collector 
FRAC-100) 
Pharmacia Biotech 
Gel Max UV transilluminator Intas 
IKA-Vibrax VXR IKA 
Incubators Memmert 
LAS-3000 chemiluminescence imager Fujifilm 
MicroPulser electroporation apparatus Bio-Rad 
NanoDrop ND-1000 spectrophotometer Peqlab Biotechnologie 
GmbH 
Avanti J-20 XP centrifuge Beckman Coulter 
Optima L-80 X ultracentrifuge Beckman Coulter 
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PCR Sprint thermocycler Hybaid 
Power Pac 3000 power supplies Bio-Rad 
Pulverisette 6 planetary mono mill Fritsch 
Roto-Shake Genie Scientific Industries 
Shake incubators Multitron / Minitron Infors 
Speed Vac Concentrator Savant 
Thermomixer compact Eppendorf 
Trans-Blot SD Semi-Dry Transfer Cell Bio-Rad 
Ultrospec 3100pro spectrophotometer Amersham 
XCell SureLock Mini-Cell electrophoresis system Invitrogen 
AxioCam MR CCD camera Zeiss 
Axiovert 200M microscope Zeiss 
Rotor-Gene 3000 Corbett Research 
Sonifier 250 Branson 
SMART System Pharmacia Biotech 
Mono Q PC 1.6/5 Pharmacia Biotech 
Superose 12 PC 3.2/30 GE Healthcare 
FLA-3000 phosphor imager Fujifilm 
 
5.1.14 Software 
Software Producer 
4000 Series Explorer v.3.6 Applied Biosystems 
Acrobat 7.0 Professional v.7.0.9 Adobe 
Data Explorer v.4.5 C Applied Biosystems 
GPS Explorer v.3.5 Applied Biosystems 
Image Reader LAS-3000 V2.2 Fujifilm 
Mascot Matrix Science 
Microsoft Office 2007 Microsoft 
ND-1000 v.3.5.2 Peqlab Biotechnologie GmbH 
Photoshop CS v.8.0.1 Adobe 
Axiovision V 4.7.1.0 Zeiss 
Multi Gauge V3.0 Fujifilm 
Rotor-Gene V6.1 Corbett Research 
Image Reader FLA-3000 V1.8 Fujifilm 
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5.2 Methods 
5.2.1 Work with Saccharomyces cerevisiae 
5.2.1.1 Cultivation of yeast strains 
Strains of the yeast Saccharomyces cerevisiae were cultivated using standard microbiological 
methods (Sherman, 2002).  
Liquid cultures were grown in the appropriate medium usually at 30°C, except for temperature-
sensitive mutants (24°C) or for temperature-shift experiments (24°C, 37°C). Cell growth was 
monitored by measuring the optical density at 600 nm (OD600).  
For cultivation on solid agar plates containing the appropriate medium, single colonies or small 
aliquots of glycerol stocks were streaked out using sterile disposable inoculation loops in order to 
obtain colonies derived from single yeast cells. Plates were incubated upside down at the 
respective temperatures for 1-5 days. Short-term storage of yeast strains was accomplished by 
keeping the agar plates at 4°C.  
 
5.2.1.2 Preparation of competent yeast cells 
50 ml of a logarithmically growing yeast culture (OD600 ∼ 0.5-0.7) were harvested by centrifugation 
for 5 min at 4000 rpm and RT. Cells were washed with 25 ml sterile H2O and 5 ml LitSorb before 
resuspending in 360 µl LitSorb. 40 µl of Salmon Sperm DNA, which were incubated for 5 min at 
99°C and immediately chilled on ice, were added to the cell suspension. After mixing, 50 µl aliquots 
were transferred to 1.5 ml tubes before storage at -80°C.  
 
5.2.1.3 Transformation of competent yeast cells 
The aliquot containing competent yeast cells was thawed on ice. DNA to be transformed (100 ng of 
plasmid DNA or 5-10 µg of linear DNA, respectively) was added and the sample was mixed. After 
addition of six volumes of LitPEG, the suspension was again mixed thoroughly and incubated for 
30 min at RT on a turning wheel. The sample was mixed with 1/9 total volume (cells plus DNA plus 
LitPEG) of sterile DMSO followed by a heat-shock at 42°C for 15 min and centrifugation for 1 min at 
3000 rpm and RT.  
When selecting for auxotrophic markers (e.g. TRP1, LEU2, HIS3, URA3), the cell pellet was directly 
resuspended in 100 µl sterile H2O and plated on SCD- or SCG-plates, respectively, lacking the 
corresponding amino acid.  
If selection for antibiotic resistance (e.g. geneticin, hygromycin B) was required, the cell pellet was 
resuspended in 5 ml YPD or YPG, respectively, and incubated for 3-6 h at 30°C while shaking to 
allow the expression of the marker before plating on the respective selection media. Since 
selection for antibiotic resistance often results in a high number of transient transformants, these 
plates were replica-plated on fresh selection media to identify positive clones.  
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5.2.1.4 Crosslinking of yeast cells with formaldehyde 
Logarithmically growing cells from 45 ml liquid culture were crosslinked by adding 1.25 ml 37% 
(v/v) formaldehyde and subsequent incubation for additional 15 min at the respective growth 
temperature while shaking. Crosslinking was quenched by adding 2.5 ml 2.5 M glycine. The culture 
was further incubated at growth temperature for additional 5 min. Cells were harvested by 
centrifugation in a 50 ml tube for 3 min at 3000 rpm and 4°C. The cell pellet was washed with cold 
1x PBS, transferred to a 1.5 ml tube, and frozen in liquid nitrogen before storage at -20°C.  
 
5.2.1.5 Yeast plasmid shuffle 
The plasmid shuffle yeast strains pRRN3 (URA) (Y2189) and pRRN3 (URA)-A43-HA3 (Y2113) were 
used to replace the essential RRN3 gene by mutant alleles. In these strains the chromosomal locus 
of RRN3 is replaced by the HIS3 marker gene and the deletion is complemented by a wild type copy 
of RRN3 on a plasmid containing the URA3 marker gene. The shuffle strains were transformed with 
another plasmid carrying the mutant allele of RRN3 and plated on the corresponding selection 
medium. If the mutant allele is able to complement the chromosomal deletion, the plasmid 
containing the wild type copy of RRN3 can be lost during cultivation. Loss of the wild type allele of 
RRN3 on the plasmid containing the marker gene URA3 was monitored by growing the cells on 
SCD+5FOA (5-fluoroorotic acid) plates lacking the corresponding amino acid, since growth on this 
counterselection medium is lethal for all cells still containing the wild type allele of RRN3. URA3 
codes for the enzyme orotidin-5'-phosphate decarboxylase of the uracil-biosynthesis pathway, 
which converts 5FOA into the toxic 5-fluorouracil.  
In each case, a transformation of the shuffle strains with an appropriate plasmid not carrying an 
RRN3 allele was performed. Single clones from these control transformations were supposed to 
grow on the corresponding selection medium but not on the corresponding counterselection 
medium as RRN3 is an essential gene.  
Putative positive clones were finally monitored for the presence of the mutant plasmid, the loss of 
the wild type plasmid, and the maintenance of the chromosomal deletion by analyzing the 
respective auxotrophic markers.  
 
5.2.1.6 Spot test analysis of yeast strains 
Overnight cultures of the yeast strains to be tested were diluted to OD600 = 0.1 with sterile H2O. 
7-10 µl of this cell suspension and of serial 1:10, 1:100, and 1:1000 dilutions with sterile H2O were 
spotted on the appropriate test plates. Phenotypes were monitored after incubation for 2-4 days at 
16°C, 24°C, 30°C, and 37°C, respectively.  
 
5.2.1.7 Growth kinetic analysis of yeast strains 
Cultures of the yeast strains to be tested were grown to stationary phase overnight. From these 
pre-cultures fresh cultures were inoculated to OD600 = 0.1 in the appropriate medium and growth 
MATERIAL AND METHODS 
 
102 
at 30°C was monitored by measuring the OD600 mostly in 1 h intervals. Since the strains were always 
kept in the logarithmic growth phase (OD600 ∼ 0.1-0.7) by dilution with the respective medium, the 
dilution factor had to be taken into account for the calculation of the growth kinetics.  
 
5.2.1.8 Long-term storage of yeast strains 
2 ml of an overnight culture of the yeast strain to be stored were mixed with 1 ml sterile 50% (v/v) 
glycerol and separated into two aliquots. Glycerol stocks were stored at -80°C.  
 
5.2.2 Work with Escherichia coli 
5.2.2.1 Cultivation of bacterial strains 
Liquid cultures were grown in LB(+amp) medium at 37°C. Cell growth was monitored by measuring 
the optical density at 600 nm (OD600). For cultivation on solid agar plates containing LB(+amp) 
medium, single colonies or small aliquots of glycerol stocks were streaked out using sterile 
disposable inoculation loops in order to obtain colonies derived from single bacterial cells. Plates 
were incubated upside down at 37°C for 1 day. Short-term storage of bacterial strains was 
accomplished by keeping the agar plates at 4°C.  
 
5.2.2.2 Preparation of competent bacterial cells for electroporation 
The XL1-Blue strain was used as a host for amplification of plasmid DNA. In order to increase the 
efficiency of plasmid DNA uptake, competent cells for electroporation were prepared. Cells were 
grown in 400 ml SOB medium at 37°C to mid-log phase (OD600 ∼ 0.35-0.6), chilled on ice for 15 min, 
and centrifuged for 10 min at 6000 rpm and 4°C. To reduce the ionic strength of the cell 
suspension, cells were washed 3x with cold sterile H2O and 1x with sterile 10% (v/v) glycerol. After 
resuspending the cells in 1.5 ml sterile 10% (v/v) glycerol, 50 µl aliquots were transferred to 1.5 ml 
tubes before storage at -80°C.  
 
5.2.2.3 Transformation of competent bacterial cells by electroporation 
The aliquot containing competent bacterial cells was thawed on ice. DNA to be transformed (1 ng 
of plasmid DNA or up to 3 µl of a ligation sample) was added and the sample was mixed. After 
pipetting the suspension into a cold 0.2 cm electroporation cuvette, pulsing was performed with 
program EC2 in a MicroPulser electroporation apparatus. Immediately after the pulse, 1 ml LB 
medium was added and the sample was transferred to a 1.5 ml tube following incubation for 30-60 
min at 37°C. 100 µl of the cell suspension were plated on LB+amp and incubated overnight at 37°C. 
The residual cells were centrifuged for 1 min at 5000 rpm and RT. About 900 µl of the supernatant 
were discarded and the pellet was resuspended in the remaining liquid, plated on LB+amp, and 
incubated overnight at 37°C.  
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5.2.3 Work with DNA 
5.2.3.1 Phenol-chloroform extraction 
To separate DNA in an aqueous solution from proteins and RNA, one volume of a 
phenol:chloroform:isoamyl alcohol-mixture (25:24:1) was added to the sample. The samples were 
mixed by vortexing until the solution was milky. After centrifugation for 5 min at 13000 rpm and 
RT, an aliquot of the upper aqueous phase was transferred to a 1.5 ml tube without disturbing the 
white layer of denatured protein between the upper aqueous and the lower phenol phase.  
 
5.2.3.2 Purification of DNA by ethanol precipitation 
DNA was precipitated from aqueous solution by mixing the sample with 1/10 volume of 3 M 
NaOAc pH 5.3 and 2.5 volumes of ethanol following incubation for at least 20 min at -20°C. Ethanol 
depletes the hydration shell from nucleic acids and expose negatively charged phosphate groups. 
Counter cations (here Na+) bind the charged groups and reduce the repulsive forces between the 
polynucleotide chains, allowing the formation of a precipitate. Samples were centrifuged for 
20 min at 13000 rpm and 4°C. To eliminate salt, the pellet was washed with cold 70% (v/v) ethanol. 
After removal of the supernatant, the nucleic acid pellet was dried at RT and solubilized in an 
appropriate volume of TE buffer [10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0].  
 
5.2.3.3 DNA quantification using UV spectroscopy 
Concentration of pure DNA samples was measured by UV spectroscopy at 260 nm using a 
NanoDrop ND-1000 spectrophotometer (1 OD260 = 50 µg/ml). To determine contamination with 
proteins, absorbance was concomitantly measured at 280 nm. The ratio of OD260/OD280 of pure DNA 
is between 1.8 and 2.0.  
 
5.2.3.4 Native agarose gel electrophoresis 
Native agarose gel electrophoresis was used to separate DNA fragments of different lengths. In this 
work, electrophoresis was performed routinely with gels composed of 1.0-1.2% (w/v) agarose and 
1x TBE and containing 0.5 µg/ml ethidium bromide (EtBr) or 1x SYBR Safe DNA Gel Stain, 
respectively. 1x TBE was used as electrophoresis buffer and gels were run at 100-120 V. To 
determine the lengths of the fragments, 0.5 µg of a DNA standard (1 kb ladder or 100 bp ladder) 
was used in a concentration of 50 µg/ml in 2.5x DNA loading buffer. DNA fragments could be 
visualized by exposing the gel to UV light (470 nm).  
 
5.2.3.5 Southern Blot (passive capillary transfer) 
Separated DNA fragments were transferred and immobilized on a positively charged membrane 
using the passive capillary transfer method. Prior to the transfer, the agarose gel was incubated for 
2x 15 min in 0.5 M NaOH/1.5 M NaCl on a shaker to denature double-stranded DNA. Subsequently, 
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the gel was incubated for 2x 15 min in 1 M NH4OAc. Transfer of the DNA fragments from the 
agarose gel to the membrane was then achieved overnight by drawing the transfer buffer (1 M 
NH4OAc) from the reservoir upward through the gel and the membrane into a stack of paper 
towels. The DNA fragments were eluted from the gel and deposited onto the positively charged 
membrane with the help of the buffer stream. After the transfer, the DNA fragments were 
crosslinked to the dried membrane by exposition for 20 sec to UV light (0.3 J/cm2).  
 
5.2.3.6 Radioactive probe labeling, hybridization, and detection 
Probes were radioactively labeled with α-[32P]-ATP using the RadPrime DNA Labeling System as 
indicated by the manufacturer.  
The membranes, separated by meshes in a hybridization tube, were pre-hybridized for 1 h at 
hybridization temperature (65°C) with 50 ml hybridization buffer. For hybridization, the 
membranes were incubated in fresh 15 ml hybridization buffer. The labeled probe was mixed with 
150 µl Salmon Sperm DNA, incubated for 5 min at 99°C, immediately chilled on ice, and added to 
the hybridization tube. Hybridization occurred overnight at hybridization temperature with tubes 
rotating in a hybridization oven. The membranes were first rinsed 1x with 30 ml 3x SSC/0.1% (w/v) 
SDS and subsequently washed in each case for 2x 15 min with 30 ml 0.3x SSC/0.1% (w/v) SDS, 0.1x 
SSC/0.1% (w/v) SDS and 0.1x SSC/1.5% (w/v) SDS at hybridization temperature. Afterwards the 
membranes were dried and covered with an erased phosphor-imaging plate (PIP) in a cassette. The 
time of exposure depended on the intensity of the radioactive signal. The PIP was scanned with a 
resolution of 100 µm by a FLA-3000 phosphor imager using Image Reader FLA-3000 V1.8 followed 
by quantitative analysis using Multi Gauge V3.0.  
 
5.2.3.7 Polymerase Chain Reaction (PCR) 
For amplification of DNA fragments for integration in the yeast genome, PCR was performed with 
yeast genomic DNA or plasmid DNA (50-100 ng) as templates in five 100 µl reactions [20 mM Tris-
HCl pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% (v/v) Triton X-100, 0.25 µM of forward 
and reverse primers, 0.25 mM dNTPs, 2.5-5 U Taq Polymerase]. The main PCR program used in this 
work was as following:  
95°C  5 min  (1x) 
95°C  1 min   
45°C  1 min  (35x) 
72°C  2 min   
72°C  10 min  (1x) 
For amplification of DNA fragments used for cloning, proofreading PCR was performed with yeast 
genomic DNA or plasmid DNA (50-100 ng) as templates in a 100 µl reaction [1x iProof HF Buffer, 
0.5 µM of forward and reverse primers, 0.2 mM dNTPs, 2 U iProof High-Fidelity DNA Polymerase]. 
The PCR program was designed as indicated by the manufacturer.  
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10% of the reactions were analyzed by native agarose gel electrophoresis and subsequently 
purified with a PCR Purification Kit according to the manufacturer.  
 
5.2.3.8 Quantitative real-time Polymerase Chain Reaction (qPCR) 
Quantitative real-time PCR was used to measure the amount of a specific DNA fragment with high 
accuracy. The amount of DNA present at the end of each single PCR cycle was detected by 
measuring the fluorescence of SYBR Green. SYBR Green is a dye that exhibits fluorescence when 
bound to double-stranded DNA but not in solution. Therefore, the intensity of the fluorescence 
signal allows direct measurement of the actual amount of DNA present in the sample. Quantitative 
real-time PCR reactions were performed in 0.1 ml tubes, the reaction volume was 20 µl. The 
reaction contained 4 µl of DNA sample and 16 µl of master mix. The master mix contained 4 pmol 
of both the forward and the reverse primer, 0.25 µl of a 1:400000 SYBR Green stock solution in 
DMSO, 0.4 U HotStarTaq DNA Polymerase and a premix. The premix was composed of MgCl2 (final 
concentration in the reaction: 2.5 mM), dNTPs (final concentration in the reaction: 0.2 mM) and 10x 
PCR buffer (final concentration in the reaction: 1x). Quantitative real-time PCR was performed in a 
Rotor-Gene 3000. The data were analyzed with Rotor-Gene V6.1.  
 
5.2.3.9 Digestion of DNA with restriction endonucleases 
A variety of prokaryotic restriction endonucleases were used in this work to digest DNA in order to 
prepare defined DNA fragments for cloning or to check for presence and correct orientation of 
inserted DNA fragments. Restriction endonucleases were essentially used as suggested by the 
manufacturer.  
 
5.2.3.10 DNA ligation 
In order to clone DNA sequences into yeast/bacterial plasmids, the quantity of purified DNA 
fragments digested with restriction endonucleases was measured by UV spectroscopy (see section 
5.2.3.3). A threefold molar excess of insert DNA compared to the plasmid DNA fragment was 
incubated in a 20 µl ligase reaction (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM ATP, 10 mM DTT, 
400 U T4 DNA Ligase) for 2 h at RT or overnight at 16°C. Up to 3 µl of the ligation reaction were 
used for transformation of competent bacterial cells (see section 5.2.2.3).  
 
5.2.3.11 DNA sequencing and oligonucleotide synthesis 
DNA sequencing was performed by GENEART and the service of primer synthesis was provided by 
Eurofins MWG Operon. Oligonucleotides used in this work are listed in section 5.1.4.  
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5.2.3.12 Plasmid construction 
5.2.3.12.1 pRRN3-Prot.A 
Both the DNA fragment derived from PCR reaction (yeast genomic DNA/2234/2235) and the 
plasmid pNOP1-RRN3-Prot.A were digested with the restriction endonucleases SacI and NdeI. The 
plasmid pRRN3-Prot.A was generated by ligation of the respective DNA fragment into the 
backbone of the plasmid.  
 
5.2.3.12.2 pGAL1-RRN3-Prot.A (A/C) and pGAL1-RRN3-Prot.A (2µ) 
Both the DNA fragment derived from PCR reaction (pRRN3-Prot.A/2472/2473) and the plasmids 
pGAL1-RRN3 (A/C) and pGAL1-RRN3 (2µ) were digested with the restriction endonucleases NdeI 
and HindIII. The plasmids pGAL1-RRN3-Prot.A (A/C) and pGAL1-RRN3-Prot.A (2µ) were generated 
by ligation of the respective DNA fragment into the backbone of the plasmids.  
 
5.2.3.12.3 pRS315-RRN3 (S102A) and pRS315-RRN3 (S102D) 
In the first case, two PCR reactions (pRS315-RRN3/2141/2137 and pRS315-RRN3/2139/2142) were 
performed to generate two appropriate DNA fragments which were both used as templates in an 
additional PCR reaction (2141/2142). Both the DNA fragment derived from this PCR reaction and 
the plasmid pRS315-RRN3 were digested with the restriction endonucleases HindIII and NdeI. The 
plasmid pRS315-RRN3 (S102A) was generated by ligation of the respective DNA fragment into the 
backbone of the plasmid.  
In the second case, two PCR reactions (pRS315-RRN3/2141/2138 and pRS315-RRN3/2140/2142) 
were performed to generate two appropriate DNA fragments which were both used as templates 
in an additional PCR reaction (2141/2142). Both the DNA fragment derived from this PCR reaction 
and the plasmid pRS315-RRN3 were digested with the restriction endonucleases HindIII and NdeI. 
The plasmid pRS315-RRN3 (S102D) was generated by ligation of the respective DNA fragment into 
the backbone of the plasmid.  
 
5.2.4 Work with RNA 
5.2.4.1 RNA extraction 
RNA extractions were essentially performed as described previously (Schmitt et al., 1990). Cell 
pellets were resuspended in 500 µl AE buffer and mixed with 500 µl phenol equilibrated in AE 
buffer and 50 µl of 10% (w/v) SDS. The samples were incubated in a thermomixer for 5 min at 
1400 rpm and 65°C and afterwards chilled on ice for 2 min. After centrifugation for 2 min at 
13000 rpm and RT, 3x 150 µl of the aqueous phase was collected and mixed with 500 µl phenol 
equilibrated in AE buffer by vortexing. The samples were again centrifuged and 3x 120 µl of the 
supernatant were mixed with 500 µl chloroform by vortexing. Phases were separated by 
centrifugation and the RNA in 3x 100 µl of the supernatant was precipitated by addition of 1/10 
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volume of 3 M NaOAc pH 5.3 and 2.5 volumes of ethanol and incubation for 30 min at -20°C. The 
precipitated RNA, when used for denaturing agarose gel electrophoresis, was solubilized in RNA 
solubilization buffer, denatured by incubation for 15 min at 65°C, and stored at -20°C.  
 
5.2.4.2 Denaturing agarose gel electrophoresis 
Denaturing agarose gel electrophoresis was used to separate RNA species longer than 1000 bases. 
In this work electrophoresis was performed routinely with gels composed of 1.3% (w/v) agarose, 
2% (v/v) formaldehyde, and 1x MOPS containing 0.5 µg/ml EtBr. The electrophoresis buffer was 
composed of 1x MOPS and 2% (v/v) formaldehyde. Gels were run for 14-16 h at 40 V.  
 
5.2.4.3 Northern Blot (passive capillary transfer) 
Separated [3H]-labeled RNAs were transferred and immobilized on a positively charged membrane 
using the passive capillary transfer method. Prior to the transfer, the agarose gel was washed for 
5 min in H2O, for 20 min in 50 mM NaOH to hydrolyze the RNAs and facilitate the transfer of larger 
RNAs, and was further equilibrated for 2x 20 min in 10x SSC. Transfer of the RNAs from the agarose 
gel to the membrane was then achieved overnight by drawing the transfer buffer (10x SSC) from 
the reservoir upward through the gel and the membrane into a stack of paper towels. The RNAs 
were eluted from the gel and deposited onto the positively charged membrane with the help of 
the buffer stream. After the transfer, the RNAs were crosslinked to the dried membrane by 
exposition for 1 min to UV light (254 nm/312 nm).  
 
5.2.4.4 Detection of [3H]-labeled RNAs 
The membrane was covered with an erased tritium-imaging plate (TIP) in a cassette. The time of 
exposure depended on the intensity of the radioactive signal. The TIP was scanned with a 
resolution of 100 µm by a FLA-3000 phosphor imager using Image Reader FLA-3000 V1.8 followed 
by quantitative analysis using Multi Gauge V3.0.  
Alternatively or subsequently, the membrane was sprayed with EN3HANCE solution and subjected 
to autoradiography.  
 
5.2.4.5 Analysis of neo-synthesized RNA 
In one case, cells were grown in YPD medium at 30°C and further cultivated either in the presence 
or in the absence of rapamycin or cycloheximide, respectively. In the other case, cells were grown 
in SCR medium depleted of leucine at 30°C before galactose was added and cells were shifted for 
8 h to 24°C.  
For each sample 1 OD600 of cells was centrifuged for 1 min at 10000 rpm and RT before the cell 
pellets were resuspended in 100 µl buffer RD (cells grown in media based on glucose) or RG (cells 
grown in media based on galactose), respectively. 60 µCi or 20 µCi of 5',6'-[3H]-uracil were added 
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and the cells were incubated either for 5 min at 30°C or 20 min at 24°C (pulse), before one volume 
of either YPUD or YPUG was added and cells were incubated either for additional 4 min, 8 min and 
16 min at 30°C or for additional 60 min at 24°C (chase). Immediately after the treatment, the 
samples were chilled on ice and centrifuged for 1 min at 13000 rpm and 4°C. The supernatants 
were discarded and the cell pellets were stored at -20°C. Total RNA was extracted as described (see 
section 5.2.4.1), same amounts of samples were separated by denaturing agarose gel 
electrophoresis as described (see section 5.2.4.2), transferred to a membrane as described (see 
section 5.2.4.3), and analyzed as described (see section 5.2.4.4).  
 
5.2.5 Work with proteins 
5.2.5.1 Preparation of yeast whole cell extract (WCE) 
5.2.5.1.1 Small scale 
For whole cell extract preparation in a small scale, logarithmically growing cells from 50 ml liquid 
culture of OD600 ∼ 0.8 were harvested by centrifugation in a 50 ml tube for 3 min at 3000 rpm and 
4°C. The cells were washed with 1 ml cold H2O and transferred to a 1.5 ml tube. After resuspending 
the cell pellet in an equal volume of high-salt extraction buffer [150 mM HEPES pH 7.6, 400 mM 
(NH4)2SO4, 10 mM MgCl2, 20% (v/v) glycerol, 5 mM β-mercaptoethanol, 2 mM benzamidine, 1 mM 
PMSF], an equal volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and the 
tube was vigorously shaken either on an IKA-Vibrax VXR for 3x 15 min at 2200 rpm and 4°C or in a 
FastPrep Instrument for 2x 40 sec at 5.5 m/s and 4°C. The tube was pierced on the bottom and on 
the lid with a hot needle and placed in a 15 ml tube to remove the glass beads from the cell extract 
by centrifugation for 2 min at 2000 rpm and 4°C. The cell extract was transferred to a 1.5 ml tube 
and centrifuged again for 1 min at 13000 rpm and 4°C to remove cell debris. The cleared 
supernatant (WCE) was transferred to a 1.5 ml tube and appropriate amounts were supplemented 
with 4x SDS sample buffer, incubated for 5 min at 99°C and analyzed as described (see sections 
5.2.5.6, 5.2.5.7, and 5.2.5.8) or if required frozen in liquid nitrogen before storage at -80°C. Protein 
concentration was determined using the Bradford assay (Bradford, 1976).  
 
5.2.5.1.2 Large scale 
For whole cell extract preparation in a large scale, logarithmically growing cells from 10 l liquid 
culture of OD600 ∼ 0.8 were harvested by centrifugation in 1 l tubes for 8 min at 6000 rpm and 4°C. 
The cells were washed with cold H2O, pooled, and transferred to a 50 ml tube. After resuspending 
the cell pellet in an equal volume of high-salt extraction buffer [150 mM HEPES pH 7.6, 400 mM 
(NH4)2SO4, 10 mM MgCl2, 20% (v/v) glycerol, 5 mM β-mercaptoethanol, 2 mM benzamidine, 1 mM 
PMSF], an equal volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and the 
mixture was shaken in a Pulverisette 6 planetary mono mill at 500 rpm and 4°C for 3x 4 min. Glass 
beads were separated by filtration prior to centrifugation of the cell extract in 50 ml tubes for 
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20 min at 4500 rpm and 4°C to remove cell debris. The supernatant was additionally 
ultracentrifuged for 90 min at 100000 g and 4°C, the clear middle phase (WCE) was separated from 
the turbid insoluble matter in the lower phase and the top layer of lipids and subjected to protein 
purification (see section 5.2.6.4) or if required frozen in liquid nitrogen before storage at -80°C. 
Protein concentration was determined using the Bradford assay (Bradford, 1976).  
 
5.2.5.2 Determination of protein concentration 
Protein concentrations were determined using the Bio-Rad Protein Assay which is based on the 
method by Bradford (Bradford, 1976). Briefly, 1-5 µl of the protein solution to be tested were mixed 
with 1 ml protein assay dye after diluting the reagent to the working concentration according to 
the instructions of the manufacturer. The approximate protein concentrations in µg/µl were 
calculated by dividing the absorbance at 595 nm by the sample volume and multiplying with the 
factor 23 which was determined using a BSA standard curve.  
 
5.2.5.3 TCA precipitation 
The volume of the protein sample to be analyzed was adjusted to 100 µl with cold H2O prior to 
mixing with 10 µl cold 100% (w/v) TCA and 2 µl 2% (w/v) DOC (Bensadoun and Weinstein, 1976). 
After incubation for 30 min at 4°C, the precipitated proteins were pelleted by centrifugation for 
15 min at 13000 rpm and 4°C. The supernatant was discarded and the pellet was solubilized in an 
adequate volume of SDS sample buffer. The pH of the sample was neutralized using NH3 gas, if 
necessary. Proteins were denatured by incubating the sample for 5 min at 99°C for subsequent 
separation by SDS-PAGE.  
 
5.2.5.4 Methanol-chloroform precipitation 
Protein precipitation for subsequent mass spectrometric analyses was performed using the 
methanol-chloroform precipitation method (Wessel and Flügge, 1984). The volume of the sample 
was adjusted to 150 µl with H2O, followed by the addition of four volumes of methanol (600 µl), 
one volume of chloroform (150 µl), and three volumes of H2O (450 µl). After each of these steps the 
sample was mixed well by vortexing. After incubation for 5 min at 4°C, the sample was centrifuged 
for 5 min at 13000 rpm and 4°C. The supernatant was discarded without disturbing the interphase 
which contains the precipitated proteins. Upon addition of another three volumes of methanol 
(450 µl) and vortexing, the sample was incubated for 5 min at 4°C before centrifugation for 5 min at 
13000 rpm and 4°C. The supernatant was completely removed and the protein pellet dried for 
10 min in a Speed Vac Concentrator.  
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5.2.5.5 Denaturing protein extraction 
Cell pellets were resuspended in 1 ml cold H2O, mixed with 150 µl pre-treatment solution [1.85 M 
NaOH, 1 M β-mercaptoethanol], and incubated for 15 min at 4°C. Proteins were precipitated with 
150 µl 55% (w/v) TCA for 15 min at 4°C and pelleted by centrifugation for 10 min at 13000 rpm and 
4°C. The supernatant was discarded and the pellet was resuspended in 25 µl HU buffer. The pH of 
the sample was neutralized using NH3 gas, if necessary. Proteins were denatured by incubating the 
sample for 10 min at 65°C for subsequent separation by SDS-PAGE.  
 
5.2.5.6 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated according to their molecular weight using the vertical discontinuous SDS-
polyacrylamide gel electrophoresis method by Laemmli (Laemmli, 1970). The discontinuous 
system consists of a lower separating gel composed of 8-12% acrylamide, 375 mM Tris-HCl pH 8.8, 
and 0.1% (w/v) SDS and an upper stacking gel composed of 4% acrylamide, 125 mM Tris-HCl pH 
6.8, and 0.1% (w/v) SDS.  
Ribosomal proteins were separated according to their low molecular weight using acrylamide urea 
gels. In this case, the lower separating gel is composed of 16% acrylamide, 375 mM Tris-HCl pH 8.8, 
0.1% (w/v) SDS, and 4.5 M urea and the upper stacking gel is composed of 4% acrylamide, 125 mM 
Tris-HCl pH 6.8, 0.1% (w/v) SDS, and 4.5 M urea.  
Gels were run for 1.5-2.5 h at 50 mA and 180 V in 1x electrophoresis buffer. Molecular weights of 
the different proteins were estimated using protein markers of known molecular weight.  
 
5.2.5.7 Western Blot 
Separated proteins were transferred to a PVDF membrane using a Trans-Blot SD Semi-Dry Transfer 
Cell. The gel and the PVDF membrane, pretreated with methanol, were placed in the transfer cell 
between two piles of three blotting papers soaked with transfer buffer. Transfer was performed for 
1 h at 24 V.  
To control the blotting of the proteins before immunodetection, the total protein content was 
reversibly stained with Ponceau S by incubating the membrane in ponceau staining solution for 
2 min and subsequent destaining with H2O until the protein bands were visible.  
 
5.2.5.8 Detection of proteins by chemiluminescence 
Prior to specific immunodetection of defined proteins, the membrane was blocked with non-
related proteins from bovine milk to avoid unspecific binding of the antibodies by incubating the 
membrane in 5% (w/v) milk powder in 1x PBS for 1 h at RT or overnight at 4°C on a shaker. The 
antibodies were diluted to an adequate working concentration in 5% (w/v) milk powder in 1x PBST. 
The incubations were performed in small bags made of sealed plastic foils on a turning wheel for 
1 h (primary antibodies) or 30 min (secondary antibodies) at RT. Following each antibody 
incubation step, the membrane was washed in 1x PBST for 2x 10 min on a shaker.  
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In order to detect the specifically bound antibodies, the membrane was incubated for 1 min at RT 
with 2-4 ml BM Chemiluminescence Blotting Substrate (POD) which was prepared according to the 
instructions of the manufacturer. This reagent contains hydrogen peroxide and luminol which is a 
substrate for the horseradish peroxidase conjugated to the secondary antibodies used in this work. 
The light, which is emitted during this reaction at the corresponding specific positions on the 
membrane, was detected with a LAS-3000 chemiluminescence imager using Image Reader LAS-
3000 V2.2 followed by quantitative analysis using Multi Gauge V3.0.  
 
5.2.5.9 Coomassie staining 
The polyacrylamide gel was stained with Coomassie Brilliant Blue R-250 in order to visualize the 
total protein content.  
Briefly, the gel was stained in coomassie staining solution for 30 min on a shaker at RT. Destaining 
was performed by incubating the gel in destaining solution for 3-4x 30 min until protein bands 
showed up significantly over the background staining. Optionally, the gel could be dried in a 
vacuum gel dryer system for 2 h at 80°C or bands could be excised for subsequent protein 
identification using mass spectrometry (see section 5.2.5.10).  
 
5.2.5.10 Protein identification using MALDI-TOF/TOF mass spectrometry 
Protein bands of interest were excised from coomassie-stained gels and digested in gel with 
modified sequencing grade trypsin (Shevchenko et al., 1996, 2006). Briefly, the excised pieces were 
cut into small cubes and subsequently washed with 50 mM NH4HCO3, 50 mM NH4HCO3/25% (v/v) 
acetonitrile, 25% (v/v) actetonitrile, and 50% (v/v) acetonitrile followed by lyophilization. The dried 
gel cubes were rehydrated with an equal volume of trypsin in 50 mM NH4HCO3 (final concentration: 
4 µg trypsin per 100 µl gel) for 30 min at RT. After addition of another volume of 50 mM NH4HCO3 
and incubation for 16 h at 37°C, the resulting tryptic peptides were eluted by diffusion upon 
shaking the gel cubes 2x for 1 h in two volumes of 100 mM NH4HCO3 and 1x for 1 h in two volumes 
of 100 mM NH4HCO3/35% acetonitrile at 37°C. The supernatants of these elution steps were pooled 
in a 1.5 ml tube and the solvents removed by lyophilization. The extracted peptides were 
solubilized in 5 µl matrix solution [2 mg/ml α-cyano-4-hydroxycinnamic acid (CHCA), 50% (v/v) 
acetonitrile, 0,1% (v/v) TFA] and manually spotted on the MALDI target plate.  
Peptide mass fingerprints (PMF) and MS/MS analyses were performed on a 4700 or a 4800 
Proteomics Analyzer MALDI-TOF/TOF mass spectrometer operated in positive ion reflector mode 
and evaluated by searching the NCBInr protein sequence database with Mascot implemented in 
GPS Explorer v.3.5.  
 
5.2.5.11 Analysis of neo-synthezised protein 
Cells were grown in SCD medium depleted of methionine and cysteine at 30°C and further 
cultivated either in the absence or in the presence of rapamycin or cycloheximide, respectively.  
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For each sample 2 OD600 of cells were centrifuged for 1 min at 10000 rpm and RT before the cell 
pellets were resuspended in 200 µl SCD-met-cys. 15 µCi of [35S]-met/cys were added and the cells 
were incubated for 5 min at 30°C (pulse). Immediately after the treatment, the samples were 
centrifuged for 1 min at 13000 rpm and 4°C. The supernatants were discarded and the cell pellets 
were stored at -20°C. Total protein was extracted as described (see section 5.2.5.5), same amounts 
of samples were separated by SDS-polyacrylamide gel electrophoresis as described (see section 
5.2.5.6), and coomassie staining was performed as described (see section 5.2.5.9). The dried gel was 
subjected to autoradiography.  
 
5.2.6 Additional biochemical methods 
5.2.6.1 Chromatin immunoprecipitation (ChIP) 
Chromatin immunoprecipitation was performed in three independent experiments for each 
protein mainly as described (Hecht and Grunstein, 1999). Cells from 45 ml liquid culture were 
crosslinked with formaldehyde as described (see section 5.2.1.4), washed with 500 µl cold ChIP lysis 
buffer [50 mM HEPES pH 7.5, 140 mM NaCl, 5 mM EDTA pH 8.0, 5 mM EGTA pH 8.0, 1% (v/v) Triton 
X-100, 0.1% (w/v) DOC] and resuspended in an equal volume of cold ChIP lysis buffer. An equal 
volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and the tube was 
vigorously shaken on an IKA-Vibrax VXR for 3x 15 min at 2200 rpm and 4°C. The tube was pierced 
on the bottom and on the lid with a hot needle and placed in a 15 ml tube to remove the glass 
beads from the cell extract by centrifugation for 2 min at 2000 rpm and 4°C. Cold ChIP lysis buffer 
was added to a final volume of 1 ml and the DNA in the suspension was sonicated using a Sonifier 
250 to obtain an average DNA fragment size of 500-1000 bp. Cell debris were removed by 
centrifugation for 20 min at 13000 rpm and 4°C. The chromatin extracts were split into three 
aliquots. 40 µl of each aliquot served as an input control. 200 µl of each aliquot were incubated 
either with 3 µg of a monoclonal α-HA antibody (3F10) and 50 µl equilibrated Protein G Sepharose 
or with 50 µl equilibrated IgG Sepharose for 2 h at 4°C to enrich either HA3-tagged proteins or 
Prot.A-tagged proteins. After immunoprecipitation, the beads were washed 3x with cold ChIP lysis 
buffer, 2x with cold ChIP washing buffer I [50 mM HEPES pH 7.5, 500 mM NaCl, 2 mM EDTA pH 8.0, 
1% (v/v) Triton X-100, 0.1% (w/v) DOC], and 2x with cold ChIP washing buffer II [10 mM Tris-HCl 
pH 8.0, 250 mM LiCl, 2 mM EDTA pH 8.0, 0.5% (v/v) Nonidet P40, 0.5% (w/v) DOC] followed by a 
final washing step with TE buffer [10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0]. 250 µl IRN buffer 
[50 mM Tris-HCl pH 8.0, 20 mM EDTA pH 8.0, 500 mM NaCl] were added to the input (IN) and to the 
beads (IP) samples. RNA in the samples was digested with 2 µl RNase A (20 mg/ml) for 1 h at 37°C. 
Afterwards, 0.5% (w/v) SDS and 2 µl Proteinase K (20 mg/ml) were added to the samples followed 
by incubation for 1 h at 56°C. The formaldehyde crosslink was reversed overnight by incubation at 
65°C. DNA was isolated by phenol-chloroform extraction as described (see section 5.2.3.1), 
precipitated with ethanol as described (see section 5.2.3.2) and resuspended in 50 µl TE buffer.  
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DNA amounts present in IN and IP samples were determined by quantitative real-time PCR as 
described (see section 5.2.3.8). Primer pairs for amplification used in this work are listed in section 
5.1.4. IN DNA was diluted 1:1000 and IP DNA was diluted 1:200 prior to analysis. Retention of 
specific DNA fragments was calculated as the fraction of the total input DNA. The mean values and 
error bars were derived from three independent ChIP experiments analyzed in triplicate 
quantitative real-time PCR reactions.  
 
5.2.6.2 Chromatin endogenous cleavage (ChEC) 
Chromatin endogenous cleavage was performed mainly as described (Schmid et al., 2004). Cells 
from 45 ml liquid culture were crosslinked with formaldehyde as described (see section 5.2.1.4), 
washed 3x with 500 µl cold ChEC buffer A (+ 1x PIs), and resuspended in 350 µl cold ChEC buffer A 
(+ 1x PIs). An equal volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and 
the tube was vigorously shaken on an IKA-Vibrax VXR for 10 min at 2200 rpm and 4°C. The tube was 
pierced on the bottom and on the lid with a hot needle and placed in a 15 ml tube to remove the 
glass beads from the cell extract by centrifugation for 2 min at 2000 rpm and 4°C. The cell lysate 
was transferred to a 1.5 ml tube and centrifuged again for 2 min at 13000 rpm and 4°C. The 
supernatant was discarded. The lysate pellet containing intact nuclei was washed with 500 µl cold 
ChEC buffer A (+ 1x PIs) and resuspended in 600 µl cold ChEC buffer Ag (+ 1x PIs). The sample was 
incubated in a thermomixer at 700 rpm and 30°C. Two aliquots (0 min, untreated) of the well-mixed 
sample were taken (100 µl). MNase digestion was started by adding 8 µl 100 mM (w/v) CaCl2. 
Aliquots were taken at 10 min, 20 min, and 60 min (100 µl). The digestion reaction was immediately 
stopped by pipetting the aliquot into 100 µl IRN buffer [50 mM Tris-HCl pH 8.0, 20 mM EDTA pH 8.0, 
500 mM NaCl]. Before taking an aliquot, the sample should be mixed at higher rotation rates since 
nuclei sediment. Stopped aliquots could be kept at RT. When the time course was complete, 100 µl 
were added to the 0 min aliquots. RNA in the aliquots was digested with 2 µl RNase A (20 mg/ml) 
for 1 h at 37°C. Afterwards, 0.5% (w/v) SDS and 2 µl Proteinase K (20 mg/ml) were added to the 
aliquots followed by incubation for 1 h at 56°C. The formaldehyde crosslink was reversed overnight 
by incubation at 65°C. DNA was isolated by phenol-chloroform extraction as described (see section 
5.2.3.1), precipitated with ethanol as described (see section 5.2.3.2), and resuspended in 50 µl TE 
buffer.  
20 µl of the DNA sample were digested with the restriction endonuclease XcmI in a 27 µl reaction 
overnight at 37°C. The restriction endonuclease XcmI can cleave cryptic recognition sites if present 
in excess, so the amount of this enzyme should be controlled well (0.5 µl of XcmI per aliquot). Total 
DNA of the digestion reaction was separated by native agarose gel electrophoresis as described 
(see section 5.2.3.4), transferred to a membrane as described (see section 5.2.3.5), and analyzed as 
described (see section 5.2.3.6).  
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5.2.6.3 Co-immunoprecipitation (CoIP) 
In one case, cells were grown in SCR medium depleted of leucine at 30°C before galactose was 
added and cells were shifted for 8 h to 24°C. Cells from 45 ml liquid culture were crosslinked with 
formaldehyde as described (see section 5.2.1.4), washed with 500 µl cold ChIP lysis buffer [50 mM 
HEPES pH 7.5, 140 mM NaCl, 5 mM EDTA pH 8.0, 5 mM EGTA pH 8.0, 1% (v/v) Triton X-100, 0.1% 
(w/v) DOC], and resuspended in an equal volume of cold ChIP lysis buffer. An equal volume of cold 
glass beads (∅ 0.75-1 mm) was added to the suspension and the tube was vigorously shaken on an 
IKA-Vibrax VXR for 3x 15 min at 2200 rpm and 4°C. The tube was pierced on the bottom and on the 
lid with a hot needle and placed in a 15 ml tube to remove the glass beads from the cell extract by 
centrifugation for 2 min at 2000 rpm and 4°C. Cold ChIP lysis buffer was added to a final volume of 
1 ml and DNA in the suspension was sonicated using a Sonifier 250. Cell debris were removed by 
centrifugation for 20 min at 13000 rpm and 4°C. Same amounts of the chromatin extract were 
either precipitated (21 µl) using methanol-chloroform precipitation as described (see section 
5.2.5.4) and served as an input control or incubated (700 µl) with 3 µg of a monoclonal α-HA 
antibody (3F10) and 100 µl equilibrated Protein G Sepharose for 2 h at 4°C to enrich HA3-tagged 
proteins. After immunoprecipitation, the beads were washed 3x with cold ChIP lysis buffer, 3x with 
cold ChIP washing buffer I [50 mM HEPES pH 7.5, 500 mM NaCl, 2 mM EDTA pH 8.0, 1% (v/v) Triton 
X-100, 0.1% (w/v) DOC], and 3x with cold ChIP washing buffer II [10 mM Tris-HCl pH 8.0, 250 mM 
LiCl, 2 mM EDTA pH 8.0, 0.5% (v/v) Nonidet P40, 0.5% (w/v) DOC] followed by a final washing step 
with TE buffer [10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0]. 30 µl 4x SDS sample buffer were added 
to the beads (IP) and proteins were eluted by incubating the sample for 10 min at 99°C. 30 µl 4x 
SDS sample buffer were added to the protein pellet of the input (IN) fraction and both the IN and IP 
samples were incubated for 30 min at 99°C to reverse the formaldehyde crosslink. Appropriate 
amounts of the samples were analyzed as described (see sections 5.2.5.6, 5.2.5.7, and 5.2.5.8).  
In the other case, cells were grown in YPD medium at 30°C. Cells from 50 ml liquid culture were 
washed with 1 ml cold H2O, transferred to a 1.5 ml tube, and resuspended in an equal volume of 
cold lysis buffer [20 mM HEPES pH 7.6, 150 mM KAc, 5 mM MgOAc, 2 mM benzamidine, 1 mM 
PMSF]. An equal volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and the 
tube was vigorously shaken in a FastPrep Instrument for 2x 40 sec at 5.5 m/s and 4°C. The tube was 
pierced on the bottom and on the lid with a hot needle and placed in a 15 ml tube to remove the 
glass beads from the cell extract by centrifugation for 2 min at 2000 rpm and 4°C. The cell extract 
was transferred to a 1.5 ml tube and centrifuged again for 15 min at 13000 rpm and 4°C to remove 
cell debris. Protein concentration of the cleared supernatant (WCE) was determined using the 
Bradford assay (Bradford, 1976). Same amounts of WCE (5 mg) were supplemented with 0.5% (v/v) 
Triton X-100 and 0.1% (v/v) Tween 20. Afterwards, cold binding buffer [20 mM HEPES pH 7.6, 
150 mM KAc, 5 mM MgOAc, 2 mM benzamidine, 1 mM PMSF, 0.5% (v/v) Triton X-100, 0.1% (v/v) 
Tween 20] was added to a final volume of 1 ml. 5 µl of the suspension served as an input control, 
whereas the residual suspension was incubated with 100 µl equilibrated IgG magnetic beads for 
2 h at 4°C to enrich Prot.A-tagged proteins. After immunoprecipitation, the beads were washed 3x 
with cold binding buffer followed by a final washing step with TE buffer [10 mM Tris-HCl pH 8.0, 
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1 mM EDTA pH 8.0]. 5 µl 4x SDS sample buffer were added to the input (IN) fraction and 50 µl 4x 
SDS sample buffer were added to the beads (IP). Both the IN and IP samples were incubated for 
5 min at 99°C and appropriate amounts of the samples were analyzed as described (see sections 
5.2.5.6, 5.2.5.7, and 5.2.5.8).  
 
5.2.6.4 Calmodulin affinity precipitation 
Cells were grown in YPD medium at 30°C. Whole cell extract from 10 l liquid culture was prepared 
as described (see section 5.2.5.1.2). Same amounts of WCE (1.2 g) were mixed with an equal volume 
of dilution buffer [20% (v/v) glycerol, 150 mM HEPES pH 7.6, 10 mM MgCl2, 400 mM (NH4)2SO4, 
15 mM β-mercaptoethanol, 2 mM benzamidine, 1 mM PMSF, 600 mM NaCl, 2 mM imidazole, 4 mM 
CaCl2, 0.2% (v/v) Nonidet P40] and incubated with 500 µl equilibrated Calmodulin Affinity Resin for 
2 h at 4°C to enrich TAP-tagged proteins. After affinity precipitation, the beads were washed with 
cold binding buffer [20% (v/v) glycerol, 150 mM HEPES pH 7.6, 10 mM MgCl2, 400 mM (NH4)2SO4, 
10 mM β-mercaptoethanol, 2 mM benzamidine, 1 mM PMSF, 300 mM NaCl, 1 mM imidazole, 2 mM 
CaCl2, 0.1% (v/v) Nonidet P40] and with cold washing buffer [100 mM HEPES pH 7.6, 20 mM NaCl, 
10 mM β-mercaptoethanol, 1 mM imidazole, 0.1% (v/v) Nonidet P40]. Proteins were eluted with 
cold elution buffer [100 mM HEPES pH 7.6, 20 mM NaCl, 10 mM β-mercaptoethanol, 1 mM 
imidazole, 0.1% (v/v) Nonidet P40, 5 mM EGTA pH 8.0].  
 
5.2.6.5 Anion exchange chromatography 
Elution fractions from the calmodulin affinity precipitation were pooled and loaded on a Mono Q 
PC 1.6/5 column using a SMART System. The column was equilibrated with buffer A [5% (v/v) 
glycerol, 20 mM HEPES pH 7.6, 1 mM DTT, 0.5% (v/v) Nonidet P40, 0.1% (v/v) Tween 20] and eluted 
with a linear gradient from 0 M to 1 M NaCl using buffer B [1 M NaCl, 5% (v/v) glycerol, 20 mM 
HEPES pH 7.6, 1 mM DTT, 0.5% (v/v) Nonidet P40, 0.1% (v/v) Tween 20].  
 
5.2.6.6 Gel filtration chromatography 
Elution fractions from the anion exchange chromatography were pooled and a fraction was loaded 
on a Superose 12 PC 3.2/30 column using a SMART System. The column was equilibrated with 
buffer C [200 mM NaCl, 5% (v/v) glycerol, 20 mM HEPES pH 7.6, 1 mM DTT, 0.05% (v/v) Nonidet P40, 
0.05% (v/v) Tween 20].  
 
5.2.6.7 Affinity precipitation of ubiquitylated proteins 
In one case, cells were grown in YPD or YPG medium, respectively, at 30°C and further cultivated 
either in the absence or in the presence of rapamycin. Whole cell extract from 50 ml was prepared 
as described (see section 5.2.5.1.1). Same amounts of WCE (6 mg) were supplemented with 750 mM 
KAc, 0.5% (v/v) Nonidet P40, and 0.05% (v/v) Triton X-100 and cold high-salt extraction buffer 
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[150 mM HEPES pH 7.6, 400 mM (NH4)2SO4, 10 mM MgCl2, 20% (v/v) glycerol, 5 mM 
β-mercaptoethanol, 2 mM benzamidine, 1 mM PMSF] was added to a final volume of 1.2 ml. 12 µl 
of the suspension served as an input control, whereas the residual suspension was incubated either 
with recombinant GST or with recombinant GST-Dsk2p bound to 50 µl equilibrated Glutathione 
Sepharose overnight at 4°C to enrich (poly)ubiquitylated proteins. After affinity precipitation, the 
beads were washed 2x with cold washing buffer [750 mM KAc, 0.5% (v/v) Nonidet P40] and 2x with 
cold 1x PBS. 50 µl 4x SDS sample buffer were added to the beads (IP) and proteins were eluted by 
incubating the sample for 5 min at 99°C. Alternatively, proteins were eluted with cold elution buffer 
[50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mM reduced glutathione]. 5 µl 4x SDS sample buffer were 
added to the input (IN) fraction, to the corresponding flow through (FT) fraction, and to the 
corresponding wash fractions. Appropriate amounts of the samples were analyzed as described 
(see sections 5.2.5.6, 5.2.5.7, and 5.2.5.8).  
In the other case, cells were grown in YPD at 24°C before cells were shifted for 2 h to 37°C and 
further cultivated either in the absence or in the presence of rapamycin. Whole cell extract from 
200 ml liquid culture was prepared as described (see section 5.2.5.1.1). Same amounts of WCE 
(20 mg) were supplemented with 750 mM KAc, 0.5% (v/v) Nonidet P40, and 0.05% (v/v) Triton 
X-100. Afterwards, cold high-salt extraction buffer [150 mM HEPES pH 7.6, 400 mM (NH4)2SO4, 
10 mM MgCl2, 20% (v/v) glycerol, 5 mM β-mercaptoethanol, 2 mM benzamidine, 1 mM PMSF] was 
added to a final volume of 1.2 ml. The suspension was incubated either with recombinant GST or 
with recombinant GST-Dsk2p bound to 50 µl equilibrated Glutathione Sepharose overnight at 4°C 
to enrich (poly)ubiquitylated proteins. After affinity precipitation, the beads were washed 2x with 
cold washing buffer [750 mM KAc, 0.5% (v/v) Nonidet P40] and 2x with cold 1x PBS. 30 µl 4x SDS 
sample buffer were added to the beads (IP) and proteins were eluted by incubating the sample for 
5 min at 99°C. Appropriate amounts of the samples were analyzed as described (see sections 
5.2.5.6, 5.2.5.7, and 5.2.5.8).  
 
5.2.6.8 Live cell imaging 
Treated cells were harvested by centrifugation in 1.5 ml tube for 10 sec at 6000 rpm and RT before 
the cell pellet was washed either with SCD (cells grown in media based on glucose) or SCG (cells 
grown in media based on galactose). Cells were immediately analyzed by fluorescence microscopy.  
Images were captured with an AxioCam MR CCD camera mounted on an Axiovert 200M 
microscope and processed with Axiovision V 4.7.1.0 and Adobe Photoshop CS v.8.0.1.  
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A ampere 
amp ampicillin 
A/C autonomous replication sequence/centromere (single copy) 
ATP adenosin triphosphate 
bp base pair(s) 
CHCA α-cyano-4-hydroxycinnamic acid 
CSM complete supplement mixture 
C-terminal carboxy-terminal 
Da dalton 
DIC differential contrast 
DNA desoxyribonucleic acid 
dNTP desoxyribonucleoside-5'-triphosphate 
ETS external transcribed spacer 
g gram(s) 
gen geneticin 
GFP green fluorescence protein 
GST glutathione S-transferase 
h hour(s) 
HA3 triple hemagglutinin 
hyg hygromycin B 
IN input 
IP immunoprecipitation 
ITS internal transcribed spacer 
k kilo(s) 
kb kilo base pair(s) 
l liter(s) 
LSU large ribosomal subunit 
m milli / meter 
M molar (mol/l) 
MALDI matrix assisted laser desorption/ionization 
min minute(s) 
mRNA messenger RNA 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
n nano 
NTS non-transcribed spacer 
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OD600 optical density at 600 nm 
PAF polymerase associated factor 
H negative decadic logarithm [H+] 
PMF peptide mass fingerprint 
PMSF phenylmethylsulfonyl fluoride 
Prot.A protein A 
rDNA ribosomal DNA 
RNA ribonucleic acid 
rpm rotations per minute 
S sedimentation coefficient 
s/sec second(s) 
Taq thermus aquaticus 
TAP tandem affinity tag 
TOF time of flight 
U unit(s) 
V volt 
v/v volume/volume 
WT wild type 
w/v weight/volume 
YNB yeast nitrogen base 
µ micro 
2µ 2 micron (multi copy) 
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